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Abstract
Development of a computational model is reported, which focuses on aspects of individ-
uality in biological phenomena. Of particular interest are factors related to the immune
response to HIV infection and how these interact within a complex system leading to sig-
nificant variations in latency period. A multi-layered approach is chosen, with the most
crucial layer comprising a large-scale agent-based model lymph network. Agent-cell reci-
procity permits isolation of key features, e.g. cell mobility, viral mutation. Cell mobility,
in particular, is incorporated in an innovative way, due to parallel implementation which
permits realistic size of the lymph network. This implementation, using lymph nodes as
key structural units, also permits inclusion of localised effects, e.g. early infection in the
gastro-intestinal tract, which is increasingly reported as having a decisive impact on long-
term disease progression.
Additional layers of the model provide a foundation for investigation into the phenotypical-
level mechanisms of the immune response implemented in the main layer. The objective
here is to gain insight on how these mechanisms originate from a sub-layer of interactions,
(both genetic and epigenetic). Gene interactions are commonly studied through microar-
ray techniques and generate highly complex dependencies. A validation framework for
such analysis is proposed, and a model of infection-induced epigenetic changes, (within the
agent-based paradigm), is developed.
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Chapter 1
Introduction
1.1 HIV infection progression
Immunity in the human body is obtained through emerging properties of a very complex
system. It involves a multitude of cells and organs, with very specific functions and nu-
merous possible interactions. This complexity often hinders understanding of the range
and variety of immune responses. Large-scale effects are easily observed, and microscopic
studies give a better insight into the sequence of interactions, but links between these two
levels are difficult to establish, in particular if we are looking for a quantitative description.
The situation is pronounced with respect to HIV infection. Mechanisms by which an HIV
virion infects an immune cell, and its genetic material is incorporated into the host chro-
mosome, are known, as are processes leading to production and liberation of new virions.
Macroscopic progression from initial HIV infection to AIDS onset are equally well de-
scribed.
However, there are still millions of people living with HIV (UNAIDS, 2004), and the pro-
cess by which interactions between the immune system and HIV lead to such variability in
individual experience of infection has yet to be fully described. Development of a vaccine
is even further down the road (Garber et al., 2004), although recent therapeutic efforts have
led to better control of disease progression (Sterne et al., 2005).
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To facilitate analysis of this complex system, numerous in silico models have been devel-
oped, (see e.g. Celada and Seiden (1992)). Early efforts suffered from a relative lack of
biomedical data, and from limited computing resources then available. However, a number
of these efforts and of subsequent developments, (see e.g. Pandey et al. (2000); Bernaschi
and Castiglione (2001), were able to match some signatures of HIV, serving as a proof of
concept and ensuring continued interest and ongoing efforts in the field of computational
immunology.
Recent models are, of course, more refined (see e.g. Ruskin and Burns (2006)), employing
more sophisticated approaches and computer resources, and offering valuable insights into
specific aspects of the system, despite their limitations.
1.2 Mechanisms of phenotypical expression
A phenotype is any observable characteristic of an organism, such as biochemical proper-
ties, morphology, behaviour. Immune response to HIV infection is, therefore, a phenotyp-
ical event: it involves interactions between observable physical or biochemical character-
istics of the organism, i.e. immune organs1 and cells2, and the virus. Indications are that
individual variations in the length of the latency period may be attributed to cell-level char-
acteristics, such as cell mobility and viral mutation.
A complex system regulates how the complete set of genes of an organism, the genotype,
is expressed and results in these phenotypical characteristics. In the long term, a better
understanding of this system is needed for a more accurate analysis of the individual char-
acteristics, and their influence.
The all-genetic paradigm introduced in the early days of Genetics has been abandoned: the
phenotype is not a deterministic consequence of the genotype. The first amendment to this
was to consider environmental effects. Recent work has led to the inclusion of another
1This refers to all organs responsible for immunity, from producing cells, (main function of the thymus), to
staging immune response, (main function of the lymph nodes). These organs are detailed in Section 2.1.
2These include lymphocyte lineages, macrophages and other cells involved in the immune response, as
detailed in 2.1.
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parameter in the equation, epigenetic changes: modifications of the chromatin structure,
heritable and leading to altered gene expression. An introduction to this paradigm shift can
be found in Speybroeck (2000).
This aspect has, so far, been neglected in development of in silico biological models at all
levels. Accounting for this in a multi-layered model of the immune system offers great
potential. In the broader context of Computational Biology, this would be a decisive break-
through for a wide range of biological systems, from cancer initiation to neural develop-
ment.
1.3 Objectives and challenges
A model is typically selective, and cannot include all parameters and interactions. The
advent of large-scale, parallel computing, however, offers opportunity for increased re-
finement of biological models. In particular, a better understanding of the events behind
emergence of individuality is of special interest.
Further refinement can be obtained through a multi-layer approach: when a single model
can not include some parameters or interactions, a complementary model may be devel-
oped, which focuses on these specific features. The limited scope of this second model
ensures a more detailed representation of these. Results can then be integrated into the
main model. Such an approach is taken here.
The main layer considers the immune response to HIV at the phenotypical level. If the ba-
sics of the infection and of the immune response are now better understood, (see Chapter 2
for details), it is, nevertheless, still largely unclear how these cell-level events interact with
each other to lead to the HIV-characteristic disease progression.
Most previous modelling efforts, because of limited computing power or implicit modelling
choices, failed to integrate what can be considered a key element of the immune response:
cell mobility. Using a large-scale agent-based model, a key objective is to realistically ac-
count for this.
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Recent research, (see e.g. Mattapallil et al. (2005)), highlights another feature of the body-
wise progression of the disease: there are localised effects, such as those within the gastro-
intestinal tract, that require incorporation into computer-based models. The proposed ap-
proach, using lymph nodes as a key model element, permits inclusion of this layer of the
system.
Since phenotypical characteristics are the results of a complex system, interactions involved
can not be directly included in this large-scale agent-based model and a second layer is,
therefore, required. This layer is divided into two additional models which complement the
main model and focus, respectively, on genetic and epigenetic considerations.
The first one is developed to analyse microarrays. To better understand gene expression3,
microarray technologies are extensively used. Yet, there is no clear consensus on analysis
techniques. Here, through adaptation of optimization techniques to microarray biclustering,
and introduction of properties to assess associated weighting schemes, the objective is to
provide a better framework for elucidation of gene-level interactions. This improves the
value of the information obtained and will, in turn, permit refined parameterisation of the
main model.
The second model focuses on epigenetic mechanisms. Research on Epigenetics is very
active, but quantitative informative is still very sparse. Due to the complexity of the mecha-
nisms involved and their interactions, model development is essential to linking biological
and medical expertise. In that sense, the situation is similar to that of early HIV research,
which focused on phenomenological explanations. Current limitations in available epi-
genetic information implies that a level of refinement similar to that of the agent-based
approach used for the main layer is not a realistic target. What is needed first is, therefore,
a proof of concept for such models, and our objective is to provide this, in the context of
infection-induced epigenetic changes.
3Genes have specific functions. Even though each cell contains the whole genetic material, it only uses a
fraction of this. The others are silenced. These complex dynamics are time dependent and cell-type dependent,
and are referred to as gene expression.
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1.4 Organisation of the thesis
The remainder of this Thesis is arranged as follows. Chapter 2 introduces concepts of im-
munity and immune response, and details the cells and organs involved. This Chapter also
covers mechanisms linked with HIV infection, from virus structure to overall disease pro-
gression. This is intended to provide the reader with sufficient background to appreciate
the motivations and challenges of the proposed model and the levels or layers which are
required in its construction. Finally, this Chapter also provides a brief overview of existing
immune models. This permits identification of limitations that need to be addressed through
any new modelling approach.
Chapter 3 discusses the agent-based paradigm, associated challenges and relevant exam-
ples. It then introduces the approach taken, in particular detailing structure, behaviour and
interactions of all agent types together with simulation procedures.
Chapter 4 focuses on the structures implemented to account for lymph nodes and the lymph
network. Further background on phenomena involved is also provided, as are details on
implementation of cell mobility.
Chapter 5 presents parallelisation efforts. Several strategies are tested and optimised, and
scale-up is assessed through development of a performance simulator.
Chapter 6 details results obtained and evaluates success in addressing the limitations identi-
fied for existing models. It introduces a further model extension, the inclusion of localised
effects in the gastrointestinal tract, and presents some initial results for this.
Further layers are added to the modelling approach, and consider gene expression as an un-
derlying cause for phenotypical-level immune response. In particular, Chapter 7 focuses on
epigenetic changes and their influence on gene expression. A brief background to this new
research field is provided to introduce motivations and challenges. A model of infection-
induced epigenetic perturbation is presented and validated.4
Finally, Chapter 8 summarises of key developments and results, and outlines future work.
4In Appendix A, we focus on microarrays and their use in analysing gene expression. In the interests of
improving the quality of information feeding the central model layer, a novel weighting scheme for microarray
analysis is proposed and evaluated, and a parallel genetic algorithm for biclustering is implemented and tested.
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Chapter 2
Background and related work
2.1 Background on the immune system
2.1.1 Self and non-self: introducing immunity
Etymologically, immunity comes from Latin immunitas, from immunis: exempt from, (in),
performing services, (minus)1. It was first used in the medical sense of “protection from
disease” in the late 1870s (Harper, 2001).
In this particular context, immunity can be defined as a function of all mechanisms which
permit the body to recognise entities belonging to its system, (which consequently it tol-
erates), and those that do not, (which it fights). There are many layers of complexity and
response in the system, involving a number of entities and interactions. This poses a clear
challenge to computer-based modelling, (as outlined e.g. in Forrest and Hofmeyr (2001)).
In this Section, we introduce the cells and organs involved in the immune system.
2.1.2 Organs and cells of the immune system
Central lymphoid organs are the birth place of the immune system. There is where lym-
phopoiesis2 takes place. Lymphoblasts are formed in the bone marrow, by differentiation,
1minus, “service performed for the community, duty, work”.
2Lymphopoiesis: generation of lymphocytes. Details of cells and precursors can be found in the glossary.
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from precursor hemocytoblasts. These are immature cells, from which prolymphocytes,
direct precursors of lymphocytes, are derived. The last development step, from prolym-
phocyte to lymphocyte, can take place in two different locations, which will decide the final
role of the cells: the prolymphocytes maturing in the bone marrow itself become B lympho-
cytes, while those maturing in the thymus become T lymphocytes (Potmesil and Goldfeder,
1973).
Once matured, lymphocytes are released into the blood circulation and migrate to peripheral
lymphoid organs and tissues. These, primarily, are lymph nodes, but include also spleen and
MALT, (Mucosa-associated lymphoid tissue), (Wiedle et al., 2001). Their associated net-
work allows interactions between immune cells. While involved in cell renewal, (through
cell divisions initiated after antigen recognition during immune responses), the main func-
tion of lymph nodes is to amplify immune responses.
At the cell-level, four populations are particularly important:
• T lymphocytes are divided in two families. CD4 T cells, or helper T cells (Th),
coordinate the immune response. Two sub-types, Th1 and Th2, are in charge of
the cell-mediated and antibody-mediated responses, respectively. CD8 T cells, or
cytotoxic T cells (Tc) are “effector cells” of the cell-mediated response, (detailed
below).
• B lymphocytes are effector cells of the antibody-mediated response. Their response
can be initiated by activated CD4 cells, (often referred to as CD4+ cells), but, contrary
to CD8 cells, they can also directly recognise antigens. B lymphocytes display these
antigens at their surface, making them antigen presenting cells.
• Natural killer, (NK), cells can have a direct cytotoxic action on abnormal cells, e.g.
cancer cells or virus-infected cells. They form the major component of the innate
immune system.
• Antigen-presenting cells, (APC), are all cells that can present antigens at their surface
and which can, therefore, activate CD4 cells. These include B lymphocytes, but also
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dendritic cells, macrophages3, endothelium cells, (from the inner surface of blood
vessels), and epithelium cells, (from cavities and surfaces of structures throughout
the body, e.g. lungs, gastrointestinal tract, reproductive and urinary tracts).
Cells and associated functions can also be found in the glossary, for later reference.
2.1.3 Types of immune response
2.1.3.1 Innate immune response
When a foreign element is identified as a threat, it can be dealt with in two different
ways: i.e. immune response can be specific or non-specific. A non-specific, or innate,
response is based upon recognition of the pattern of the microbial surface components of
the pathogens4, rather than by a specific antigenic sequence (Levy, 1990). Innate response
does not confer long-lasting immunity to the host, i.e. there is no memory of previous re-
sponses.
Major functions of the vertebrate innate immune system include:
• Recruiting immune cells to infection sites. This is achieved using cytokines5.
• Identifying bacteria, activating cells and enhancing clearance of antibody complexes,
through complement cascade (Barnes and Weiss, 2003; Sacks et al., 2003).
• Initiating the adaptive immune system, through antigen presentation to cells regulat-
ing the immune response (Martin and Carrington, 2005).
2.1.3.2 Antigen-specific immune response
In contrast to the innate response, the specific, or adaptive, immune response is based on
the accurate recognition of foreign non-self antigens. As seen above, recognition involves
3Macrophages are a type of white blood cell that ingests foreign material. In that sense, they are involved
in the non-specific immune response. They are also involved in the specific immune response: they carry the
antigen on their surface and present it to a T cells.
4A pathogen is a biological agent which causes disease or illness to its host.
5Cytokines are a category of diverse signalling proteins and glycoproteins, which are essential to cellular
communication. Other categories of signalling proteins include hormones and neurotransmitters.
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innate response cells as intermediaries, and a weakened innate response may, therefore,
lead to a delay in initiation of antigen-specific response. This is, for instance, observed
for neonates6, leading to higher susceptibility to pulmonary bacterial and viral infections
(Garvy, 2003).
Antigen-specific response has two arms, namely cell-mediated and antibody-mediated re-
sponses. The latter, also known as the humoral response, features B lymphocytes as effector
cells, and mainly targets bacterial attacks. Humoral response is characterised by produc-
tion, by these cells, neutralizing antibodies, following activation by CD4+ T helper cells
through release of interleukin IL-4 (Howard and Paul, 1982).
Cell-mediated response is targeted more specifically at viral attacks and takes place in
lymph nodes. It is, therefore, the main focus of this work. Cell-mediated response involves,
(Kaufmann, 1999; Pathak and Palan, 2005):
• Activation of antigen-specific cytotoxic, (CD8), T lymphocytes, which induce apop-
tosis in body cells displaying epitopes7 of foreign antigen on their surface, (e.g. virus-
infected cells, or cancer cells displaying tumor antigens);
• Activation of macrophages and natural killer cells, which then destroy intracellular
pathogens;
• Secretion of a variety of cytokines that enhance function of other cells involved in
adaptive immune responses and innate immune responses. This is the role of CD4+
T helper cells.
Prevalent in the fight against HIV are CD8+ T cells. This particular response involves
three steps. Antigen Presenting Cells (APC) acquire foreign biological entities and start
presenting these antigens at their surface. These encounter CD4 lymphocytes which will
self-activate and multiply, if designed to recognise the given antigen. These, in turn, activate
specific CD8 cells, which will multiply and then target infected cells.
6A human infant less than four weeks old.
7An epitope is a protein site which is recognised by the immune system, (specifically by antibodies, B
cells, or T cells). For simplicity, an epitope can be considered as the 3D surface features of a molecule. These
“shapes” fit precisely and thus bind to specific antibodies. Epitopes are also known as antigenic determinants.
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2.2 Mechanisms linked with HIV infection
2.2.1 HIV is a retrovirus
HIV belongs to a very particular viral family, Retroviridae. Traditionally, in biological
processes, DNA is transcripted as RNA, which is then used as an intermediary for protein
production. This is known as the central dogma of molecular biology (Crick, 1970). The
defining feature of these retroviruses is that they use the opposite process: they possess an
RNA genome and replicate using a DNA intermediate, (called a provirus). This reverse
transcription is performed using an enzyme8, reverse transcriptase9, and a second enzyme
integrates the obtained DNA into the host’s genome10. These transfers of biological infor-
mation are shown in Figure 2.1.
Original classification of retroviruses is based on their pathogenicity and include oncoviruses11,
spumaviruses12 and lentiviruses13, which are characterised by the slow progression of the
infections they induce. HIV belongs to this sub-family.
2.2.2 Structure and genome
As with other retroviruses, HIV has two copies of its RNA genome. This genome con-
tains nine genes, with three of them, (gag, pol and env), characteristic of all retroviruses,
and containing information needed to make the structural proteins for new virus particles
(Lever, 2005). The other genes e.g. control transcription activation (tat), counteract the
antiretroviral defenses of the host cell (vif ), or enhance virus release (vpu) (Sierra et al.,
8Enzymes are molecules which increase the rates of chemical reactions. This is referred to as a catalytic
action.
9A reverse transcriptase is an enzyme which transcribes single-stranded RNA into double-stranded DNA.
This process is the reverse of the normal transcription, which corresponds to the synthesis of RNA from DNA.
These enzymes are also known as RNA-dependent DNA polymerases.
10The genome of any living organism is its whole hereditary information. It is encoded in the DNA or, for
some viruses such as HIV, the RNA.
11Oncoviruses are the largest sub-family of retroviruses. They can induce several types of tumours, e.g
carcinoma, lymphoma and leukemia. They have been isolated in humans as early as 1980s, (see e.g. Rho et al.
(1981)).
12Spumaviruses, also known as foamy viruses, are non-pathogens. They are mainly prevalent in non-human
primates, and were first described in the early 1950s. They are easily isolated, thanks to the characteristic
foam-like effect they induce (Delelis et al., 2004).
13Lentiviruses are cytopathogens and are responsible for slow-progression infections, hence their name.
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D N A R N A
P r o t e i n
Figure 2.1: Information flow in biological systems.
Plain lines represent general transfers, (occuring normally in most cells), and dotted lines represent
special transfers (known to occur, but only under specific conditions, e.g. some viruses or during in
vitro experiments). For retroviruses, transfer of information from RNA to DNA is occurring.
2005). This genome is enclosed by a conical capsid, which is surrounded by a matrix, in
turn surrounded by a viral envelope.
An important glycoprotein complex is embedded into this viral envelope. It is made of six
glycoprotein (gp) molecules, (three gp120 and three gp41), and enables virus attachment
and fusion with target cells (Chan et al., 1997). This complex clearly appears in Figure 2.2,
which shows the overall structure of the virus.
2.2.3 From cell infection to release of new virions
A complex sequence of mechanisms are involved, from the infection of an immune to the
release of new virions. This is summarised in Figure 2.3, (p.14). These mechanisms have
been studied in detail, (see e.g. Wyatt and Sodroski (1998)), so we focus, in what follows,
only on essential points.
The first step in infection of macrophages or CD4+ T cells is high-affinity attachment of the
CD4 binding domains of their surface glycoprotein gp120 to CD4 receptors. This is fol-
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Figure 2.2: Structure of HIV virus (adapted from a public-domain image from the National
Institute of Health, USA)
lowed by interactions between chemokine14 binding domains of gp120 and the chemokine
receptors of the target cell. It must be noted that, even though the prime target for HIV
infection is CD4 cells, HIV can also infect dendritic cells using other specific receptors
such as DC-SIGN (Wyatt and Sodroski, 2001). This alternative route is believed to play an
important role in early stage of infection (Pohlmann et al., 2001). Even though the binding
process is different, subsequent steps in cell infection are similar.
The viral envelope and cell membrane are fused. This allows release of viral capsid into
the cell. Viral RNA and essential enzymes, e.g. reverse transcriptase, are then transferred
into the cell, and RNA is transcribed into double-strand DNA. Finally, This DNA material
is then integrated into the cell genome.
This reverse transcription is a fast process, (generation of 109 to 1010 virions every day), but
this high rate leads to many transcription errors, i.e. mutations, (approximately 3 × 10−5
per nucleotide base per cycle of replication), (Robertson et al., 1995). New variants are
created every day in any individual patient.
14Chemokines are a family of small cytokines. They induce directed chemotaxis, (innate movement), in
nearby cells, hence their name.
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It is evident, therefore, that HIV has a very high genetic variability. It is categorised by
two species, HIV-1 and HIV-2, where the latter is both less virulent and less transmittable
(Reeves and Doms, 2002), but the former is responsible for much of the global infection
and attracts most research effort. In the remainder of this Thesis, unless stated otherwise,
use of “HIV” refers to HIV-1.
Newly integrated viral DNA remains dormant. Active production of new virions only starts
in the presence of certain transcription factors. Ironically, these factors are upregulated
when cells are activated, (Nabel and Baltimore, 1987), so that virus production is increased,
and the infection progress catalysed, by the immune response resisting it.
Viral RNA is produced in small sections, which are then assembled (Wu and Marsh, 2003).
This leads to the production of large polyproteins, which are cleaved into smaller structural
proteins, which assemble near the cell inner membrane and form a bud, subsequently re-
leased from the cell (Cimarelli and Darlix, 2002). Maturation, (i.e. obtention of functional
proteins and enzymes), can take place either in the forming bud, or after the virion is re-
leased from the cell, (see e.g. Ohagen et al. (1997)). Once mature, a virion is then able to
infect a new cell.
2.2.4 Progression of infection
Macroscopic evolution of the disease is divided into three phases, starting with acute HIV
infection. This is characterised by rapid viral replication and high presence of virus in
the peripheral blood. This results in massive activation of CD8+ T cells, which target and
destroyed HIV-infected cells. The development of HIV-specific immune responses, and
“consumption” of available targets, by the virus, result, within a few weeks, in peak and
decline of the viral population (Derdeyn and Silvestri, 2005; and references therein). The
virus is not eliminated though, and has been widely disseminated, and seeded in lymphoid
organs, (because of high target cell concentration in those regions).
Once most original strains are eradicated, the importance of the mutation rate becomes
critical. It allows appearance of new strains, which have not been detected by the organ-
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Figure 2.3: Cycle of HIV infection
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ism yet, and can therefore develop freely. As soon as a strain becomes too intrusive, its
detection probability increases and it is eradicated, but in the meantime, new strains have
again emerged. During this second phase, there are no visible symptoms. This is known,
(somewhat erroneously), as the latency period, and can last several years. The immune
system is heavily loaded, and a state of chronic, generalized immune activation develops.
This, added to the fact that destruction of a strain implies destruction of all cells it infected,
leads to T-cell depletion (Hazenberg et al., 2000).
Once CD4+ T cell count declines below a critical level, (typically defined to be between 200
and 400 cells/mm3, see e.g. MacDonell et al. (1990)), the cell-mediated immune response
can no longer be initiated, and a variety of opportunistic diseases occur, signatures of full-
blown AIDS, (acquired immunodeficiency syndrome), ultimately leading to the death of
the patient.
2.3 Mathematical and computational models: historical
2.3.1 A complex biological system
The immune system is both a complex and adaptive system. Not only does it involve vari-
ous cells and organs, and interactions between these, but its behaviour can also evolve over
time, changing and learning from experience, through memory of past immune responses.
Complex adaptive systems are encountered everywhere, including other biological systems
such as RNA folding (Ndifon, 2005), but also in social systems (Janssen and Ostrom, 2006),
ecosystems (Horwitz and Wilcox, 2005), manufacturing (McCarthy and Tan, 2000), and fi-
nancial analysis (Sharkasi et al., 2006; Thurner and Biely, 2007), among may others. Key
principles of complex adaptive systems are emergence and self-organisation.
Emergence refers to patterns of system evolution which arise from an abundance of simple,
low-level, interactions (Crutchfield, 1994). (In the context of the immune system, this is
particularly relevant, as the response is obtained from the multiplicity of cell interactions
throughout the body.)
15
Self-organisation refers to increased complexity obtained without intervention from an out-
side source (Goertzel, 1992). (Again, this defines both the infection mechanisms of HIV
and the immune response to these.)
Given these properties, complex adaptive systems are often difficult to describe fully. In
particular, defining the contribution and importance of low-level unsupervised interactions
to the overall evolution process is far from trivial. Consequently, several models are pro-
posed in what follows. Concepts and approaches are detailed, with a particular focus on
immune models.
2.3.2 Bottom-up vs. top-down design
2.3.2.1 Concepts
Two categories of complex system modelling are discussed, top-down and bottom-up de-
signs (Bohringer and Rutherford, 2008).
The main concept of a top-down design is to break down a system into several compo-
nents, which are expected to be easier to manipulate and understand. The overall system
is formulated and specified, but without going into details of its parts. In an iterative pro-
cess, each component is then defined in more detail and, if necessary, split into lower-level
subsystems. This process, repeated until entire specification is obtained for base elements,
involves use of black boxes which facilitate model development, but may also hinder model
validation if they fail to elucidate elementary mechanisms of the system studied.
In a bottom-up approach, individual base components are detailed and designed, and then
linked together. These form more complex systems, which are again linked, in an iterative
process, and the top-level model increasingly emerges. This approach is, therefore, particu-
larly suited to complex adaptive systems, which in their structure already show emergence
and self-organisation.
The remainder of this Section considers several examples of these two approaches, grouped
in three families: mathematical, shape-space, and agent-based models.
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2.3.2.2 Mathematical models
In the context of HIV research, mathematical models were first introduced to study the epi-
demiological aspect of the infection, (i.e. spread in a human population).
This early focus was motivated by the need to understand dynamics of the infection and
population threat, but also by a lack of detailed biological information, which ruled out
models of pathogenesis. Although data even on spread of HIV were sparse, models were
developed, which focused on specific “at risk” groups, e.g. early work by Anderson (1988).
More accurate medical information and improved computing resources have now led to
considerably more advanced epidemiological models, e.g. Naresh et al. (2006).
In the context of this research, the mathematics of pathogenesis are directly relevant. Mod-
els using differential equations, (DE), to reproduce variations of cell counts and viral loads
appeared in the late 1990s, (see e.g. Perelson and Nelson (1999)) and are typical of top-
down designs. These have been refined for each count variation by detailing different DEs
to account for viral production, and drug therapies such as RT inhibitors or protease in-
hibitors. An equation describing the rate of change of infected CD4+ T cells (T ∗), for
instance, would have the following structure:
dT ∗(t)
dt
= (1− rt)kT0Vi(t)− δT ∗(t) (2.1)
This corresponds to the virus infecting CD4+ cells at a constant rate k, less the currently
infected CD4+ cells, which die at constant rate δ.
These models, however, can not currently cover the whole infection progression, and each
focuses on either long-term, mid-term, or short-term variations.
2.3.2.3 Shape-space models
Immunological models based on the shape-space paradigm were first introduced as a means
to account for dynamics of antibody-antigen bindings (Perelson and Oster, 1979).
The main concept of this bottom-up approach is to represent each clonotype by N integer
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parameters and, therefore, to consider clonotypes as points in anN -dimensional Euclidiean
space. In that shape space, (space of clonotypes), two cells sharing the same clonotype
are located on the same point. Each cytotoxic lymphocyte clonotype c is surrounded by
a sphere of radius r. To any antigen a within this sphere is applied a clearance pressure
inversely proportional to the distance between a and c in the shape space.
Technical considerations such as adequate values for N are still subject to intense discus-
sion, which will not be detailed here, in order to avoid a digression which does not focus
primarly on models of interest. Several papers include models with N ∈ [1, 5], (see e.g.
Papa and Tsallis (1996)), while on rare occasions others imposeN ≥ 20, (see e.g. Carneiro
and Stewart (1994)), but no clear consensus emerges.
The most recent and interesting examples take the shape-space paradigm further. These
include considerations of real space, and formation of hybrid models (Burns and Ruskin,
2004; Ruskin and Burns, 2005; 2006). The focus is on emergent principles of CD8 cell
clonotype repertoire and its distribution and differentiation, with emphasis on systemic self-
organisation, (for which the shape space paradigm is particularly suited). Here, clonotypes
and viral epitopes are represented as nodes in a two-dimensional network space, and edges
between nodes again model the affinity and clearance pressure applied to the APC which
bears the target epitope. Hybridisation of shape space is obtained through use of a stochas-
tic model of the lymph system as stimulus to the network shape space model. Emergent
topology obtained from this model resulted in introduction of a theoretical network archi-
tecture for immune system shape space. It includes α and β nodes: the latter correspond to
CD8 cells that act only against the antigen, which stimulated its activation, while the former
represent those which also effect clearance pressure on subsequent APCs. The argument
outlined suggested that disruption (or suppression) of α nodes results in a signicantly de-
graded pathogen clearance, compared to β node disruption. This was proposed as a possible
cause of individual variations in the latency period.
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2.3.2.4 Cellular Automata and Agent-based models
The Cellular Automata, (CA), paradigm is another popular example of bottom-up model
design. Even though the concept was introduced in the 1940s, (through the work of Ulam
and von Neumann), the paradigm gained large popularity only in the 1970s, with the in-
troduction of a two-state, two-dimensional cellular automaton, Conway’s “Game of Life”
(Gardner, 1970). On a 2D grid, cells have eight neighbours, and two possible states, live or
dead. At each time step, cells are updating using simple defined rules, e.g. a live cell with
fewer than two live neighbours dies, while a live cell with more than three live neighbours
dies.
The popularity of this interpretation of the paradigm can be attributed to its obvious anal-
ogy with living systems, (e.g. rules which embody death by overcrowding or competition),
but also to this CA being a perfect and simple illustration of concepts of emergence and
self-organisation. Pattern evolution in this CA is well documented, with example entities
such as blocks, gliders and pulsars (Berlekamp et al., 2004).
More realistically, when including more than two possible states, Cellular Automata provide
a powerful modelling paradigm. Since the early efforts of e.g. Celada and Seiden (1992);
Seiden and Celada (1992), CA have been widely used to investigate immune events, and
several models in particular provide useful insights into some aspects of the immune re-
sponse to HIV infection.
CA-based immune models outlined the importance of viral mutation on dynamics of im-
mune cell population (Mannion et al., 2000; Pandey et al., 2000; Mannion et al., 2002;
Ruskin et al., 2002). A threshold value was identified, under which steady-state density of
immune cells is larger than that of the virus, (i.e. dominant to deficient phase transition).
These authors also provided one of the rare attempts to account for cell mobility and, sub-
sequently, variable viral load.
Another CA model focused on latency period and treatment solutions (Benyoussef et al.,
2003). Combining a mean field approximation method and CA simulations, these authors
reproduced the three-phase evolution of HIV infection and identified a threshold for treat-
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ment, (a combination of protease inhibitors and RT inhibitors), above which virus load de-
creases over time. They also indicated that such treatment would need to continue for years
even if viral load falls under detectable limits, (this is, we think, a direct consequence of
blood samples not being an accurate reflection of disease progression within lymph nodes).
The agent-based paradigm can be considered as an extension of the CA approach, but pre-
vious agent-based models of immune events have been limited in implementation. A brief
review follows.
An early example of such models, (Bernaschi and Castiglione, 2001; Castiglione et al.,
2004; Baldazzi et al., 2006), is, in strict terms, closer to a CA than to an agent-based model,
but the authors themselves use both terms, and it is more important to focus, here, on im-
plemented features rather than terminology. The authors main objective is development of
a simulator including features introduced in the Celada-Seiden model, (IMMSIM), but with
various refinements, particularly in terms of performance and fidelity to the real immune
system. Implemented entities include CD4 and CD8 T cells, B cells, macrophages and
dendritic cells. These interact, based on location in a 2D or 3D lattice, and according to an
affinity function that depends on values of bit strings representing their respective binding
sites, (e.g. lymphocyte receptors, or class I and II major histocompatibility complexes15).
Interactions lead to changes of internal state. The time step for these simulations is eight
hours. This approach successfully reproduced the three-phase disease progression.
Another successful attempt at reproducing typical HIV progression was recently proposed
(Zhang et al., 2005). Here, types of agents are limited to T cells and HIV virions, with the
objectives of simulating large populations, (hence the term “massively multi-agent”), and
improving detail on aspects such as immune memory and HIV sequence representation.
The former objective is achieved through introduction of a global memory repertory, which
is empty when simulation starts and which subsequently stores all HIV genomes that have
15There are two primary classes of major histocompatibility complex molecules, MHC class I and MHC class
II. MHC class I molecules are found on almost every nucleated cell of the body. They present antigen fragments
to cytotoxic T-cells and bind to the CD8 receptor on these cells. MHC class II molecules are found only on
antigen-presenting cells. They present antigen fragments to T-helper cells by binding to the CD4 receptor on
these cells. In humans, these MHC molecules are sometimes referred to as human leukocyte antigen (HLA)
molecules.
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been recognized and were targeted by immune responses. The latter objective is achieved
by introduction of finite-size binary arrays, which each represent a viral strain, a measure
of similarity between these arrays, (based on Hamming distance), and a “recognition prob-
ability” as a function of this similarity.
2.4 Limitations and proposed focus
2.4.1 General considerations
Models of HIV progression have been developed for the last twenty years, with some suc-
cesses reported, as detailed above. There are, however, a number of limitations that need be
addressed in order to improve realism with respect to the biological system modelled.
A major limitation of top-down models, especially mathematical ones, is that ability to deal
with subsystems small enough to be informative on the interactions involved is crucial in
the context of HIV progression. Immune response typically is bottom-up, and these models
may not, therefore, be the most suited to describe it.
The shape-space paradigm is very elegant, and hybrid models based on this provide new
insight into self-organisation of the immune response. It is, however, sometimes difficult
to explain observed emergent features in biological terms (Burns, 2005). This may be at-
tributed to the fact that such models, even though bottom-up, can rarely achieve sufficient
refinement of the individual base components. Extensions proposed to current models may
improve this situation (Burns, 2005).
CA and agent-based design seem well-suited to the nature of the biological system being
considered and recent biomedical studies, involving direct tracking of HIV viral genotypes
in local microenvironments, provide further validation for these approaches, (e.g. infected
cells releasing virions will only induce infection of local targets (Cheynier et al., 1994)). It
seems evident that local interactions and cell densities are more important to disease pro-
gression and experience than overall cell counts in the body (Grossman et al., 1998). As a
bottom-up approach, the agent-based paradigm offers the best prospects for detailed local
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solutions and has been adopted for the work of this Thesis.
2.4.2 Advancing the agent-based approach: limitations and improvements
Balance between diversity and population size
Inherent to any agent-based approach is choice of agent types, where several permit im-
proved tuning of the model to the observed system. It is particularly relevant in the context
of immune responses, as several lineages of cells are involved. However, there is a balance
to be achieved between the range of agent types and size of their populations, due to the
computational cost involved. This is important in the immune context, as overall behaviour
emerges from a very large number of interactions, (involving many cells). It is not clear
that sufficiently large cell populations have hitherto been modelled. The theoretical limit in
Bernaschi and Castiglione (2001) is not explicitly specified, but appears to be of the order
of two million, and it is debatable whether this is enough to account for HIV progression
and complex evolution through the whole body.
Lymph nodes modelling
Another essential aspect is that of spatial location of immune response elements. Most of
the immune response to HIV is taking place in the lymph nodes, as opposed to within circu-
lating blood, but no clear modelling approach has been explicitly described for this. There
are indications, in Baldazzi et al. (2006), that overall structure is recognised as important,
but implementation remains vague and no report of validation tests could be found at the
time of writing. Any novel agent-based approach needs to explicitly account for lymph
nodes and, specifically, the lymph network in order to gain insight on the importance of cell
mobility16. The proposed model is, therefore, organised as shown in Figure 2.4.
16Such compartmentalised approaches were also considered in the context of HIV epidemics, (see e.g. Ball
et al. (1997) who considered transmission through a network whose nodes are families, which are assigned
higher individual-to-individual transmission probabilities). The main difference, however, is that distant infec-
tion from a lymph node to another is not possible: physical contact between the cells is needed, and the force
of the infection can not be directed. Their results, therefore, are not directly relevant to our study.
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Figure 2.4: Overall structure of the lymph network model
The model is based on an explicit lymph node model. This key unit is used to locate the agents
and implement their interactions. Low-level biomedical information, (e.g. microscopic interactions
detailed above), are used to design both model levels. High-level information, (e.g. structure of the
lymph chains), is also used for the lymph network model. The overall model produces high-level
data, such as cell counts.
Temporal granularity
The proposed structure in Baldazzi et al. (2006), although non-specific, could provide a so-
lution basis, as it includes vessels between lymph nodes, but the long eight-hour time step
of the associated simulations seems unrealistic, especially in the context of a bottom-up de-
sign and need for detailed modelling of cell-level interactions. The temporal granularity is
not refined enough to account for cells passing through these vessels, (which occurs within
minutes), so that the context for inclusion does not add to realism of the model. Small time
steps are required, even though this adds to the overhead on code in order to increase com-
putational efficiency.
These two conditions, (explicit structure for the lymph network, and high granularity), per-
mit accurate implementation of cell mobility, which is an essential aspect of immune re-
sponse, as activation involves not only affinity between epitopes, but also physical contact.
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Immune memory, and antigen recognition
Memory of previous responses is also important, (see Zhang et al. (2005)), but the imple-
mentation here is slightly counter-intuitive, and features a centralised control. Memory at
cell-level is potentially more useful in light of the role of localised interactions.
A common feature of the most advanced models is incorporation of viral mutation. This is
core to viral model success but consideration of variable properties, (e.g. to account for less
stable strains, or for those with higher probability of successful infection), is also important
for sophisticated model development.
Finally, current implementations for antigen recognition are based on lock-and-key or on
naive distances, and response is binary: there is complete recognition, or no recognition at
all. This contradicts recent immunological understanding (Brehm et al., 2002), and requires
explicit improvement in any newly-proposed model.
Localised effects
Including all these new features requires extensive code optimization, and parallel imple-
mentation, and the costs are, additionally, a longer development process and additional
tests. The gains, however, are significant. The objective is a model which permits large-
scale simulations and inclusion of layered, localised, effects, such as those found recently
for the gastro-intestinal tract, (see Chapter 6), and which accounts for multiple facets of the
biological immune response.
2.5 Chapter summary
In this Chapter, an overview of essential entities and mechanisms, associated with immune
responses and HIV disease progression, was presented, together with a brief review of pre-
vious efforts to model this complex adaptive system.
In our view, the agent-based paradigm is most suited to describe the way in which complex
combination of cell-level interactions create individual variations in length of the latency
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period, but challenges linked with this approach have been highlighted. They include mod-
elling choices at all levels of implementation, from cell level, (i.e. decentralised immune
memory, refined antigen recognition) to organ level, (i.e. explicit lymph node implemen-
tation, inclusion of localised effects), and simulation strategies, (balance between agent
diversity and population sizes, refined temporal granularity).
Any new model will need to address these issues in order to gain further insight into the
biological system. The following Chapter describes how the local model structure can be
part of the solution to gaining key insight into the overall biological system behaviour.
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Chapter 3
Basis of the agent-based structure
3.1 Concept of agent-based models
3.1.1 Agents and agent-based formalism
An agent-based model is a model in which the key abstraction elements are agents with
both spatial and temporal positioning. The generally-accepted properties for an intelligent
agent, there being no unique definition, are given by Wooldridge and Jennings (1995):
• Autonomy: it can act without any intervention and has some control over its actions
and its internal state.
• Social behaviour: it can interact with other agents through a specific language.
• Reactivity: it can scan part of its environment and change its behaviour to take ad-
vantage of it.
• Proactivity: it not only reacts to its environment but also acts and takes initiatives, to
satisfy identified goals.
It is theoretically possible, though counter-intuitive, to design an agent-based approach and
implement it without explicit references to agent-like entities in the code. In practice, effi-
cient realisation of the agent-based paradigm requires both.
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Advantages of the approach include modelling efficiency, robustness, interoperability be-
tween existing systems, and reasonably intuitive solving of problems for which data, ex-
pertise and control are distributed Jennings et al. (1998). The approach is this particularly
useful in the context of Natural Sciences, as it permits reciprocity between agents and bi-
ological entities as well as between interactions of the real system and exchanges between
agents.
3.1.2 Agents, environment: coordination and challenges
Communication modes
Each agent has limited access only to information about the environment it evolves within,
and agent sociability, therefore, is a crucial aspect of abstraction. Agents can communicate
in several modes, as detailed in Chaib-Draa and Dignum (2002) and summarised, for con-
venience, in Table 3.1. Not all systems involve the complete set of communication modes,
but all modes used in a given system must be identified and explicitly managed.
Communication mode Definition
Representative Providing information on a state
Directive Commanding or asking the recipient to perform an action
Commissive Leading the agent to commit itself to performing an action
Expressive Defining a “psychological” state
Declarative Adding something to the environment
Permissive Granting permission for an action
Prohibitive Opposing an action
Table 3.1: Agents can communicate in several modes
Cooperation vs. competition
Excluding very rare exceptions, an agent always shares its environment with other agents.
It is, therefore, necessary to coordinate all actions of the multitude of agents. Of course,
coordination does not imply cooperation. Cooperation is unnecessary: an agent may op-
pose another in the sense that advantage may be taken to coordinate actions in response to
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a competitor’s decision. Reciprocity is also not implied as a decision, affecting e.g. move-
ment to a proximate location, need not be influenced by an agent already in that location.
In any coordination strategy, the size of the agent population is fundamental and, if every
agent can mutually interact, the number of interaction pairs increases quadratically with the
population size. If interaction can occur between several agents, the coordination overhead
increases exponentially and soon challenges available computing facilities (Durfee, 2001).
Even on recent, large-scale computing resource, developing a coordination strategy is there-
fore both essential and non-trivial, and avoidance of conflicts and blocks is often as much
as can be managed. As already noted, the main drawback of the agent-based approach is
the fact that it is resource-greedy; for this reason, parallelism is desirable, (Chapter 5).
Other challenges
Several challenges exist, (see e.g. Bond and Gasser (1988); Franklin and Graesser (1997);
Iglesias et al. (1997); Sycara (1998); Chaib-Draa et al. (2001)). In particular, formula-
tion, description and decomposition of problems are non-trivial. This is common to most
bottom-up approaches. Analysis is, similarly, not evident, and requires, where possible, the
elimination from the global system of chaotic or oscillatory behaviour.
Even on parallel implementations, resource allocation is challenging, especially when deal-
ing with a large agent population. In particular, when some resources are limited, sensible
allocation of these is required. For instance, a balance between a local treatment by a single
agent and a solution involving several agents, (and, therefore, communication), must be
achieved.
Finally, agent sociability is also non-trivial in most cases. Each agent must be able to rep-
resent its actions and reflect on them, but also to communicate on these with other agents.
This implies possible conflictual intents and divergent points of view, which must be man-
aged during the coordination of agents. Similarly, each local decision an agent takes has
global implications. Damaging interactions must be identified and deleted.
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3.1.3 Examples
Agent-based models implementing several agents are referred to as multi-agent systems.
These systems provide a generic framework for model development and have been widely
applied. A brief review follows.
One of the earliest, and most productive applications was air traffic scheduling. In the
model proposed, (Cammarata et al., 1983), each agent represents a flight and the objective
of each agent is to build a flight plan which maintains a minimum security distance with
neighbouring planes, but also satisfies a number of additional constraints such as minimiz-
ing fuel consumption. In cases of conflict, (e.g. of flight plans), one selected agent acts as a
central negotiator to determine new options for each agent. This agent is chosen based on
a set criteria such as best informed agent, or agent with smallest number of constraints. A
related problem, dealing with optimum service to the public under constraints, (e.g. mainte-
nance and crew requirements), was solved using an agent-based approach (Langerman and
Ehlers, 1997), with agents representing origin and destination airports, and interacting for
resources.
As an illustration of application in the public sector, GUARDIAN was developed to solve
structural issues in the context of an intensive care unit (Hayes-Roth et al., 1989). Here,
unit structure is based on information exchange between experts in their own field who col-
laborate with the common objective of deliver efficient patient care. GUARDIAN imple-
mentation is based on three types of agents; perception/action agents; organisation/decision
taking agents; high-level system control, (performed by a single agent).
In DVMT (Distributed Vehicle Monitoring Task), the paradigm is applied to a radically dif-
ferent field: agents are scattered over geographic areas, which they monitor (Durfee, 1998).
Over regular time steps, each agent detects the characteristic noise emitted by vehicles.
Based on this, it draws a description of vehicle movements throughout its allocated area.
Communication between agents is then used to increase reliability and prevent redundancy
of information in areas monitored by multiple agents. Communication is implemented us-
ing a blackboard.
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Agent-based programming can also be used to control robots (Mizoguchi et al., 1999). Ac-
tions require high refinement of communication, negotiation, collaboration, decision-taking
and execution, as robots interact both with each others and with humans.
Finally, while these examples are developed ab initio, there are several development envi-
ronments which can be used for agent-based models, such as Swarm (Minar et al., 1996),
Cougaar (Helsinger et al., 2004) or JAMES (Uhrmacher et al., 2000). The latter, for in-
stance, is a Java-based framework aimed at modelling and simulation, and permits creation
of mobile agents. These development solutions are not suitable in the context of this study,
which demands a very large agent population, with extensive optimization requirements at
every level of implementation.
From the few examples above, (the list is not intended to be exhaustive), it is evident that
the agent-based paradigm is a versatile approach. In the next Section, details are given on
applying this efficiently to immune modelling.
3.2 Model structure
3.2.1 Modelling approach
Object-oriented modelling techniques describe a system by identifying key object classes
in an application domain and by specifying their behaviour and their relations with other
classes. Essential details of a system are, therefore, traditionally reported using an object
model1, a dynamic model2, and a functional model3.
The proposed model of the immune system is implemented using C++, and could be de-
scribed using models of all three types. In the context of agent-based systems, a more effi-
cient specification technique operates on levels of abstraction (Kinny and Georgeff, 1996).
At the external level, the system is divided into agents, which are modelled as complex
1An object model gathers all details on objects within the system, describes their structure, their relations
and the operations they support.
2A dynamic model describes the states, transitions, events, actions, activities and interactions of the system
structures, which characterise system behaviour.
3A functional model describes data flow during system activity, both within and between components.
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objects characterised by their aim, their responsibilities, the services they provide, and their
interactions with the environment. At an internal level, required elements for each agent
type and structure are modelled.
For clarity and efficiency, the proposed model is detailed using this specification technique.
3.2.2 External structure
At the external level, two specifications are provided (Kinny and Georgeff, 1996). An agent
model describes hierarchical relations between abstract and concrete classes, and identifies
agent types involved in the system, their populations, and the dynamics of these. An in-
teraction model describes responsibilities of an agent type, services it provides, associated
interactions and control relations between agent types.
3.2.2.1 Agent model
Balance between agent diversity and agent population is essential, (Section 2.4.2). In order
to simulate populations large enough to account for immune response throughout a body,
reduced diversity is needed, at least in the first instance. As immune response to HIV is
predominantly cell-mediated, it can be modelled using three types of agents, (based on
agent-cell reciprocity): CD4, CD8 and APC. A fourth type of agent is needed for HIV
virions. The agents evolve in lymph nodes modelled as 2D matrices in which each element
is a 3D physical neighbourhood able to host several agents of all types. (For the lymph
network environment, see Chapter 4.)
Each agent type corresponds to a specific class in the C++ implementation, and inherits
from a common, abstract base class. This class contains attributes and functions needed
for management of ageing and of location within matrices. Being abstract, this class does
not correspond to any agent during simulations. For immune (CD4, CD8, APC) and viral
agents, the number in each matrix element is limited to 10 and 20, respectively, to ensure
realistic neighbourhood size for interactions. An element can, for instance, contain 8 CD4
agents, 7 CD8, 5 APC and 17 virions.
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At the start of a simulation, initial agent populations are specified in a parameterisation file.
Agent populations then dynamically evolve, following rules summarised in Table 3.2.
Variations Viral agents CD4 agents CD8 agents APC agents
Increases
Production Created in thymus, Created in thymus, New agent
by infected CD4 or produced by or produced by created
multiplicating agent multiplicating agent
Decreases
Agent ingested Infected agent End of immune Presenting
by APC, or destroyed, or response, or agent destroyed,
infecting CD4 end of life end of life or end of life
Table 3.2: Agent population dynamics
3.2.2.2 Interaction models
The reciprocity between agents biological entities, (cells and virions), mirrors real-system
interactions between the latter. These are summarised in Figure 3.1.
3.2.3 Internal structure
At the internal level, each agent class is described using three specification models of the
agent-based paradigm. Following the structure proposed in Kinny and Georgeff (1996),
the chosen approach is to use BDI models, (Belief-Desire-Intention), which describe infor-
mation possessed by the agent, together with its objectives and potential behaviour. These
“models”, therefore, guarantee an exhaustive description of essential properties of the agent.
The belief model describes the type of information the agent has access to, both in its envi-
ronment and its internal state. In particular, several states can be specified as initial states.
The desire model describes objectives of the agent, and events it can react to. Finally, the
intention model describes the behaviour of the agent, i.e. ways in which the agent can fulfil
its objectives or adapt to events it perceives.
These “models” will be used to describe each agent class: virions, CD4, CD8, and APC.
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Figure 3.1: Agent interactions.
Viral agents can move from one neighbourhood to the next, (providing there is sufficient space for
them, which is checked using a dedicated function). Upon arrival in a new neighbourhood, these
agents can perform a single operation only: infection of a CD4 agent. First step is the selection
of CD4 target. Possibility of infection is then assessed, (e.g. if CD4 agent is activated). Infection,
if it takes place, is implemented as transfer of viral genome information into the CD4 agent and
destruction of viral agent. CD4 agents incorporate mobility and can reach new neighbourhoods.
As for viral agents, this includes checking, through a dedicated function, that space is available.
Upon arrival and if already activated, the agent can activate a CD8 neighbour. Activation follows a
process similar to that of infection, detailed above. A possible target is selected, assessed, (in terms
of agents bearing “compatible” clonotypes), and then activated when this is possible. If a CD4 agent
is infected, it may produce a new viral agent. In the early stages after its own activation, an agent
also produces some additional CD4 agents, to enhance immune response. CD8 agent mobility
is implemented similarly. In its new neigbourhood, the agent produces new CD8 agents, (if it is
currently multiplicating), or targets infected CD4 and APC agents, (if it is activated). Some CD8
agents can enter a state representing memory cells. These agents, (with a greater life span and faster
reactivation), interact with all agent types in their neighbourhood, in order to monitor known viral
strains, and can be directly reactivated. Final agent type, APC, implements mobility and associated
functions needed to query the environment. APC agents interact with viral agents, in the sense that
they can ingest them to present viral strain information to other agents. They also interact with CD4
agents, which they can try to activate by presenting viral information. Success of activation is based
on affinity between viral epitope and CD4 clonotype.
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3.2.3.1 Belief-model specifications
Each agent has complete knowledge of its parameters and, therefore, of its internal state.
Knowledge on its environment is, however, limited and temporary. Information on the en-
vironment is, indeed, limited to presence of targets for interaction in the neighbourhood.
Agents have no memory of the evolution of their neighbourhood, as is the case with biolog-
ical entities of the real system.
All internal parameters are coded as integers, (or lists of). Age is involved in the internal
state of all agents. Other parameters are type-specific, and are given in Table 3.3.
Agent type Parameter Value stored Initial value
Virion Viral strain Strain ID Fixed value
CD4
Clonotype Clonotype ID Fixed value
Activation Responsible strain 0
Multiplication Expansion status 0
Infection Responsible strain 0
Memory Past activation status Fixed value
CD8
Clonotype Clonotype ID Fixed value
Activation Responsible strain 0
Multiplication Expansion status 0
Memory Past activation status Fixed value
APC Antigen list Strain IDs Empty list
Table 3.3: Agent parameters and initial internal state
3.2.3.2 Desire-model specifications
Viral agents. These agents have a single objective: infecting a CD4 agent. This objective is
permanent and is, therefore, also the initial objective. In the biological system, the objective
is then to produce new virions, (implemented directly within CD4 agents).
CD4 agents. As long as a CD4 agent is neither activated nor infected, its single objective is
to stay on “stand-by”, ready to initiate immune responses. This is the initial objective and,
since it does not correspond to any particular action, it can be limited to moving within the
environment. The objective of an activated agent is to activate CD8 agents, while that of an
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infected agent is to produce new viral agents. These two objectives can, of course, coexist.
The objective of a CD4 agent which assumes the task of maintaining memory is similar to
that of its initial state.
CD8 agents. As long as a CD8 agent remains non-activated, its single objective is simi-
lar to that of initial CD4 agents, and is implemented in the same way. The objective of a
memory CD8 agent is similar. The objective of an activated CD8 agent is to multiply, and
to eliminate target agents.
APC agents. An APC has two objectives: locating viral agents, and activating. The for-
mer is the initial state, and is similar to initial state of other immune agents. The latter can
treated as is proposed for CD4 agents activating CD8.
3.2.3.3 Intention-model specifications
Viral agents, (Figure 3.2a, p.37). The raison d’eˆtre of a viral agent is species survival.
This is reflected by the single objective: reproduce, i.e. infect. As infecting a CD4 agent
is a permanent objective, every aspect of agent behaviour is targeted towards fulfilling this.
Strategy is, therefore, simple, and is divided in three steps: the agent moves, inspects its
new environment and, if possible, infects an immune agent. This is repeated until infection
is successful or agent is destroyed.
CD4 agents, (Figure 3.2c). The initial objective being to explore the environment, be-
haviour is limited to agent movements. Once the agent is activated, each movement is
followed by multiplication, (for a few iterations after activation), and information gathering
on the environment, to determine whether there is a suitable target for activation. If such
a target exists, activation follows. If infected, a new virion may also be produced. The
behaviour of agent in “memory status” is again limited to agent movements.
CD8 agents, (Figure 3.2d). Initial and “memory” behaviour is similar to that of CD4 agents.
Once the agent is activated, each movement is followed by information gathering on the en-
vironment, to determine whether there is a suitable target for elimination. If such a target
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exists, it is eliminated.
APC agents, (Figure 3.2b). Behaviour of an APC agent has first divided in two steps:
the agent moves, and then gathers information on its environment, in order to locate viral
agents. Once it starts presenting details of such agents, it also looks for CD4 agents, in
order to activate them.
3.2.4 Agent implementation
A summary is proposed in Figure 3.3, (p.38), of the four specific classes and single ab-
stract class used for agent implementation. We introduced an early implementation of these
classes in Perrin et al. (2006a;b). Here, we give a detailed and updated presentation of the
attributes and methods. The former are used to implement an agent’s internal state, while
the latter are used for interactions, through several communication modes, (Section 3.1.2).
In this case, commissive, expressive and declarative modes are not used. The other modes
are required, and implemented.
3.2.4.1 Base class
Base class attributes are related to the management of agent location and age. Direct im-
plementation of the age would be ill-advised, as it would require updating age of all agents
at each iteration, even when this information is not immediately required. This can be quite
slow, especially as the number of agents increases.
A more suitable alternative is to save the number of the iteration at which the agent was cre-
ated. No repetitive update is required, and calculation of the difference between the current
iteration number and the “birth date” of the agent provides its age when needed.
3.2.4.2 Viral agent class
The viral agent class must manage viral strain information. Methods are, therefore, im-
plemented to access and update this information, (i.e. representative and directive modes).
Different viral strains mean different properties are needed for the associated viral agents:
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Figure 3.2: Intention specifications: behaviour of the four types of agents
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Figure 3.3: Agent implementation: class diagram
these are not recognised by same set of immune agents, may have distinct mutation rates,
etc. Explicitly implementing all these properties within each agent would make them too
“big”, in terms of memory usage, (which is to be avoided for large simulations). The solu-
tion here is to use a single integer, coding the viral strain. This identification can then be
used to access strain-specific properties, which are stored in a large array, (representing tens
of thousands of potential strains).
An interesting property, here, is the identification of which immune clonotypes recognise
each strain. As outlined, (Section 2.4.2), antigen recognition must be refined with respect
to lock-and-key concepts. Proposed here is that two list of clonotypes should be available.
The first list corresponds to clonotypes for which recognition is certain, (i.e. p = 1), and
the second accounts for those for which recognition is not perfect, (i.e. p < 1). An impor-
tant characteristic is that when an agent from the second list recognises the viral strain, the
associated clonotype moves from the second list into the first. This is critical to the realism
of the model, since it allows us to introduce some adaptability.
Infection of immune cells is implemented within CD4 agents. As this interaction involves
only these two classes, this is biologically equivalent, but it is more efficient, in terms of
computing performance.
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3.2.4.3 CD4 and CD8 agent classes
Commonalities. Class attributes are related to management of the class-specific parame-
ters that make up the internal state of these agents: agent clonotype, multiplication status,
activation status, memory status, (and infection status for CD4 agents). Methods are pro-
vided, to update or access information, as for viral agents.
The clonotype is coded as an integer, randomly valued when the agent is created. Activa-
tion status is also coded as an integer. This value, set initially to zero, is used to store the
identification integer representing the viral strain which led to agent activation. A positive
value corresponds to an agent activated to respond to HIV strains, while a negative one is
linked with another infection the immune system is currently responding to. This is crucial,
as not all immune cells are available for a given response: some are already involved in
other responses. It is also important, for CD4 agents, since infection requires that the cell
is activated, but the response it is involved in need not be targeted to HIV.
Multiplication status is an integer, initially set to zero. It is then incremented at each step of
the multiplication phase, until it reaches a limit and is set back to zero, signalling the end
of this phase. Memory status is also coded as an integer and initially set to zero. When an
agent starts assuming the role of a memory cell, it takes the value previously assigned for
activation status, and that activation status is then set back to zero.
CD4-specific attribute values. Infection status is coded as an integer, initially set to zero,
and storing HIV strain identification. Infection by multiple strains is possible in the real sys-
tem. This is not, however, considered in the proposed model, as each set of strain properties
may implicitly account for several strains in the real system, if these differ on properties
which are not explicitly considered here. A possible extension of the model may be to con-
sider multiple infections.
CD4-specific methods. Methods are implemented to account for modes related to infection
of a CD4 agent. These correspond to assessment of viral presence in the neighbourhood,
and transfer of viral content to the infected agent. Additional methods are also implemented
for these agents, to deal with activation of a CD8 agent. The process is similar that of in-
39
fection of CD4 by a viral agent: presence of targets is assessed, and activation takes place
if possible.
Similarly, other methods account for production of virions by infected CD4 agents. Here,
the agent needs access both to the strain properties array and to its environment.
CD8-specific methods. Additional methods are also implemented for these agents, to ac-
count for elimination of infected agents. The process is similar that of previous interactions:
presence of targets is assessed, and elimination takes place where necessary.
3.2.4.4 APC agent class
The APC agent class attributes are related to the management of the single parameter that
makes up the internal state: the list of presented viral strains. Viral strains are coded using
their identification integer. The list is initially empty, and new integers are added as strains
are detected by the agent. Methods are provided to access and update this list.
Additional methods account for activation of CD4 agents. The process is similar that of
previous interactions: presence of targets is assessed, and activation takes place where pos-
sible.
3.2.5 Multi-agent simulations of implemented model
3.2.5.1 Description of a typical iteration
Because of the nature of the system being studied, stochastic events are included, and the
analysis of each configuration or set of parameters requires several simulation “runs”. A
key element for each of these is the update loop used to implement each iteration of the
model. The time step used for these iterations in the implemented model is based on those
mechanisms which have the fastest change, (e.g. production of a new virion by an infected
CD4 cells, which takes on average just under a minute). The update loop is detailed below.
Since all interactions take place within the physical space delimited by the matrix element,
the update sequence of the matrix is not significant: it is not necessary to randomly select
a different sequence at each time step. The focus here is, therefore, on updates at the agent
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level.
Note: An interesting property of this update procedure is that not all agents are updated at
each time step. This is to account for the fact, if all biological entities can move and interact
at any given time, they do not do so on a continuous basis, nor on a regular rhythm shared
by all. This pattern is implemented through uniform random selection, within a matrix ele-
ment, of agents that are updated at the current time step. Due to the finite size of the matrix
element, an agent will not spend an infinite time without being updated. Moreover, since
the first action when selecting an agent is to check its age, it also guarantees that no agent
will have an effect outside of its life span, even if not updated for some time. Finally, while
each agent type is responsible for a given type of interaction, all are also passively involved
in other interactions. For instance, CD4 agents coordinate CD8 activation explicitly, but are
also implicitly updated when they are involved in their own APC-controlled activation.
This random selection of agents involved is a significant advantage, as it is both biolog-
ically realistic and computationally efficient, (due to reduction of operations required for
each update iteration). An important consequence is that it allows larger agent populations
to be modelled, (a key objective).
Update of viral agents:
1. Movement. An agent is selected within the current matrix element, and moves to a
new matrix element.
2. Query. The agent gathers needed information on this new environment, i.e. number
of CD4 agents.
3. Infection. Providing there are such agents, one is randomly selected. (This accounts
for the fact that not all agents within that small space are considered to be in physical
contact with this viral agent). If this selected CD4 agent is a suitable target, (i.e.
activated and not previously infected), an infection process starts: value of attribute
“infected” of this agent is set to value of attribute “strain” of viral agent, (or to a
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related value if successful mutation occurs4), and the viral agent is then destroyed. If
no suitable target was accessible, nothing else happens.
Update of CD4 agents:
1. Memory. When an active CD4 agent reaches the end of its life span, it may become
a memory cell, which is implemented as follows: value of “memory” is then taken
from “activated” attribute, which is set back to zero.
2. Movement. The agent moves to a new matrix element. If it is not activated, nothing
else happens.
3. Query, (presence of CD8 agents if activated, presence of “reactivation agents” if non-
active memory cell).
4. Reactivation. If the CD4 agent is a non-active memory cell, it can be reactivated if it
locates infected agents or agents involved in immune responses, and recognises viral
strains associated to these. If the CD4 agent is not reactivated, the update stops here.
5. Expansion. If the CD4 agent is currently multiplying, a clone agent is produced, (the
only distinct parameter corresponding to age of the new agent). If the CD4 agent is
not infected, the update stops here.
6. CD8 activation. Providing there are CD8 agents, one is randomly selected and, if it
is not already activated, clonotypes are compared. If these are compatible, activation
occurs: value of attribute “activated” of CD4 is copied into the respective attribute of
selected CD8 agent.
7. Infection. A new virion may be created, based on properties stored in the strain array,
and accessed using value stored in “infected” attribute.
Update of CD8 agents:
1. Memory, (as for CD4 agents).
4If mutation is unsuccessful, infection fails, but the viral agent is still eliminated
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2. Movement. The agent moves to a new matrix element. If it is not activated, nothing
else happens.
3. Query, (presence of targets if activated, i.e. infected CD4 agents and presenting
APC agents, presence of “reactivation agents” if non-active memory cell). Possible
reactivation, (as for CD4 memory agents).
4. Reactivation, (as for CD4 agents).
5. Expansion, (as for CD4 agents).
6. Elimination. If targets are located, they are randomly selected and eliminated.
Update of APC agents:
1. Movement. The agent moves to a new matrix element. If it is not activated, nothing
else happens.
2. Query, (presence of viral agents, and presence of CD4 agents if already presenting
antigens).
3. Antigen acquisition. If viral targets are present, one is selected, its “strain” attribute
added to the list, and the agent destroyed.
4. CD4 activation. If the list is not empty and if there are potential CD4 targets for
activation, one is selected and activated, through a copy of a “presenting” integer
from the list into “activated” attribute of target.
3.2.5.2 Random number generation
Many aspects of a real-life system involve stochastic events, and, consequently, most meth-
ods and functions in our model have to include random number generation. Details on
stochastic aspects of the immune system are well-reported, (see e.g. Germain (2001)). Ex-
amples include the process by which new lymphocytes are created: a lymphocyte can only
recognize a specific set of antigens so that, to protect itself against any attack, the body
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has to generate thousands of “variations” between lymphocytes. This is implemented using
random numbers. Further, one of the most distinctive features of the virions is their high
mutation rate, which occurs randomly. Finally, there is no sensible way to deal with mobil-
ity unless we include stochasticity.
A full-scale model will involve millions of agents in very long simulations, with parallel
aspects involved. A reliable and efficient random number generator which can deal with
all these stochastic elements and features is essential. Many generators are, of course,
available, and good ones can also be designed explicitly (see e.g. Press et al. (2002)). A
top-quality parallel generator is needed, and our model can interface both with the Scalable
Parallel Random Number Generators library, (SPRNG), (Srinivasan et al., 2003) and with
the “Mersenne twister” generator (Matsumoto and Nishimura, 1998). These libraries in-
corporates recent, state-of-the-art developments in the mathematics and computer science
of parallel pseudorandom number generation. They both have an existing, active user base,
ensuring high standards. In particular, they allow the streams to be also absolutely repro-
duced, for computational verification, independent of the number of processors used in the
computation. High confidence in the statistical results, at a very low computing cost, is a
feature of this library usage.
3.3 Chapter summary
In this Chapter, detailed implementation of agent structure is presented. Four types of
agents are used, in order to fully describe cell-mediated response and HIV mechanisms,
while reducing agent diversity to a level which permits simulation of large populations. The
proposed implementation, therefore, provides a basis from which to address the limitations
outlined in Chapter 2.
Implementation of agent classes, as well as typical iteration of simulation, are detailed. This
outlines several features that were also presented as essential in that Chapter:
• Sensible granularity is obtained by using a time-step of fifty seconds, which ensure
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that no significant interaction is unaccounted for.
• Structure of CD4 and CD8 agents allows direct cell-level control of immune memory.
This is expected to be more realistic than a centralised implementation.
• Antigen recognition is refined to include adaptability: recognition is not binary, and
this essential feature is also expected to enhance model realism.
The following Chapter focuses on implementation of the lymph network and details how
this can address limitations outlined for previous models.
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Chapter 4
Building the lymph network
4.1 Structure of the lymph network
Objectives detailed in Chapter 2 include explicit implementation of lymph nodes and the
lymph network. In the next two Sections additional details on these structures and a further
demonstration of their essential role in achieving model realism, are provided.
4.1.1 Lymph nodes
Lymph nodes are key components of the lymphatic system, and are found throughout the
body. An important function of a lymph node is to act as a “filter” for foreign particles such
as viruses, by collecting antigens. Even more crucial, however, is that this “filtering” is used
to enhance immune response. A node’s structure is designed for this function, and is char-
acterised by high content of immune cells, which use these lymph nodes as meeting points
for large-scale responses that could not be mounted in a less favourable environments.
The normal size of lymph nodes ranges from a few millimeters to around 1-2 centimeters,
(see e.g. Tiguert et al. (1999)), but, as lymphocytes multiply during activation of the im-
mune response, nodes can become significantly enlarged during such periods.
The inner structures of a node, illustrated in Figure 4.1 (reproduced from Gray (1918)),
are associated with a predominant cell in each case: outer cortex is rich in B lymphocytes,
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while deep cortex and medullary cords predominantly host T lymphocytes, and medullary
sinuses can contain some immobile macrophages.
A node is connected with the “outside” through blood and lymph circulations.
Figure 4.1: Section of a lymph node, (reproduced from public-domain book (Gray, 1918))
4.1.2 Distribution and circulation
As key defense units, lymph nodes are distributed throughout the body. Humans have
around 500 lymph nodes, and lymphocytes constantly circulate through these lymph nodes.
To guarantee this cell circulation, connectivity is an essential property of the lymph net-
work: a cell newly produced in the thymus must be able to reach any lymph, and efficient
immune response implies interactions between nodes, (by means of cell exchanges).
The lymph network, however, is not equivalent to a complete graph: between any given
pair of nodes, there is a path, but not necessarily a direct connection. In contrast, the lymph
network is organised as a set of chains. These “clusters” of nodes can be found in the neck,
chest, abdomen, underarm, etc. For illustrative purposes, lymphatic chains of head and
neck, and of stomach, are shown in Figures 4.2 and 4.3, respectively, (reproduced from a
public-domain edition of Gray’s Anatomy, (Gray, 1918)).
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Figure 4.2: Lymph nodes of head and neck, (reproduced from Gray (1918))
The circulation of immune cells between nodes is not trivial. Cell migration is non-random
(Witherden et al., 1990), and is, in particular, type-dependent: CD4/CD8 ratio is always
higher in the recirculated compared to overall population, (and often more than twice as
important). Interestingly, however, transit kinetics are equivalent for both subsets of T
cells. Naive and memory cells also have different recirculation pathways (Mackay et al.,
1990).
Circulation is also tissue-specific, in the sense that T lymphocytes preferentially recirculate
back to the tissues they came from. This is controlled at the molecular-level through spe-
cific chemokines (Kunkel and Butcher, 2002).
As might be expected, circulation patterns are affected by immune response. In particular,
lymphocyte input and output is significantly increased in nodes where immune activation is
taking place (Cahill et al., 1976).
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Figure 4.3: Lymph nodes around stomach, (reproduced from Gray (1918))
4.2 Importance of lymph nodes and lymph network in the con-
text of HIV infection
Lymph nodes are essential units, since they host the most crucial part of immune response to
any infection. An immediate consequence of this is that any immune model, not explicitly
dealing with these nodes, is neglecting most of the immune response it is trying to account
for.
This remains true, of course, in the context of HIV infection, and in many respects, the
lymph system is even more crucial in this particular context. In recalling that HIV repli-
cation cycle is based on infection of CD4 cells, lymph nodes are precisely where most of
these immune cells migrate to. Recirculation of course implies that some also are found in
blood vessels, for instance, but at any given time the majority of CD4 is located still within
lymph nodes. A model without explicit lymph node implementation fails, realistically, to
account both for the immune response and for the infection this response is targeting.
Moreover, dynamics of cell mobility are known to be altered by HIV infection (Douek et al.,
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2003). This is a direct consequence of generalised immune activation, which is known to
affect cell recirculation. In particular, an inversion of the CD4/CD8 ratio is observed in
peripheral blood, due to diverging population dynamics for these cell types: CD8+ cells
undergoing rapid expansion through immune activation are not subject to viral infection.
This has led to reports that decline in peripheral blood CD4+ cells overestimates actual
cell loss in lymphoid tissue (Rosok et al., 1996). However, more recent evidence suggests
that, on the contrary, total-body depletion is underestimated by peripheral blood cell counts
(Douek et al., 2003). Whether these counts under- or overestimate actual effects is (almost)
irrelevant. More crucial is the fact demonstrated that these counts are not an accurate mea-
sure of fitness of the immune system, and that an explicit model is required.
HIV infection also affects node structure, (through chronic activation and cell depletion,
see e.g. Biberfeld et al. (1985)), and cell dynamics, (through altered balance between naive
and memory cell (Roederer et al., 1995), and increased pressure on thymic output Douek
et al. (1998)). An explicit implementation of the lymph nodes can permit inclusion of this
structural distortion.
4.3 Node structure and implementation
The proposed model provides a solution to explicit implementation by using lymph node as
the key abstraction element for the “world” in which agents evolve. Details are provided in
this Section.
4.3.1 Matrix-based representation and associated neighbourhood
In order to efficiently account for cell interactions and corresponding physical contact, accu-
rate localisation of agents within the lymph node is required, implying division into smaller
subunits. A standard approach to spatial representation requirements is to use a 2D or 3D
matrix, and to consider either a Von Neumann neighbourhood, or Moore neighbourhood,
(Figure 4.4).
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Figure 4.4: Von Neumann (left) and Moore (right) neighbourhoods
Division into subunits is not trivial however, and the standard approach does not appear
particularly suited for multi-agent systems involving several types of agent. In our new
model, each matrix element has to be able to contain at least one agent of each type. If it
can contain no more than one, limitations related to size of the matrix and of the modelled
entities are an issue. In the former case, modelling a million viral agents requires at least
a 1000x1000 matrix; in the latter, not all biological entities involved have a similar size. It
is, therefore, unrealistic to assume that a matrix element should contain the same number
of viral agents, (small entities), and APC agents, (significantly larger cells).
More usefully, matrix elements can be considered to be “physical”, containing several
agents of each type, with a limit based on size of modelled entity. This implies that all
cell interactions will take place within this physical neighbourhood, and considering sur-
rounding matrix elements is not necessary. In our model, lymph nodes are, therefore, im-
plemented as 2D matrices where each element represents a physical, 3D, neighbourhood.
4.3.2 Memory allocation and agent localisation
A naive implementation of agents within the matrix representation of a lymph node would
allow for arrays of agents within each element. Each array would store agents of a given
type and localisation of agents would, therefore, be trivial, with agent movement between
elements involving simple deletion from one array and addition to another.
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Memory allocation for agents also offers an intuitive solution: memory could be dynami-
cally allocated whenever an agent is created, and freed when one is destroyed.
Both these solutions would be suitable for a small-scale system, but would not be efficient
for a large model such as the one studied here. In the first place, memory allocation is one
of the slowest operations on a computer, and would be intensively solicited here. At each
iteration, a large number of agents are created or destroyed, (Table 3.2, p.32). Successions
of dynamic allocations and deallocations would be used and would, therefore, significantly
hinder efficient computation. Moreover, as immune response is initiated, agent count will
sharply increase, and may reach values close to theoretical limits of the model. The main
advantage of dynamic allocation, (i.e. using only as much memory as is needed at any time
point), would not apply in such a simulation.
Consequently, our implementation is based on static memory allocation. Large arrays of
agents, (one for each agent type), are allocated when simulation starts, and store the max-
imum number of agents which can be present in the whole matrix at the same time. Each
matrix element then only stores integers, used as offsets, to locate agents currently held in
these arrays.
4.4 Cell mobility and validation of the lymph node model
4.4.1 The importance of cell mobility
Cell mobility is often neglected in existing models, in part, due to lack of explicit implemen-
tation of lymph nodes. Nevertheless, consideration of mobility is essential, especially for a
bottom-up approach, as accurate accounting for low-level mechanisms is the aim. The main
focus is on cell-level interactions, with results based on cell-dependent information. For in-
stance, (see Chapter 2), affinity between immune clonotype and viral epitope determines
efficiency of immune response, and physicochemical binding between viral glycoprotein
gp120 and CD4 receptors of lymphocyte is a first step in cell infection.
Some models try to account for physical contact in these interactions by probability state-
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ments on proximity of cells, but there is no biological basis for such a function to be used,
and it seems unlikely that a single constant probability would be valid throughout the body.
The agent-based paradigm offers the opportunity to fully account for cell mobility, both
within and between lymph nodes.
4.4.2 Intra-node mobility
Implementation
Intra-node mobility refers to agent movements within each matrix. Overall movement is
based on flow, created by the fact that agents enter the node on one side, and exit on the
other. The required distribution of agents and time spent in each node is stochastically gov-
erned.
Using the implementation and memory allocation strategy detailed in Section 4.3, updates
of agent localisation are easily managed: (i) creation of an agent requires initialising its
internal state and saving the offset, to access this state, in the matrix element; (ii) deletion
of an agent involves deletion of this offset; a new agent can subsequently be created in this
space; (iii) movement from a one matrix element to the next requires transferring the offset
value to the destination element.
Validation
Intra-node mobility is validated using a “covering test”. Generic agents are created, (i.e.
biological interactions are not taken into account here), and are randomly scattered over a
matrix. These movements are then monitored over a number of iterations, to assess whether
all matrix elements are indeed accessible. Tests were performed with a single agent in a
50x50 matrix, and with ten agents in a 200x200 matrix, and results are shown in Table 4.1.
Even with limited iterations (50,000, as opposed to several millions for a full-scale sim-
ulation) and few agents, covering is very satisfactory and supports adequate modelling of
intra-node mobility. Interestingly, this model feature is implemented at a very low comput-
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ing cost, since agent movement only involves alteration of two integer values. It does not,
therefore, limit other modelling objectives such as efforts towards simulation of large agent
populations.
Matrix size Visited elements Maximum Minimum Average Std. deviation
50x50 2500 (100%) 103 3 39.94 15.45
200x200 39795 (99.49%) 108 0 24.98 15.14
Table 4.1: Covering tests on intra-node mobility
4.4.3 Validation of cell-level mechanisms in the lymph node model
The lymph node structure is fully implemented, and populated with agents which incorpo-
rate mobility features. The immediate objective is to validate this structure, before subse-
quent validation of the lymph network model, which uses this node model as key abstraction
unit, (Figure 2.4, p.23).
The first stage is to guarantee a high temporal granularity, which is essential to model real-
ism (Section 2.4.2). A time step of just under a minute has, therefore, been chosen for this
lymph node model, which addresses the limitations of the long time-step models and allows
accurate simulation of cell-level mechanisms. Tests to validate these basic interactions are
presented here.
The difficulty is that there is no simple criterion, such as a convergence rule, since the
system is continuously evolving. The only solution here is to run a significant number
of simulations, acquire sufficient clinical data (e.g. Buseyne and Riviere (2001); Murali-
Krishna et al. (1999); Oxenius et al. (2001)), and isolate similar patterns in both sets: this
motivates the following tests.
A first consideration is to validate the activation of the effector cells of the cell-mediated
response, i.e. CD8 lymphocytes. In the biological system, we highlighted three steps:
1. CD8 cells are activated by CD4 cells to target a specific antigen;
2. newly-activated CD8 cells multiply themselves and “attack” suitable targets;
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3. once the response is over, a portion of the created cells become memory cells, while
the others are destroyed.
To assess how the lymph node model deals with the biological system requirements, a par-
ticular configuration is simulated with no viral agents, but a set of artificially activated CD4
cells. These agents activate their CD8 counterparts, which rapidly multiply themselves.
Once the response is seen as over, (no further targets), most excess CD8 cells are destroyed
while a few are kept as memory cells. Observed patterns are satisfactory, (see Figure 4.5).
Next, consideration is given to the three steps leading to activation of CD8 cells in the
cell-mediated response:
1. APCs detect foreign entities and start presenting specific antigens on their surface;
2. given CD4 lymphocytes recognize these antigens and activate themselves;
3. these cells activate CD8 lymphocytes, which then behave as previously described.
To assess the lymph node model in this case, “passive” viral agents are simulated: these
move within the node and can be recognized as foreign entities, but do not show any HIV-
specific behaviour. This generates results, which are focused on the response itself. In
Figure 4.6 (p.57), the chain of activation is reproduced. The delay between each activation
step is due to the mobility condition: cells need physical contact to interact.
The last validation step for local interactions is the HIV-specific behaviour that viral agents
have to reproduce. HIV virions use activated CD4 lymphocytes as hosts. Once a cell is
infected, it starts producing new virions, while its life expectancy is greatly reduced, even
without the consideration that it may be destroyed by activated CD8 lymphocytes.
This specific behaviour was highlighted in a famous experiment conducted by a research
group led by Montagnier, (Barre-Sinoussi et al., 1983). It was thought at the time that the
first human retrovirus discovered, HTLV-1 (Human T cell leukemia virus), was responsible
for AIDS. HTLV-1 is known to make T cells capable of indefinite growth and division. A
set of CD4 T lymphocytes was introduced to biosamples from a patient suffering from early
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symptoms of AIDS. Some retrotranscriptase activity was detected, but soon disappeared. A
new set of lymphocytes was introduced into the culture: activity was again observed ini-
tially, then disappeared. The virus responsible for AIDS cannot, therefore, be HTLV-1, as
the former “kills” CD4 cells.
The lymph node model must reproduce this expansion strategy and its success has been as-
sessed through a simulation involving only virions and CD4 agents, and featuring a massive
input of “fresh” CD4 agents at some stage. As can be seen, (Figure 4.7), for the new set
of lymphocytes introduced after 750 iterations, a decline in CD4 is again observed and the
test suggests that the model satisfactorily reproduces in vitro behaviour. Visualisation1 of
expansion strategy is shown in Figure 4.8, (p.58).
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Figure 4.5: Activation and multiplication of CD8 lymphocytes
1Visualisation was only available for early single-node tests, (see Section 8.2 for details).
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Figure 4.6: Chain reaction leading to the cell-mediated response
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Figure 4.7: Viral agents using Th cells as hosts, leading to cell depletion
57
Figure 4.8: Graphical representation. Infected CD4 agents, (black dots), are producing new
viral agents, (dark grey dots).
58
4.4.4 Inter-node mobility
Concept
Cell movements also involve inter-node mobility. This refers to agents leaving a lymph
node entirely and entering another one. As far as node structure itself is concerned, this
requires addition of entry and exit points to the matrix, for agent arrivals and departures.
When an agent reaches the exit at the far corner of the matrix, it is added to a transfer list,
and then removed from the node. At the end of the iteration, lists are shared and agents
transferred to their new locations.
Structure
It is important to account for lymph network structure: this, (as mentioned earlier), is similar
to a directed connected graph, but is not complete. It implies that the final destination of an
agent leaving a node can theoretically be any node, but its immediate destination is limited
to a small subset of nodes.
Final destination
Selection of final destination is random, but not based on a uniform distribution. Lym-
phocyte recirculation features preferential recirculation back to tissues of immune cell ori-
gin. To account for this, each lymphocyte agent leaving a node has a 0.5 probability to
be assigned this node as its final destination, ensuring circulation through the whole lymph
chain corresponding to this node. To respect the higher lymph node to overall population
CD4/CD8 ratio in departing agents, a function is also added to guarantee that not all CD8
agents evolving in the neighbourhood of the exit point are selected for departure.
Immediate destination
Selection of immediate destination is based on the lymph network structure modelled. The
number of lymph nodes modelled during a given simulation may vary, for instance de-
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Figure 4.9: Principal algorithm for lymph network generation
pending on available computing resources. What is needed here, therefore, is an automated
technique to generate a network of nodes reproducing the lymphatic chain structures for any
number of nodes. A generation method has been developed, implemented and tested, and
the principal algorithm is shown in Figure 4.9. It is based on creation of several lymphatic
chains, which are linked together by a “main-chain” to ensure connectivity of resulting
structure. An example of a generated network is shown in Figure 4.10.
Inter-node mobility, of course, implies simulations with a significant number of nodes, and
this implies increased computing load. A parallel implementation, (detailed in the next
Chapter), is employed to address this final requirement. The results of inter-node mobility,
in conjunction with parallelisation features, are detailed in Chapter 6.
4.5 Chapter summary
In this Chapter, it was demonstrated that an explicit implementation of lymph nodes and
associated network is both necessary and achievable. It is necessary, due to the organisation
of the immune system, where lymph nodes are key defense units which host most of the
immune response to HIV. Furthermore, HIV uses immune cells as hosts to replicate and
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Figure 4.10: Example of generated lymph network structure with 32 nodes
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proliferate, and it is in lymph nodes that the highest concentration of these is found.
The generic nature of the agent-based paradigm allows agents to evolve in any user-defined
environment, and an implementation is proposed here, which explicitly implements lymph
nodes and lymph network structure, and accounts for cell mobility, both within lymph nodes
and between them. As such, it addresses an essential feature, (Section 2.4.2).
Intra-node mobility was obtained at very low computing cost, for which the implementation
does not limit modelling of large agent populations, while tests on different matrix sizes
have shown that behaviour is satisfactory. Inter-node mobility was implemented by adding
entry and exit points to matrices, and probability functions to determine the final destination
of circulating agents. The immediate step on the path to that lymph node is obtained through
introduction of an algorithm generating lymph network structure.
Four of the six limitations identified, (Section 2.4.2), have been addressed satisfactorily. An
efficient parallel implementation of the lymph network is also required to fully account for
inter-node mobility and large-scale, biologically-meaningful simulations. Details on this
are given in the next Chapter.
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Chapter 5
Parallel Implementation
5.1 Rationale for a parallel implementation
5.1.1 Achieving realism: one is not enough
Since most of the immune response to HIV infection takes place within lymph nodes, these
key organs were chosen as the basis for the agent-based model.
Mechanisms for ensuring physical contact with respect to immune interactions generated a
discussion on mobility, and the chosen implementation was detailed in the previous Chap-
ter. Cell mobility within each node can be examined with a single-node simulation, as
movements are local. Mobility between nodes, however, implies that nodes must be con-
nected via a network.
Another motivation of this work, identified in Chapter 1, is to look into localised effects
such as early infection in the gastro-intestinal tract. This again requires the implementation
of an additional layer, or network, that changes local node properties, (Chapter 6). In or-
der to create these subnetworks, i.e. areas with distinct behavioural patterns, there is, thus,
a need for a lymph network large enough to accommodate both “normal” and “localised”
nodes.
The approximately five hundred nodes mimicking those of the human body can not be han-
dled on a single-processor computer, because of limitations in both available memory, (it is
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not possible to allocate a large number of nodes), and computing power, (it would take too
long to simulate all nodes). The only solution is to consider a parallel implementation of
the lymph network.
5.1.2 Parallel nature of the problem
When considering the parallel nature of a problem, classification is built on three categories,
(see e.g. Gropp et al. (1999b) for details):
• Embarrassingly parallel problems, which can be broken down into subparts, each
completely independent of the others. As a consequence, no communication is re-
quired, except to split up the problem during initialisation and to combine the final
results at the end. In such cases, linear speedup can be expected from a parallel
implementation. A well-known example is Monte-Carlo simulations.
• Regular and synchronous problems, in which the same instruction set, (regular algo-
rithm), is applied to all data with synchronous, or loosely synchronous, communica-
tions, with each processor finishing its task at the same time. These usually require
local, (neighbour to neighbour), and collective communication, the latter being used
to combine final results. As long as the ratio of computation to communication is
large, parallel implementations for these problems provide almost linear speedup for
local communication, (and is slightly less efficient for non-local communication).
Examples include Fast Fourier transforms (synchronous), matrix vector products and
sorting (loosely synchronous).
• Irregular and/or asynchronous problems, characterised by irregular algorithms which
cannot be implemented efficiently except with message passing and high communi-
cation overhead. In such cases, communication is usually asynchronous and requires
careful coding and load balancing. Dynamic repartitioning of data between proces-
sors is often required. Speedup is, therefore, difficult to predict, but should not be
expected to be linear, or even close to. Any moving boundary simulation typically
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falls into this category.
The model proposed here uses the lymph network as the “world” in which agents evolve.
As there is no direct interaction between cells located in separate lymph nodes, (Chapter 4),
cell-level interactions require physical proximity. The consequence is that, apart from cell
transfer, each node is independent of the others. A node influences its neighbours solely
through cells exiting their current location and reaching the next node.
Local interactions have been implemented by a regular algorithm, (detailed in Chapters 3
and 4). Since node size is constant, there is little variation in the agent counts of the various
nodes, and we can expect local iterations to finish around the same time. Our problem is
thus regular and loosely synchronous, and the model is suited for a parallel implementation.
5.2 Challenges and implementation choices
5.2.1 Parallelisation: Divide et impera
The main principle of program parallelisation can be found in the famous Latin proverb
Divide et impera, “Divide and conquer”. Identification of possible “divisions” within the
program is essential. In some programs, a set of instructions is repeated several times, with
each iteration independent of the others. Monte-Carlo simulations are a typical example
here. In such cases, several iterations can run at the same time, using a time parallelisation.
This technique can not be applied to the lymph network model however: each iteration i
uses the final state of the agents after iteration i − 1, so that two iterations can not run at
the same time. Yet, as highlighted in the previous section, the problem does have a parallel
nature, in the sense that each node is largely independent of the others.
We can, therefore, use a spatial parallelisation, based on a reciprocity between the lymph
nodes and the computer nodes of a cluster. Each lymph node of the model is assigned to
a computer node of the parallel architecture, and communication network is designed to
mimic cell mobility along the lymph network.
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5.2.2 Expected difficulties
Spatial parallelisation has previously been investigated, e.g. in the context of Monte-Carlo
simulations, for HIV infection (Hecquet et al., 2007), with the main disadvantage in that
case being the communication overload. The parallelisation strategy, detailed above, guar-
antees that communication is kept to a minimum. Indeed communication between computer
nodes is only used to represent actual cell exchanges; we do not add any communication
overhead due to the parallelisation itself, apart form initial problem splitting and final re-
sults gathering.
This is an important point: as communication is often seen as the bottle-neck of any parallel
implementation. This is usually a consequence of the hardware architecture, where physi-
cal data transfer is significantly slower than computing operations. As shown in Equation
5.1, data transfer time depends on data size, of course, but also includes a fixed network
latency1.
TransferT ime = Latency +DataSize/Bandwidth (5.1)
Over the last decade, efforts on parallel hardware architectures have led to a reduction of
the network latency, which is now generally less than 100 µs (Mamidala et al., 2006), and
sometimes advertised to be as low as 1.5 µs (PathscaleTM, 2005). This needs to be put in
context with current computing speeds, where recent configurations reach hundreds of ter-
aFLOPS2, i.e. in that context, a millisecond represents a million basic operations. Clearly,
therefore, no unnecessary communication should take place if avoidable. The choice out-
lined, (Chapter 4), is to use a single list for agent transfer, (rather than as many lists as agent
types).
For biological models, a balance must be found between minimal communication and need
for realistic exchange of information, and this concern motivates much of the remainder of
this chapter. Firstly, in what follows, we introduce the communications protocol used for
1Network latency corresponds to the time delay between initiation of the communication and actual start of
data transfer.
2FLOPS: FLoating Operations Per Second.
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implementation.
5.2.3 Implementing: MPI
In brief, MPI3 is a communications protocol used for parallel implementation of programs.
MPI provides support for point-to-point and collective communications, enquiry routines
to query the execution environment, as well as constants and data-types (Gropp et al.,
1999b;a).
MPI is a low-level library, which provides an interface to C, C++ and Fortran 90. MPI
is, therefore, a language-independent protocol. Portability was a priority during its de-
velopment, and MPI is platform-independent. This is decisive in the context of the study
presented here, as the model is executed on various parallel platforms.
This, along with high performance and scalability, made MPI the de facto standard and
most current distributed-memory computers offer MPI implementations. MPI is taught and
used widely, which, together with the availability of open-source implementations and the
large body of programs that require MPI, (including both Research models and commercial
products), guarantees long-term legacy of MPI and sustainability of our model.
5.3 Communication strategies
5.3.1 Types of data transfer
MPI supports communication types:
• Point-to-point communication. Data is sent from one node to another. Default com-
munications are blocking: the send call blocks until the send buffer can be reclaimed.
This implies that after the send, the sender can safely over-write the contents of a
variable used for communication. The situation is similar on the receiving end: the
3MPI, or Message-Passing Interface, “is a message-passing application programmer interface, together with
protocol and semantic specifications for how its features must behave in any implementation”, which “includes
point-to-point message passing and collective (global) operations, all scoped to a user-specified group of pro-
cesses” Gropp et al. (1996).
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receive function blocks until the receive buffer actually contains the contents of the
message. If needed, MPI also supports non-blocking communications, which allow
possible overlap of message transmission with computation, or of multiple message
transmissions.
• Collective communication. This is used when information located on one cluster
node must be shared with all the others, or when information scattered over the nodes
must be gathered on one of them. A single instruction, called by all involved nodes,
replaces a loop of point-to-point transmissions.
In the next subsection, naive implementations using these two types of data transfer are
tested, in order to estimate the communication influence on simulation time.
5.3.2 Naive data transfer
5.3.2.1 What data is sent
As noted, spatial parallelisation based on lymph network structure means that communica-
tion is only required when agents are going from one node to another. In Chapter 4, we
detailed the lymph node implementation. In particular, we highlighted that inter-node mo-
bility is implemented through use of lists of “migrating” agents. During iterations of the
parallel model, these lists are the only information that need be exchanged between cluster
nodes. A communication strategy is, therefore, the decision basis for the frequency and the
method of list transfer.
5.3.2.2 Point-to-point transmissions
A first strategy is to use point-to-point communication only, and to exchange data at the
end of each iteration. From here on, we will refer to this strategy as “strategy 1”, and
improvements to this strategy will be referred as “1.x”, (with x ∈ [1,9]).
Strategy 1 implies point-to-point communications between each pair of nodes. First, each
node must create n − 1 sublists (with n the number of nodes); each sublist contains the
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agents going from the current node to a given other. Exchange of lists between the nodes
involved can then take place. This can be implemented using the algorithm presented in
Figure 5.1, and requires n(n− 1) list transfers.
Figure 5.1: Principal algorithm for strategy 1
For MPI, each list transfer requires two communications, with one parameter of the MPI
communication routines the size of the transmission. It means that, to send a list containing
m values, we must first send m in a one-integer message, and then send the list. Strategy 1,
therefore, leads to 2n(n− 1) point-to-point communications.
5.3.2.3 Collective transmissions
Another strategy is to exclusively use collective communications. In the following, we refer
to this as “strategy 2”, and use the same naming convention as above for future improve-
ments.
Here, each node will send the whole list to all the others. The first step is, therefore, the
communication process, as presented in Figure 5.2. It represents n collective list transfers,
i.e. 2n actual MPI collective communications. The next step is performed locally by each
node: searching in all the received lists for the agents which are entering the node.
Figure 5.2: Principal algorithm for strategy 2
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5.3.2.4 Communication is indeed a bottle-neck
Strategies 1 and 2 were tested on a local cluster, for small configurations, (i.e. 4, 10, and
16 nodes), and short simulations. The results were discussed in Perrin et al. (2006c), and
are here displayed in Table 5.1. The first remark is that communication is, indeed, a bottle-
neck. Tested strategies are of course naive, and connectivity on the cluster is known not to
be very recent, but these first results still highlight the need for an efficient communication
strategy.
It is also important to note that local iteration time is largely constant and independent of
communication strategies. This is a confirmation of the parallel nature of the problem.
Strategy 2 performs very poorly. This is due to the fact that, with this approach, destination
nodes receive more data than they actually need, since they receive information about all
the agents which left their host node, irrespective of their destination. There is a reduction
in the number of communication steps4, (n, compared to n(n− 1) with strategy 1), but this
is obtained at too heavy a price: excessive data transfer eliminates strategy 2 as a viable
solution.
Performances obtained from strategy 1 are more encouraging. They still highlight the need
for further improvements, but communication overhead is more reasonable. A first solution
is to consider the frequency at which lists are shared between nodes. More efficient com-
munication implies sending non-empty lists. Obviously, the longer the interval between list
transfers, the bigger this list gets, and the likelihood of sending an empty list decreases. In
Table 5.2, computation times are shown for 20,000 iterations, when communication is per-
formed at the end of every iteration or every other time-step. The program appears slightly
faster when we communicate data less often. However the gain is not significant for very
low agent count: in this case, few agents are scattered in the lymph node and are less
likely to reach the exit point, even over several time-steps. The improvement is highest for
medium agent count: for a high count, it is likely that at least one agent will reach the exit
point during each iteration, and iterations leading to an empty list are, therefore, less com-
4and, therefore, also in the number of actual MPI communications
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mon, but do occur. We observe an improvement when sending only at every other iteration;
this pattern is confirmed if we wait three, four, or five iterations before sending the lists.
There are, however, two limitations. The first is a memory concern, since an ever bigger list
is resource-consuming. More importantly, there are biological considerations involved. A
time-step is equivalent to fifty seconds, and the number of iterations must therefore be kept
close to the actual time estimated for a cell to commute from one node to another. Separat-
ing the communication phases by more than five iterations is thus less realistic and should
be avoided. Further improvements on the communication protocol are, therefore, required.
Cluster configuration 4 nodes 10 nodes 16 nodes
Strategy 1
Local iterations (s) 69 71 68
Communication (s) 57 206 324
Strategy 2
Local iterations (s) 67 65 63
Communication (s) 62 377 1239
Table 5.1: Naive strategies tested on small configurations
Communication frequency Every iteration Every other iteration
Low agent count 377 s -1.48%
Medium agent count 982 s -34.9%
High agent count 2187 s -10.8%
Table 5.2: Influence of the list transfer frequency on communication time
5.3.3 Improving data transfer
In addition to eliminating solutions based on collective communication, early tests also
provided a basis for improving strategy 1. In fact, direct transfer between every couple of
nodes would on several occasions, due to MPI constraints detailed above, lead to sending
information about an empty list, thus slowing the program down. For this approach to be
efficient, we need a node to act as the intermediary between these pairs of nodes, with all
the nodes sending their list to this one. On that node, the agents are sorted according to their
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destination, and, to every node, a list is sent, containing only the agents which are relevant
(strategy 1.1). This reduces the number of communication steps to 2(n − 1). The main
drawback for this improved communication protocol is that a node can only receive from
(or send to) one other node at a time. It implies that in the meantime, the others are idle.
Dedicating one node, (called node 0 hereafter), on the cluster solely to this role of inter-
mediary ensures it is always ready to send and receive, rather than engaged in an iteration,
and should reduce this shortcoming (strategy 1.2, see Figure 5.4a, p.74), though it will not
eliminate it entirely.
Even if node 0 is available and immediately receives the list from node i, that node will be
idle while waiting for list i of all agents migrating to node i, as this list can only be prepared
once all incoming transmissions have been completed on node 0. Inclusion of an iteration
between the sending of the first list, (agents leaving a node) and the reception of the second
list, (agents arriving at that same node), prevents “computing nodes” from being idle, and
gives time for node 0 to finish receiving every list and sorting the agents (strategy 1.3).
As the number of nodes increases, so does the time that a given node has to wait before
being able to send/receive. An alternative is to create more “intermediary nodes”, and sub-
networks. For instance, on a 16-node cluster, we could have four groups, each formed with
three “computing nodes” to deal with modelling and one node only used for communica-
tion. The first three would run an iteration, send their list, compute another iteration, and
receive the new list. The other one receives the lists, shares information with other similar
nodes, and sends the new lists. With this configuration, any node finds a maximum of three
nodes in the queue at the time it joins, and the program is expected to be faster as a result
(strategy 1.4, see Figure 5.4b, p.74).
To determine agent destination, the strategies, detailed so far, rely on a local function con-
trolling inter-node cell mobility, (Chapter 4). The lymph network is not a “dense” network.
Using terminology from graph theory, (see e.g. Diestel (2005)), it can be described as a di-
rected finite graph which includes cycles, but is not a complete graph: if two lymph nodes
are randomly chosen, it is likely that there will be no direct connections between them
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(incomplete), even though there is always a path from one to the other (connected), (see
Figure 5.3). These properties can be used to implement the lymph network. A communi-
cation network can be created explicitly, rather than only by a function as described above;
communication can then be physically limited to this network (strategy 3). Without causing
any biological issues, we can also impose the requirement that nodes have either two (one
incoming and one outgoing) or three connections (two incoming and one outgoing, or vice
versa). This would imply that for any given node, at any stage of the simulation, there is a
maximum of two nodes in front of the queue.
A further improvement is to design this network to satisfy two-colouring, (strategy 3.1, see
Figure 5.4c), thus decreasing the communication load: during odd iterations, black nodes
send data and white ones receive it, and vice versa during even iterations.
Figure 5.3: Complete graph with six nodes (left); directed and connected graph (right)
5.4 Validation
5.4.1 Final results on small clusters
All advanced strategies were tested on the same local cluster. In Table 5.3 (p.75), the results
for 20,000 iterations and 16 nodes are shown. More advanced versions of the first strategy
provide improved performance, with the notable exception of strategy 1.4. Tested on 16
nodes, it is faster than other implementations of strategy 1. We must mention, however, that
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(a) Strategy 1.2 (b) Strategy 1.4
(c) Strategy 3.1
Figure 5.4: Communication strategies
this configuration means that only 12 nodes are used for actual biological simulation, while
the other 4 nodes focus solely on data transfer. A fair comparison with other strategies must
take this into account and look at results on smaller node counts for these. In that case,
strategy 1.4 does not show any particular improvement, and was not, therefore, included
in Table 5.3. Strategy 1.3, on the other hand, demonstrated useful performance and is a
candidate for large-scale implementation.
Another promising candidate is the new strategy, in particular in its 3.1 coloured version.
It shows significant improvements compared to any other communication protocol. The
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fact that all 16 nodes are used for biological simulation is further encouragement: that is
this strategy combines efficient communication and better resource usage. This can be ex-
plained by the number of communication steps; since each node has a maximum of three
connexions, the number of transfers is of the order of 3n/2, for a cluster of n nodes, (com-
pared to n(n− 1) for strategy 1). Strategy 1.1. offers a count of the same order, (2(n− 1)),
but a greater idle time is observed. Indeed, with strategy 3.1, idle time for each node is
reduced, as it is communicating with a small subset of nodes and, therefore, is less likely to
wait for one already involved in another communication.
Communication strategy Relative communication time
1 2.68
1.1 1.00
1.2 0.97
1.3 0.92
1.4 N/A
3 0.89
3.1 0.76
Table 5.3: Communication times for advanced strategies, compared to baseline strategy 1.1
5.4.2 Scaling-up
5.4.2.1 The need for a performance simulator
A model size of hundreds of nodes should lead to enhanced realism, but large clusters to
handle this are a limited resource, and an optimal communication strategy is vital. This also
implies that it is preferable to determine the optimal strategy before using these clusters. In
other words, small clusters can be used for development, but larger clusters should be kept
for actual biological simulations.
An interesting property of MPI is its very good scalability, so that an implementation val-
idated on a small configuration has every chance of working on larger ones. This is still
not enough in this case, however. What is required is an accurate estimate of communi-
cation time associated with each strategy, to satisfactorily assess which is the best one for
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this particular model. As we saw with naive implementations 1 and 2, a communication
strategy may have a critical model size above which performance is significantly reduced.
This size was small for strategy 2, (which is only efficient on very small networks), but
more advanced strategies may have a high critical point.
We considered that the best answer to this dilemma, (defining the best strategy without
excessive physical testing), was to develop a performance simulator.
5.4.2.2 Evaluation of the strategies
The performance simulator, developed, has six parameters:
• Communication algorithm. This corresponds to the communication strategy currently
tested, i.e. which node is sending to which node, type of communication, and time of
the transmission.
• Node size. This is the size of the matrix modelling the lymph node.
• Agent count. Each node is initialised with a particular number of agents. This number
is kept up-to-date throughout the performance simulation by taking into account the
agents that are sent or received. For simplicity, population variations due to other
biological variations, (e.g. production of virions by infected immune agents), are
neglected in this context.
• Length of local iteration. This is a function of the node size and agent count.
• Network latency. This is a property of the hardware architecture under virtual evalu-
ation.
• Bandwidth, or rate of data transfer. Another property of the simulated cluster.
• Length of data transfer. Transfer is obtained, (Equation 5.1, p.66), where data size is
a probabilistic function of agent count.
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This performance simulator was implemented, and validated using the results obtained on
the local cluster, and strategies were then repeatedly tested. Of main interest here were
performance measures, such as the average total execution time and communication time.
Maximal values were also monitored, in case a particular configuration proved able to block
a communication strategy or lead to abnormal performance. As shown in Table 5.4, tests
focused on strategies 1.3 and 3.1, as these proved the most promising versions of the two
types of communications. Again, as found for small configurations, strategy 3.1 performs
best.
These results are consistent with expectations based on the configuration of communication
steps. Strategy 1.3 leads to n(n− 1) communication steps, and strategy 3.1 to the order of
3n/2, but the distribution of these data transmissions is very different. Strategy 1.3 puts an
increasing load on node 0 as the number of nodes increases, while strategy 3.1 conserves
the limit of three connections per node. Since the latter does not correspond to an increase
in the size of transferred data, evolution of communication time is more satisfactory.
Importantly, this strategy was designed with biological realism in mind, in the sense that
there is no unnecessary communication between nodes that are not connected in the lymph
network structure. Increased efficiency of communications is not, therefore, balanced by
any inaccuracy introduced into the model. As a consequence, this is the strategy we have
chosen for large-scale model implementation.
Cluster configuration 16 nodes 32 nodes 64 nodes 128 nodes 256 nodes
Strategy 1.3 1.00 1.39 1.96 2.81 4.02
Strategy 3.1 0.83 0.89 0.96 1.05 1.17
Table 5.4: Performance evaluation on large clusters for strategies 1.3 and 3.1
5.5 Chapter summary
In this Chapter, it was demonstrated that a parallel implementation is both necessary and
achievable. It is necessary, because of the size and complexity of the biological system to
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be dealt with. Immune responses involve millions of cells, which are travelling through
hundreds of lymph nodes. An accurate model of these complex interactions requires an
important number of nodes and agents. This can not be implemented on a single computer
long-term.
It is possible, however, because of the parallel nature of the biological system itself: apart
from influence achieved through mobility of cells, lymph nodes act as independent defense
units. This allows for efficient spatial parallelisation, by allocating each lymph node to each
processor of a cluster-based configuration.
Even though such an implementation limits communication, designing an efficient com-
munication strategy remains crucial, as highlighted through earlier tests with naive ones.
Advanced strategies were, therefore, created, implemented with MPI, and tested on small
cluster configurations.
Sensible use of computing resources also suggested the development of a performance sim-
ulator, used to evaluate communication strategies on larger configurations while saving
these resources for actual biological simulations.
These tests allowed identification of one strategy, based on a mimic of the lymph network,
as the best communication protocol for the immune system model.
This Chapter concludes, therefore, having built and tested an efficient parallel implementa-
tion of the lymph network, which is now suitable for large-scale, biologically-meaningful
simulations. These are discussed in the next Chapter.
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Chapter 6
Validation of the main model layer,
and further improvements
6.1 Summary of current model
In Chapter 2, we detailed several existing immune models, identified the agent-based paradigm
as promising, in the context of modelling immune response to HIV, and outlined limitations
of current similar approaches, demonstrating a need for a new implementation.
Aspects of this model and implementation were detailed through Chapters 3 and 4, while
selected features to exploit large computing resources, and the development of parallel so-
lutions were discussed in the previous Chapter.
Challenges outlined as needing to be addressed, (Section 2.4.2), include overall modelling
choices, (i.e. balance between agent diversity and agent population, explicit modelling of
lymph nodes and reasonable granularity), as well as considerations of refined implementa-
tion, (e.g. cell-level implementation of immune memory, more refined antigen recognition).
Basic cell-level mechanisms have been validated, (Section 4.4.3), and the remaining tasks
are to validate the other features implemented so far and, finally, to look at the inclusion of
localised effects in the overall model.
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6.2 Validation and results of the lymph network model
6.2.1 Computing efficiency of the lymph network model
Optimisation of the communication strategy was considered in Chapter 5, and permits sim-
ulations of large agent populations on configurations including several lymph nodes. Com-
munication optimisation was performed on a cluster based on an outdated network hard-
ware, which over-emphasised the importance of MPI data exchanges as a potential bottle-
neck. This allowed a better isolation of the communication component of the computing
process and, in turn, the development of a very efficient protocol for data transfer between
lymph nodes.
The focus here is on model performance when it is run on a more sophisticated and more
recent cluster. Tests are performed on a 56-node cluster. Each “cluster node” has a dual-
processor, and each processor has four cores. The cluster therefore offers 448 “computing
cores” at 2.66 GHz, and modelling hundreds of lymph nodes is a reasonable target, (and
would be on a scale similar to that of the whole immune system).
MPI allows specification of how many processes will be run on each “cluster node”, (these
are then scattered over cores of this node). For the lymph network model, one process is
one lymph node. Of particular interest, therefore, is the evolution of the computation time:
• as a function of the number of agents at the start and the number of lymph nodes.
• as a function of the number of lymph nodes and the number of processes per “cluster
node”.
Table 6.1 displays the relative computation time as a function of the number of agents at
the start, (a.p.n), and the number of lymph nodes, (l.n.), for simulations using eight pro-
cesses per cluster node, (p.p.n.). Optimisation of local iteration allows simulation of very
large populations of agents at a relatively low computing cost. Significant increases in agent
count only generate moderate overheads in terms of computation time. This is very impor-
tant, as immune response and viral spread both lead to variations of specific agent counts.
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Table 6.2 displays the relative computation time as a function of the number of lymph nodes
and the number of processes per cluster node, for simulations starting with 150,000 agents
per node. As expected from performance simulations, optimisation of the communication
strategy allows simulation of a large lymph network, of size similar to that of real system.
This is crucial to model realism, as was confirmed by tests on cell mobility and its effects
on immune activation and on viral propagation throughout an organism.
Implementation efforts, therefore, provide the opportunity for simulations reaching the
scale of the immune system1, both in terms of involved populations and “geographical”
entities throughout the body. This is a significant increase in scale compared to existing
models, and permits a more detailed representation of the immune system.
8 l.n. 16 l.n. 32 l.n. 64 l.n. 128 l.n. 256 l.n.
∼30,000 a.p.n 1.00 1.04 1.08 1.12 1.16 1.21
∼150,000 a.p.n 1.08 1.10 1.12 1.16 1.24 1.29
∼300,000 a.p.n 1.21 1.22 1.23 1.24 1.27 1.31
∼600,000 a.p.n 1.58 1.58 1.59 1.60 1.64 1.78
∼1,500,000 a.p.n 1.89 1.90 1.92 1.93 2.11 2.11
Table 6.1: Model efficiency: relative computation time for several configurations of lymph
nodes (l.n.) and agents per node at initialisation (a.p.n.)
8 l.n. 16 l.n. 32 l.n. 64 l.n. 128 l.n. 256 l.n. 512 l.n.
1 p.p.n 1.00 1.06 1.14 N/A N/A N/A N/A
2 p.p.n 1.08 1.09 1.10 1.14 N/A N/A N/A
4 p.p.n 1.25 1.26 1.27 1.28 1.30 N/A N/A
8 p.p.n 1.68 1.71 1.75 1.81 1.94 2.00 N/A
16 p.p.n N/A 3.47 3.52 3.54 3.57 3.58 4.04
Table 6.2: Model efficiency: relative computation time for several configurations of lymph
nodes (l.n.) and processes per “cluster node” (p.p.n.)
1Using all 448 cores of the cluster available for testing, and allocating two lymph nodes to each, simulations
involving more than one billion immune agents were successfully run.
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6.2.2 Validating the biological features of the lymph network model
In validating a model of the lymph nodes and associated network, it is not possible to use
cell counts seen in typical graphical representations of the three-phase disease progression,
as these refer to peripheral blood. Moreover, cell counts from blood samples are known not
to be an accurate measure of actual disease progression, as recirculating cell populations
are significantly different from the overall cell populations. This means that a model, based
on matching variations in peripheral blood cell counts, would, in fact, be unlikely to give
a good representation of the overall immune response and disease progression through the
lymph network. This approach is, however, common in existing models, which do not
explicitly deal with lymph nodes, (see e.g. Castiglione et al. (2004)), and limits comparisons
with our lymph network model.
Validation of our model must, therefore, be based on known signatures of HIV infection,
(such as mutations and massive loss of memory cells), and evaluation of relevant model
properties based on clinical data relevant to the lymph node context.
6.2.3 Balance between agent diversity and agent population
Abundance and diversity of cells are crucial to the efficiency of the immune response. The
evolutionary argument is that, given the complexity and “cost” of maintaining such popu-
lations, this structure would not have been largely conserved between all vertebrates if it
was not essential. More details on this “biological arms race” between invading organisms,
(viruses, bacteria, fungi), and the host immune defenses can be found in the specialised
literature, (e.g. Kasahara et al. (2004); Murphy et al. (2007)).
As complexity of a system increases, selection of the parameters and mechanisms to rep-
resent becomes less trivial. In the context of immune response, relatively simple cell-level
interactions lead to considerable complexity of outcome for the system as a whole. Emer-
gence of tissue-level and, even more crucially, body-level patterns are, nevertheless, clearly
dependent on size of cell populations, as demonstrated e.g. by HIV progression: the whole
immune system collapses once cell counts, (especially CD4 cells), decrease below critical
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levels. Model realism therefore requires large agent populations and careful selection of
parameters, given that accounting for every immune cell of every lineage is not a realistic
target, even with current computing resources.
The lymph node model, therefore, implements three essential cell types, as well as viral
agents, (Chapter 3). In the first instance, it guarantees enough diversity to account for most
immune and viral mechanisms, and also permits simulation of large populations. The cur-
rent model can, in fact, simulate up to two million agents per lymph node.
The parallel implementation of the lymph network model permits large-scale simulations,
(Chapter 5). These simulations involve approximately 500 to 1000 lymph nodes, for a total
population more than one billion agents. An adequate balance between agent diversity and
large agent population is, therefore, obtained.
6.2.4 Explicit modelling of lymph nodes, and inter-node mobility
The lymph node model incorporates two levels of cell mobility. Intra-node mobility is
crucial to physical contact between cells, and was validated, (Chapter 4). The chosen im-
plementation for inter-node mobility was detailed, and the parallel structure for the lymph
network model permits validation on large sets of lymph nodes.
Of particular interest in this context is to look at viral spread through the lymph network.
Simulations are run on the 32-node lymph network shown in Figure 4.10, (p.61). In Table
6.3, (p.85), shown, for each node, is the iteration range of the first appearance of HIV, and
the corresponding time since infection, with a precision of 10 iterations, (i.e. less than nine
minutes), for the first simulated hundred minutes, and of 300 iterations, (i.e. less than five
hours), subsequently. Due to cell mobility and the associated spread through the network,
there are important variations of the time of infection for each individual node, from one
simulation to another. Complete infection of the network, however, is always obtained af-
ter about a month, with a standard deviation of less than three days2. These results are in
accordance with known patterns of viral spread through body. Information propagation in
2Average and standard deviation are obtained performing twenty simulations.
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terms of immune activations follows a similar pattern, as could be expected.
The importance of cell mobility in the early stages of infection is clearly apparent, both
from the delay of viral spread through the lymph network and the propagation of activated
immune agents which initiate a body-wise response. Reproducing the progression pro-
vides an additional insight into the early stages of infection, and is a significant advance
from previous models. In these models, even when the node and network structures are
acknowledged as being essential, (see e.g. Baldazzi et al. (2006)), the implementation and
the temporal granularity does not permit investigation on the node-to-node progression if
the infection. This is, nevertheless, important, and may provide a basis for new treatments.
The contribution of our model is, in that context, significant.
6.2.5 Immune memory
Transformation into memory cells is achieved by copying the agent activation state into the
memory state, and restoring the former to initial state, (i.e. 0). Reactivation can then be
obtained by physical contact with any viral or infected agent related to previous activation.
Reactivated agents regain previous behaviour, but multiplication is faster, (Chapter 3).
To highlight the significance of this feature, tests are performed on a small, 16-node,
lymph network, with a high viral load, (to obtain faster spread than that for Table 6.3),
and with/without immune memory. A short infection is initiated, which is performed on
a system including naive agents only, (i.e. there is no memory), and on a system which
is initialised with 50% of agents created with memory of a previous infection, (for which
the strain corresponding to that infection is randomly chosen). Results shown in Table 6.4,
(p.87), represent the immune response to infection in both configurations during the first
week after infection, in terms of time to detection of the infection and number of immune
cells activated by HIV-related antigens and involved in the response in the twenty-four
hours following this detection. The results shown correspond to two simulations initiated
with the same seed for the random number generator, and the differences between the two
are, therefore, a direct consequence of the inclusion of immune memory. These can be
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First local infection Time since infection Average Standard dev.
Node 0 [27,600; 27,900] 16 days 11.9 days 6.1 days
Node 1 [31,200; 31,500] 18 days 13.2 days 6.2 days
Node 2 Origin of infection 0 minute 0 minute 0 minute
Node 3 [300; 600] 6 hours 64 hours 52 hours
Node 4 [2,700; 3000] 40 hours 96 hours 62 hours
Node 5 [16,500; 16,800] 10 days 7.7 days 4.7 days
Node 6 [18,300; 18,600] 11 days 11.2 days 7.0 days
Node 7 [23,100; 23,400] 13 days 10.4 days 6.4 days
Node 8 [34,800; 35,100] 20 days 4.3 days 5.1 days
Node 9 [37,500; 37,800] 22 days 5.9 days 5.0 days
Node 10 [39,600; 39,900] 23 days 15.1 days 8.3 days
Node 11 [44,400; 44,700] 26 days 16.4 days 8.1 days
Node 12 [46,800; 47,100] 27 days 17.9 days 7.9 days
Node 13 [49,200; 49,500] 28 days 18.7 days 7.8 days
Node 14 [57,300; 57,600] 33 days 22.6 days 9.6 days
Node 15 [49,800; 50,100] 29 days 24.2 days 11.4 days
Node 16 [44,400; 44,700] 26 days 24.9 days 10.2 days
Node 17 [46,500; 46,800] 27 days 25.7 days 9.9 days
Node 18 [49,800; 50,100] 29 days 27.4 days 13.5 days
Node 19 [51,300; 51, 600] 30 days 26.8 days 12.8 days
Node 20 [52,800; 53,100] 31 days 27.9 days 12.4 days
Node 21 [54,300; 54,600] 32 days 29.1 days 11.9 days
Node 22 [51,300; 51, 600] 30 days 29.3 days 12.4 days
Node 23 [31,200; 31,500] 18 days 16.9 days 8.9 days
Node 24 [32,400; 32,700] 19 days 17.6 days 7.6 days
Node 25 [35,100; 35,400] 20 days 18.9 days 7.7 days
Node 26 [36,600; 36,900] 21 days 20.1 days 7.7 days
Node 27 [39,900; 40,200] 23 days 21.4 days 7.6 days
Node 28 [43,500; 43,800] 25 days 22.7 days 7.5 days
Node 29 [46,500; 46,800] 27 days 16.1 days 7.2 days
Node 30 [49,800; 50,100] 29 days 17.4 days 7.3 days
Node 31 [50,100; 50,400] 29 days 26.1 days 8.2 days
Table 6.3: Inter-node mobility: influence on viral spread.
The delay between the initiation of the infection in the body and the first local infection in a lymph
node is given, for a typical simulation, as a range, (for iterations), and as its equivalent in “real time”.
We also give the average time, and standard deviation.
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observed, both in terms of rapidity and efficiency of immune response, when memory is
taken into account. Another consequence is that, due to faster and more important activa-
tion, more potential targets are available for HIV infection and, as a result, viral infection
also spreads faster and further during the first week. Here, only HIV-related patterns are
reported, but the process is similar for other infections, with impact of immune memory
on viral spread clearly crucial. As for previous tests reported in Table 6.3, variability can
be observed, for a given node, from one simulation to another, but the overall pattern is
conserved, and the inclusion of immune memory does not significantly alter the variability
detailed in this earlier Table.
This is consistent with known mechanisms and offers satisfactory validation of this feature.
The loss of memory cells is also observed in other models, such as Zhang et al. (2005).
Our model, however, is a more accurate reflection of the effects of this loss. In Zhang et al.
(2005), the immune memory is centrally controlled and, even though memory cells are sim-
ilarly eliminated, the memory of past infections can not be lost. In our model each memory
cell incorporates its small fraction of the overall memory, and the elimination of immune
cells leads to a loss of memory: repeated infections are each treated as an initial infection,
and the response becomes less efficient as the simulation progresses, which is a factor in
the appearance of opportunistic diseases (Mathe et al., 1996).
6.2.6 Refined antigen recognition
In the lymph node model, antigen recognition is implemented so as to allow adaptability.
This is obtained by using two lists to account for affinity between viral strains and immune
clonotypes, (Chapter 3). Using a single list can be equivalent to distances commonly used
in other models, (e.g. Hamming distance3). Addition of a second leads to more refined
modelling, and inclusion of adaptability.
To demonstrate the significance of this second list, an experimental design similar to that for
the immune memory tests is used: on a 16-node lymph network, simulations are performed
3The Hamming distance between two strings of equal length is the minimum number of substitutions re-
quired to change one into the other.
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No immune memory With memory
First activation HIV-activated First activation HIV-activated
after local infection population after local infection population
Node 0 no activation 0% infection first < 0.01%
Node 1 no activation 0% infection first < 0.01%
Node 2 ∼1 min. 13.05% ∼1 min. 21.72%
Node 3 ∼25 min. 1.05% ∼5 min. 2.47%
Node 4 < 4 h. 0.11% ∼10 min. 0.41%
Node 5 infection first < 0.01% infection first 0.09%
Node 6 no activation 0% infection first 0.13%
Node 7 no activation 0% no activation 0.24%
Node 8 no activation 0% no activation 0.08%
Node 9 no activation 0% no activation < 0.01%
Node 10 no activation 0% no activation 0%
Node 11 no activation 0% no activation 0%
Node 12 no activation 0% infection first 0.03%
Node 13 no activation 0% no activation < 0.01%
Node 14 infection first < 0.01% infection first 0.11%
Node 15 no activation 0% no activation 0.10%
Table 6.4: Immune memory: effects on rapidity and efficiency of response.
For both configurations we report, for the first week of infection, the delay in the spread of the
immune response, (in “real time”). If the infection is reaching a node first, the response in that node
may be a consequence of the infection, (i.e. local initiation of a new immune response), rather than
due to the spread of the original immune response, and this is reported accordingly. When there
is an immune response in a node, we also report the proportion of cells involved in this response,
twenty-four hours after the start of the local response, (in “real time”).
with and without second list. This is done for the first two weeks of infection, and, (as for
memory tests), with a high viral load in order to obtain a faster spread than that reported in
Table 6.3. Results are shown in Table 6.5.
As for Table 6.4, the results correspond to two simulations initiated with the same seed,
to highlight the effect of the change of configuration. Clearly, adaptability leads to a more
efficient immune response: viral infection was recognised more quickly in the node of ori-
gin, (node 2), and was better contained, as can seen from the increased activation delay
in node 3, reached next. Adaptability also has a significant impact once the virus starts
spreading from one lymph node to the next, and overall activation through the whole net-
work is achieved faster. This influence is, however, a “double-edged sword”, as increased
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activation implies more infection targets. The damaging influence of chronic cell activation
is a well-known component of overall dysregulation of the immune system associated with
HIV infection (Brenchley et al., 2006; Munier and Kelleher, 2007; Tesselaar et al., 2002).
The viral spread described in Table 6.3 is obtained from the complete model, which in-
cludes adaptability. The corresponding considerations on variability therefore also apply to
the right column in Table 6.5. Using a single list, we observe a reduction of the standard
deviation, (reduced by a third), which is a consequence of the limited immune activation.
Using a single list Including adaptability
Node 0 no activation ∼12 days
Node 1 no activation no activation
Node 2 ∼6 min. ∼2 min.
Node 3 ∼22 min. ∼6 h.
Node 4 ∼21 h. ∼12 h.
Node 5 ∼10 days ∼29 h.
Node 6 ∼9 days ∼21 h.
Node 7 ∼10 days ∼12 days
Node 8 ∼10 days ∼37 h.
Node 9 ∼12 days ∼12 days
Node 10 no activation ∼13 days
Node 11 no activation ∼13 days
Node 12 ∼11 days ∼12 days
Node 13 no activation ∼13 days
Node 14 no activation ∼13 days
Node 15 no activation ∼13 days
Table 6.5: Refined antigen recognition: effects on time of occurrence of first activations.
We report the delay in local initiation of the immune response, in the first two weeks after
infection. If during this period there is no HIV-related immune activity in a given lymph
node, this is also indicated.
6.2.7 Long-term disease progression
As detailed in Sections 4.2 and 6.2.2, disease progression within each lymph node is sig-
nificantly different from the well-known plots depicting the three-phase evolution of the
disease, using blood samples. From these plots, even though the cell levels are not directly
relevant to our study, the time scales are very useful, and can be used for validation.
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Indeed, variations on blood samples, (shown in Figure 6.1, p.91), are the visible sign that
interactions are taking place within lymph nodes. Sharp phase transitions in those samples
indicate a change of regime in the lymph nodes.
To analyse our model, we focus on three of these critical points in disease progression: the
peak and end of the initial acute phase, and the end of the latency period, which corresponds
to AIDS onset.
The peak of acute infection corresponds, in the blood sample, to the point when viral
load starts decreasing and the CD4 count increases. This is generally observed after six
weeks. For our lymph node model, we consider this point reached when infection has
spread through the whole lymph network and three quarters4 of the nodes have a similar
direction of change in cell counts.
The acute phase ends when, in the blood samples, viral load is back to low levels, and CD4
count starts decreasing again, (more very slowly). This typically occurs after approximately
nine weeks. The main difference, in our context, is that viral load persists in lymph node, so
we consider this point reach when, for three quarters of the node, the virion count is below
10% of its peak value and CD8 count is decreasing, (which is a sign that the viral load is not
high enough to initiate a large-scale immune response in the corresponding lymph node).
The end of the latency period is characterised, from blood samples, by a significant in-
crease of viral load and a CD4 count decreasing well below 300 cells/mm3. Clinically, it
corresponds to the onset of AIDS and the appearance of opportunistic diseases, which the
immune system can no longer handle. Consequently, in our model, it corresponds to a sharp
increase in viral load which is not followed by an increase of the CD8 count, (which would
have signaled an immune response, even a weak one).
The results of our long-term simulations, based on these three points, are shown in Table
6.6, (p.91). The three phases are reproduced, and realistic orders are obtained for each
time span, in particular the latency period. The length of the acute phase is slightly over-
4This is an arbitrary value, used to highlight the fact that we require a general trend. It should be noted,
however, that variability between the nodes is, at this stage, more limited than in the very early stages of
infection. Using other thresholds, (e.g. 2/3 or 4/5), does not significantly alter the results.
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estimated. This may be due to recirculation dynamics or proportions of activated cells at
the start of the run, which may need to be refined.
With respect to the length of the latency period, it is important to note that, while we obtain
realistic values, (in terms of both average latency length and high variability between in-
dividual progressions), the model is not able to simulate long-term nonprogressors5. Such
individuals are very rare, (less than 1% of patients), and it is not fully understood why they
do not progress to AIDS. From the model results, it would seem the cause is related to an
aspect not parametrised in our approach.
The model also reproduces some cases of early progression to AIDS, (as short as five years),
but these do not qualify as rapid progressors6. Again, this may suggest for the cause for
rapid progression is outside of what is taken into account in our current model.
Some parameters have an interesting impact on the length of the latency period. Increasing
the mutation rate or the viral production of infected cells leads to sooner onset of AIDS, (as
more viral strains are able to simultaneously target the immune system), while an increased
list of immune clonotypes recognising each viral strain leads to a longer latency period, (un-
realistically large lists would even lead to elimination of the virus, which is not surprising).
The former is consistent with the current understanding of the infection dynamics, and the
latter should be considered in the light of ongoing efforts to develop a vaccine to HIV.
In the context of possible future inclusion of medical treatment in our model, it is also im-
portant to note that our model gives a more detailed resolution on disease spread throughout
the infection progression, compared to existing models. This is a consequence of our ef-
forts on the early stages of the infection. The long-term progression is, in fact, a “sum”
of successive short-term spreads: when a mutation occurs, the new strain contaminate the
whole network and, once detected, is responsible for the initiation of an immune response.
This process is similar to the initial infection. The magnitude and time scale of the response
5Long-term nonprogressors are individuals who have been living with HIV for over 10 years (there is no
agreed time span, but authors generally use 10 to 12 years as a threshold), have stable CD4+ counts of 600
or more cells per cubic millimeter of blood, show no sign of HIV-related diseases, and have not received any
antiretroviral therapy.
6Rapid progressors are individuals who progress to AIDS within four years of HIV infection.
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are different, (because the immune is already active, and may also be weakened), but the
mechanisms involved, (such as cell mobility), are accurately handled by our model.
The end points we obtain are not different from previous models or clinical data, (which is
not surprising, and is reassuring, since we are dealing with the same biological system), but
the increased resolution of the simulation offers greater prospects for treatment inclusion,
(see Sections 6.4.3 and 8.2).
Figure 6.1: Standard three-phase disease progression, (reproduced from Zorzenon dos San-
tos and Coutinho (2001)).
Average [Standard deviation] Clinical data
Peak in acute phase 6.7 weeks [1.2] ∼6 weeks
End of acute phase 9.4 weeks [1.6] ∼9 weeks
End of latency period 8.0 years [3.7] 6-12 years
Table 6.6: Long-term disease progression. Comparison between clinical data, (not includ-
ing rapid progressors and long-term nonprogressors), and time points obtained from the
model.
6.3 Local and vital: early infection of the gastro-intestinal tract
Tests, detailed above, highlight the importance of cell mobility and explicit lymph node im-
plementation, particularly for features of early infection. Viral spread from one lymph node
to the next is not trivial, (with a crucial factor the internal state of agents within one node,
characterised for instance by a higher proportion of activated CD4 cells when the spread of
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viral infection is faster). This leads to formation of localised patterns.
When considering the whole immune system, a given area may exhibit very distinct pat-
terns: this includes the gastrointestinal tract, (illustrated in Figure 6.2, p.93). Of major
importance is the role of this tract in terms of immune population: it harbours the majority
of the body’s lymphocytes, where for instance blood only accounts for a few percent of
these (Mehandru et al., 2005a).
Even more importantly, these cells are in close proximity to the external environment and
are, therefore, constantly exposed to countless antigens, (food, microbes, etc.). This results
in two crucial properties: more than 90% of these lymphocytes have a memory phenotype,
and proportion of activated cells is significantly higher (Mehandru et al., 2005b; Schiefer-
decker et al., 1992). Another property, (high prevalence of CD4 cells expressing CCR5
receptor), is thought to be important, but quantification seems problematic, and apparent
expression of CCR5 does not correlate with infection (Mattapallil et al., 2005).
These factors mean that there is, typically, a massive infection in the tract even in the early
stages of HIV infection, and the response in that area is, therefore, also very active. Re-
cently published experimental results show:
• A very rapid and very significant decline in CD4+ counts, exceeding 25% after four
weeks of infection (Guadalupe et al., 2003).
• Significant levels of infection and destruction observed even within days of infection
for memory CD4+ cells (Mattapallil et al., 2005).
• An increased cell proliferation in response to infection. The cell proliferation marker
was found on 80% of intestinal CD4+ cells four weeks after infection, as opposed to
less than 10% in healthy patients (Guadalupe et al., 2003).
Due to this local but substantial depletion of immune cells, the overall cell population is
also severely reduced, and this imposes significant pressure on the immune system in terms
of memory pool maintenance (Brenchley et al., 2004). It also damages lymphoid tissue
architecture, and this hinders the ability to support normal lymphocyte homeostasis and
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Figure 6.2: Some lymph nodes of the GI tract, (reproduced from Gray (1918))
antigen presentation.
Early infection in the gastrointestinal tract has, therefore, become an essential of research
against HIV. Exact implications of GI tract infection remain largely unclear, but some in-
teresting progress is being made. At the molecular level, it has been shown that preferential
targeting of gut-associated CD4+ cells may be due to interactions between viral glycopro-
tein gp120 and integrin α4β7, which is specific to these cells, as it is required for migration
through lymph nodes to lamina propria7 of the gut-associated lymphoid tissue (GALT)
(Sattentau, 2008).
At a higher level, restoration of cell populations after the acute phase is also under investi-
7The lamina propria mucosae, (“the mucosa’s own special layer”, in Latin), is a thin layer of tissue which,
together with the epithelium, constitutes the mucosa. It is often referred to as lamina propria.
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gation. Observations highlight a delayed and incomplete restoration of cell populations in
chronically infected patients, even for those receiving highly active antiretroviral therapy,
(HAART), for more than five years (Guadalupe et al., 2003). This standard therapy leads
to restoration of cell levels in peripheral blood, but not in the tissue considered. A similar
therapy, however, if initiated during primary infection, is effective in restoring cell popula-
tions. In this case, restoration is a consequence of cell recirculation and increased homing
from the periphery of the tract, rather than local cell proliferation.
The extension of the current lymph network model aims to address the following questions:
• Is early infection in the gastrointestinal tract a good indicator of long-term progres-
sion throughout body?
• What is the effect of gastrointestinal tract infection on overall disease progression?
• Would efficient treatment of early gastrointestinal tract infection have a significantly
beneficial effect on overall disease progression?
The remainder of this Chapter will detail early attempts to account for gastrointestinal tract
infection and related effects.
6.4 Current implementation and future work
6.4.1 Accounting for localised properties
In an agent-based model, entities update their internal state based on interactions with other
agents, but also with the environment itself. It is, therefore, possible to create compartmen-
tal properties which will locally alter agent behaviour.
Explicit implementation of the lymph nodes is crucial in the lymph network model. Since
each node is modelled separately, it is possible to select a subset of them and add additional
properties for agents in those nodes. For instance, a higher probability of activation by some
foreign antigen, not related to HIV, can be specified.
Not all components of gut-associated lymphoid tissue are, in the strict sense, lymph nodes.
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These also involve tonsils, Peyer’s patches, or diffusely distributed lymphoid cells in the
lamina propria. For most, however, function and structure is very similar to lymph nodes,
and generic matrix structure used for node implementation can, therefore, also be used for
these components.
Thus implementation of the gastrointestinal tract is obtained through selection of a long
lymph chain in the lymph network structure and alteration of local properties:
• Selected nodes are initialised with agent populations reflecting known cell properties,
e.g. 90% of memory cells, most of them active.
• Agent counts in these nodes are initialised to high values, so that these account for
half of the overall agent population.
• The probability, for a non-active CD4 or CD8 agent, to be activated by a foreign
antigen not related to HIV is increased, so as to maintain overall levels mentioned
above.
• The input of “fresh” cells in those nodes is similarly altered.
6.4.2 Early results
To assess the proposed model extension, tests are first performed on a 24-node lymph net-
work for which 10 lymph nodes are used to account for the gastrointestinal tract. These are
indicated in Figure 6.3.
To estimate the influence of gastrointestinal tract infection on the overall disease progres-
sion, simulations are performed with and without local specification for nodes associated
with the GI tract, (using, as previously, the same seed for random number generation). As
shown in Table 6.7, (p.97), significant differences appear between the two “runs”, and are
due to GI tract inclusion8. In the simulation with no GI tract, as expected from previous
results, the virus spreads rapidly through one lymph chain, but two weeks are not enough to
8As for previous tests on inclusion of new features, these two simulations are initialised with the same
“seed”, ensuring the differences are not due to stochastic variability.
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obtain complete infection. In the second simulation, however, once the GI tract is infected,
the virus finds large amounts of potential targets, and viral spread is enhanced. After two
weeks, most of the network is infected. Another difference is in the proportion of infected
cells: ten days after local infection, twice as many cells are infected in node 11 during the
second simulation, amounting to 70% of overall node cell count. This value is in agreement
with biological studies, which found peak infection occured at day 10-11, with a subsequent
loss of 60 to 80% of memory cells (Mattapallil et al., 2005).
GI tract inclusion clearly affects the overall viral spread, but does not appear to alter the
variability reported in Table 6.3. This is due to the fact that this variability is a consequence
of inter-node cell mobility, which is not altered by this new model feature.
Similar patterns are observed for simulations on larger networks. Thus the proposed model
successfully implements gastrointestinal tract properties. Since such an attempt has not
been previously reported, and given the importance of the tract in early disease progression,
this is a useful complement to existing models.
It is also important to consider the effects of this new model feature on long-term progres-
sion, as reported in Table 6.8, (p.99). Including the GI tract reduces the acute phase, which
is expected for the short-term simulations. The model results are now realistically reproduc-
ing observed time scales. The variability of this phase is not significantly altered, and the
small difference is consistent with the current knowledge on the influence of the GI tract:
because of the reaction of the tract to the infection, the overall peak is in part determined by
the time the infection reaches the tract, (with a local peak ten days after local infection, as
detailed above), which increases variability compared to a “uniform” network. Conversely,
since cell depletion is increased in the GI tract, the acute phase is locally shorter, and often
ends before the overall acute phase, therefore slightly reducing the overall variability of the
latter.
With respect to the length of the latency period, obtained values are slightly lower than
clinical results, but the difference is not significant. Overall, GI tract inclusion therefore
improves the model behaviour. This is confirmed by looking at ratio between the peak of
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acute phase, (t), and the end of the latency period, (T ). The ratio between these two time
points, (which are the easiest to observe and quantify), is just under 70, (∼ 69.6). In the
initial model, we obtained T/t = 62.3 while, with the GI tract included, T/t = 66.7.
Refining this early GI tract implementation will probably further improve model realism,
(and, therefore, this ratio). Our understanding of the model is also that the function used
to simulate the input of new cells may now be the limiting factor, and that explicit thymus
implementation may significantly enhance the model realism.
Standard network Including GI tract
Node 0 ∼ 6 days ∼ 4 days
Node 1 ∼ 7 days ∼ 6 days
Node 2 origin of infection origin of infection
Node 3 ∼ 6 min. ∼ 2 h.
Node 4 ∼ 10 h. ∼ 17 h.
Node 5 ∼ 42 h. ∼ 29 h.
Node 6 ∼ 3 days ∼ 46 h.
Node 7 ∼ 5 days ∼ 4 days
Node 8 ∼ 5 days ∼ 3 days
Node 9 ∼ 6 days ∼ 5 days
Node 10 ∼ 7 days ∼ 6 days
Node 11 ∼ 10 h. ∼ 8 h.
Node 12 ∼ 17 h. ∼ 29 h.
Node 13 no infection ∼ 5 days
Node 14 no infection ∼ 7 days
Node 15 ∼ 6 days ∼ 5 days
Node 16 ∼ 7 days ∼ 6 days
Node 17 no infection ∼ 10 days
Node 18 no infection ∼ 11 days
Node 19 no infection ∼ 12 days
Node 20 no infection no infection
Node 21 no infection ∼ 12 days
Node 22 no infection ∼ 8 days
Node 23 ∼ 8 days ∼ 7 days
Table 6.7: Gastrointestinal tract: effects on disease progression during first two weeks of
infection (time of first local infection)
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Figure 6.3: Lymph network used for tests on GI tract, represented by grey nodes
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Standard network Including GI tract
Peak in acute phase 6.7 weeks [1.2] 6.1 weeks [1.4]
End of acute phase 9.4 weeks [1.6] 8.9 weeks [1.4]
End of latency period 8.0 years [3.7] 7.8 years [3.7]
Table 6.8: Long-term disease progression. Comparison between clinical data, (not includ-
ing rapid progressors and long-term nonprogressors), and time points obtained from the
model.
6.4.3 Future work
Initial tests on the gastrointestinal tract extension are very promising and confirm explicit
lymph node implementation a useful basis for model development. Further simulations will
provide valuable insight into importance of the gastrointestinal tract on overall disease pro-
gression.
In particular, further tests will be aimed at clarifying whether early infection in the GI tract
can be seen as a prototype of overall infection patterns over the whole course of disease
progression. To this end, it is necessary to look more closely at some signatures of HIV
infection, and in particular viral mutation. Latency is characterised by an increasing num-
ber of viral strains, each maintaining a relatively small population: when one becomes too
prominent, probability of successful recognition by the immune system increases, and it is
soon eradicated.
A future focus will also be on assessing suitability of early treatment in the gastrointestinal
tract as a way to better contain disease progression. Early indications are that this could be
an interesting prospect for drug development (Guadalupe et al., 2003), but in silico investi-
gation could provide further understanding of dynamics of cell population restoration. To
this end, accurate modelling of treatment is required, so that different intervention frame-
works can be evaluated.
This extension, (treatment modelling), requires detailed consideration. Could it be included
as additional constraints on agent behaviour, or does it demand implementation of a new
agent type? Drug dissolution and interactions between drug, immune system and virus are
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non-trivial. Expertise in modelling these phenomena, however, exists within our research
group: results from drug dissolution simulations, (see e.g. Barat et al. (2006a;b)), may, in
the medium term, be adapted to account for diffusion of anti-viral treatment over the lymph
network, and models of bacteria-antibiotics interactions, (see e.g. Walshe (2006)), could
provide an interesting basis for analysis of virus-drug complexes.
6.5 Chapter summary
In this Chapter, modelling choices, detailed earlier, were successfully combined to facilitate
emergence of known macroscopic signatures of HIV infection.
Cell mobility, in particular, results in a realistic representation of the viral spread through the
lymph network. This is a consequence of detailed implementation of this particular feature,
with significant efforts to improve local update optimisation and overall communication
strategy.
These efforts permit simulation of hundreds of lymph nodes and more than a billion agents.
This is a scale similar to that of the real immune system, and provides a useful insight into
how observed patterns emerge from very precise local interactions.
All limitations identified in existing models have now been addressed:
• The balance between agent diversity and agent population is adequate, since simu-
lations can involve a very large number of agents, (cell population several hundred
times larger than in existing models), from types which are sufficient for the obtention
of known immune and viral characteristics.
• Explicit modelling of lymph nodes has been implemented and validated, and proves
a very important feature.
• A reasonable granularity, to account for cell-level interactions and movements, is
guaranteed, as code optimisation allows time step of one minute.
• Cell-level implementation of immune memory is successful, and observed results are
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in agreement with biomedical studies.
• More refined antigen recognition provides adaptability to the immune system, and
effects on overall behaviour have been successfully assessed.
• The inclusion of localised effects is under way, and early results confirm the suitabil-
ity of the lymph network model for such an objective.
This Chapter concludes, therefore, with a large-scale agent-based model which significantly
advances the field of immune modelling. This model is based on a bottom-up approach and,
as a consequence, further improvements will the result of a refined agent implementation.
The next Chapter will, therefore, introduce methods to further improve model realism: to
better understand the immune system, it is crucial to consider how this system is obtained.
This requires additional layers to the current overall model, at the genetic and epigenetic
levels.
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Chapter 7
Beyond genotype: epigenetic
modelling
7.1 Phenotypical immune response as a consequence of gene ex-
pression
7.1.1 Motivations
In previous Chapters, we saw how, using a bottom-up approach, based on cell-level inter-
actions and using a large-scale implementation of the lymph network, it is possible to gain
a better insight into the dynamics of disease progression. If agent implementation can be
refined, overall model realism will be enhanced.
By definition, the immune system is a phenotypical system: we have considered and imple-
mented “visible” cell characteristics. A better understanding of the development of these
would, in turn, improve the accuracy of the modelled interactions and, therefore, of the
overall immune system model behaviour.
In this context, it is useful to look at another layer of the immune system, and study how
the immune responses patterns are obtained. In particular, how do various gene expression
patterns result in different phenotypical expression? In other words, what are the mecha-
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nisms for acquisition of phenotypical characteristics?
To analyse gene expression and function, microarray experiments are commonly used, and
specific datasets dedicated to the immune system are appearing, (even though they are not
currently available for humans). To permit analysis of such datasets, we developed a bi-
clustering technique, (see Appendix A for details).
However, as will be detailed next, the phenotype is not a deterministic consequence of the
genotype, and is controlled by epigenetic mechanisms. A further layer is, therefore, added
to the model, to permit a more detailed investigation into these changes, both in the context
of the main model layer and for other biological systems, (e.g. cancer initiation). The con-
nection between the model layers is shown in Figure 7.1, (p.104).
In this Chapter, we introduce our objectives for this layer and present the current status of
research on Epigenetics, before detailing a model of infection-induced epigenetic changes.
7.1.2 Gene expression is controlled by epigenetic changes
Early advances in Genetics led to the all-genetic paradigm: the phenotype is a deterministic
consequence of the genotype. Obvious counter-examples were outlined and this was later
amended and expressed using P = G + E, encompassing the notion that the visible char-
acteristics of a living organism (i.e. the phenotype, P ) combine hereditary genetic (i.e. the
genotype, G) and environmental factors (E).
However, this formula fails to explain cell differentiation from a zygote, and why, for high
heritability diseases such as schizophrenia, differences between monozygotic twins can be
seen. Furthermore, identification of environmental factors, (e.g. smoking Mucha et al.
(2006) and air quality Spurny (1996) for lung cancer), is relatively rare.
Early work Waddington (1949), and more recently over the last decade, (see e.g. Bird
(2002); Wilkins (2005), has emphasised that genotype expression can be altered with-
out changing DNA sequence itself, and tagged this phenomenon as Epigenetics: P =
G+ E + EpiG.
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Figure 7.1: Epigenetic modelling as an additional layer of the overall model.
Low-level biomedical information, (e.g. genetic and epigenetic background) is used as an input
to this layer. The results from the model are obtained at a low level, (i.e. epigenetic status, gene
expression), and at a high-level, (e.g. effects of these mechanisms on disease development). They are
useful in every research field where epigenetic changes are involved, including immune modelling,
as they can be used for instance to refine the agent implementation in the lymph node model.
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Epigenetic mechanisms involve heritable alterations in chromatin structure, (e.g. DNA
methylation and histone acetylation, detailed in Section 7.2), amongst other epigenetic
“signatures”. In turn these regulate gene expression, but do not involve changes in DNA
sequence. These “stable alterations” arise during development and cell proliferation and
persist through cell division. While information within the genetic material is not changed,
instructions for its assembly and interpretation may be.
7.1.3 Objectives
Similarly to the immune system, epigenetic mechanisms form a very complex biological
system, and the objective here is to propose early models of such phenomena. Results
obtained, in the long term, from these models can then be used to refine the lymph node
model, as well as to better describe systems such cancer initiation or neural development.
Bioinformatics methods have been applied to Epigenetics, for instance to predict methy-
lation status of a given DNA sequence (Das et al., 2006), but Computational Biology has
yet to contribute in a significant way. In particular, no previous modelling work was found
to exist on epigenetic changes, and this Chapter provides a stepping stone towards a large-
scale project, (which we recently detailed (Perrin et al., 2008)). An analogy can be drawn
with early modelling work on the immune response to HIV. Research on Epigenetics is in
a position similar to that of research on HIV over a decade ago: the basics of the infection
were understood, but lab testing was difficult, and in vivo testing implied evident ethical is-
sues, which meant that quantitative data were sparse. Models developed at that stage were
able to match some signatures of disease progression, (as outlined in Chapter 2), and were,
therefore, used as a proof of concept for computational immunology. Ongoing refinement
of proposed approaches has led to recent models, including that which has been proposed
in this Thesis.
From collaboration discussions with the National Cancer Center (Tokyo, Japan), the chosen
focus for an early model is aberrant DNA methylation induced by H. Pylori infection.
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7.2 Epigenetic changes, interactions and perturbations
7.2.1 Chromatin structures
Chromosomes, which store all genomic information, are formed by a complex combination,
called chromatin, of DNA and proteins. The major proteins involved are histones. Nine hi-
stones combine to form a nucleosome, shown in Figure 7.2. The characteristic structure of
a nucleosome is that of four pairs of histones forming a core around which about 146 base
pairs of DNA are wrapped. This is maintained in place by a linker histone, H1, and repeats
over the chromatin every 200 base pairs. The remaining 50 base pairs of this repeating unit
consist of “linker DNA”.
This structure is crucial in gene expression: when a gene needs be expressed, several pro-
teins must interact with it and nucleosome are, therefore, far apart, to facilitate access. In
contrast, condensation of chromatin structure leads to gene silencing. Several epigenetic
changes on histone structures participate in the control of these dynamics.
The link between nucleosome positioning and epigenetic changes is two-directional, and
the positioning influences DNA methylation. Linker DNA is very susceptible to methy-
lation changes, while core DNA is very difficult to methylate. As an additional complica-
tion, nucleosome positioning dynamically evolves, and is both DNA-dependent and energy-
dependent. Changes in DNA methylation can also lead to nucleosome repositioning. Until
recently, dynamics of these position changes in vivo were poorly understood, but new bi-
ological techniques are now being developed and offer promising results, (see e.g. Davey
et al. (2003); Fatemi et al. (2005); Pennings et al. (2005); Segal et al. (2006)).
7.2.2 DNA methylation
DNA methylation corresponds to addition of a methyl group to a DNA strand. In humans,
only 1% of DNA bases undergo DNA methylation. In differentiated cells, DNA methy-
lation is typically limited to CpG dinucleotides1. Non-CpG methylation can be found in
1CpG: a cytosine followed by a guanine in the DNA sequence.
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Figure 7.2: Schematic representation of a nucleosome, (adapted from Brenner (2005))
embryonic stem cells (Dodge et al., 2002).
Of particular interest are CpG islands. These correspond to areas with higher proportion of
CpG, and are formally defined as follows (Gardiner-Garden and Frommer, 1987):
• Length of the considered region is at least 200 base pairs.
• GC percentage is greater than 50%, (i.e. more than half of amino-acids are cytosine
or guanine).
• Observed/expected CpG ratio that is greater than 60%.
In humans, these islands are found in or near to 70% of gene promoters (Saxonov et al.,
2006). While most CpG are methylated over the genome, these regions have a very distinct
pattern: methylation of a CpG island corresponds to silencing of the associated gene.
Aberrant changes in CpG island methylation are, therefore, linked with abnormal gene
expression.
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7.2.3 Histone modifications
Histone modifications correspond to the addition, (or removal), of a functional group,
(methyl, acetyl, etc.), to specific amino acids of histone proteins. As detailed above, these
proteins form a nucleosome core, around which DNA strands wrap. For each nucleosome,
nine histones are required: two of each class H2A, H2B, H3 and H4, and one H1.
Modifications can occur on tails of histones H3 and H4, and in the core of H2A and H3.
Some amino-acids can undergo several successive modifications. Lysine 79 of histone H3
can, for instance, be mono-, di-, or trimethylated (Barski et al., 2007).
Role of changes is modification-specific. For instance, trimethylation of H3K92 is associ-
ated with gene silencing (Barski et al., 2007), while acetylation of the same amino acid is
linked with gene activation (Koch et al., 2007). It is also molecule-specific, as effects of
trimethylation of H3K9 and H3K4 have opposite consequences on gene expression (Barski
et al., 2007; Koch et al., 2007).
7.2.4 Interactions
While other epigenetic mechanisms exist, such as perturbations by siRNA, (small interfer-
ing RNA3), and piRNA, (Piwi-interacting RNA), they will not be detailed here. Lack of
detailed information on these is even more limiting than for DNA methylation or histone
modifications, and they can not, therefore, be an immediate target for model development.
Those two mechanisms are, however, sufficient to explore the behaviour of epigenetic sys-
tems. A complex interaction exists between DNA methylation and histone modifications,
and epigenetic changes have different dynamics and stability. For instance, histone deacety-
lation is considered very rapid, while histone methylation is slow and DNA methylation
very stable. Each modification is due to a specific family of enzymes4. These will not be
detailed here, but it is important to note that such enzymes are part of larger complexes,
2H3K9: Lysine 9 of histone H3.
3Also known as short interfering RNA, or silencing RNA.
4e.g. DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b are controlling DNA methylation in mammals.
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which lead to chain reactions. For instance, MeCP25 binds to methylated DNA and then
forms a complex with HDAC6, leading to histone modifications, (including methylation,
through later recruitment of another complex involving Polycomb-group proteins). This is
crucial during cell division. DNA methylation is, indeed, the only epigenetic change di-
rectly conserved during cell division, but through recruited MeCP2-HDAC complex and
further interactions, histone modifications are restored.
DNA methylation can, therefore, be seen as the “lock” of gene silencing, (since it leads to
recruitment of complexes reinforcing unstable histone modifications), but also as its “mem-
ory”, (since its conservation during cell division ensures restoration of associated changes)7.
There are, in addition to this, complex interactions within histone-related mechanisms.
These are collectively known as the histone code (Gilmore and Washburn, 2007; Jenuwein
and Allis, 2001; Strahl and Allis, 2000). An exhaustive list of all these interactions will
not be provided here but, for instance, phosphorylation of serine H3S10 facilitate acety-
lation of H3K14 and inhibits methylation of H3K9, in turn enhancing gene transcription,
while simultaneous acetylation of H4K5, H4K8, H4K12 and H4K16 inhibits methylation
of arginine H4R3.
7.2.5 Perturbation of epigenetic patterns
Epigenetic mechanisms are involved in normal cell differentiation. All cells of an organism
have, indeed, the same genomic information, and epigenetic changes are part of the process
which switches genes on or off and leads to cell differentiation. Interactions between epi-
genetic changes in the early stages of development are, therefore, a crucial topic for stem
cell research, (see e.g. Nimura et al. (2001)).
If epigenetic patterns are involved in normal gene silencing as part of cell differentiation,
aberrant changes can also lead to abnormal silencing or transcription.
Alterations in DNA methylation, imprinting and chromatin structure are common in cancer
5MeCP2: methyl CpG binding protein 2.
6HDAC: histone deacetylase.
7This representation was proposed by Prof. Shoji Tajima when I visited his Laboratory of Epigenetics, at
the Institute for Protein Research (Osaka University, Japan).
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and links to epigenetic changes have been established in several cases, e.g. in Wilm’s tu-
mour (Rainier et al., 1993) and colon cancer (Liou et al., 2007), both of which involve Loss
of Imprinting, (LOI, silencing specific genes on a parent lineage). In the latter, apparently
predating the tumours, LOI occurs in surrounding tissue - i.e. an environmental or “field
effect”. Motivation for this type of research is that, if information is accessible, this may
yeld pre-critical information on tumour formation.
Epigenetic mechanisms are also studied in other medical fields because of association with
obesity (Cooney et al., 2002), abnormal neural development (Kubota, 2008), mood disor-
ders such as stress vulnerability and bipolar disorder (McGowan and Kato, 2008), or risk of
heart failure (Mano, 2008).
Common to this research is costly and time-consuming lab testing. Ethical issues also arise
(study of epigenetically induced differentiation of stem cells being an obvious example).
Another limitation is that, while successful in investigating specific phenomena, they so far
fail to explain system-wide complex interactions. This can be explained both by overall
system complexity and by technical constraints leading most research groups to focus on
one epigenetic change in one given context.
This need for integration of these partial results is crucial to understanding the overall bio-
logical system, and computer-based modelling, (increasingly used as a complement to lab
testing in other fields, see e.g. Dove (2006)), can provide useful framework to address such
need.
7.3 Immune response and epigenetic changes
7.3.1 Epigenetics in the immune system
Agent-based models and other bottom-up approaches are often used to examine individu-
ality in a system. In the lymph network model implemented, individuality of response is
obtained through the implementation of local rules. At the epigenetic level, another layer
of individuality can be observed: cells, through differentiation, have individual profiles.
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Epigenetic changes are involved in differentiation of CD4 cells. Naive CD4 T cells de-
velop into either type Th1 or type Th2 CD4 cells that predominantly secrete IFN-γ or IL-4,
respectively. The former are mainly interacting with macrophages and cytotoxic CD8+ T
cells, promoting cell-mediated response. The latter interact with B lymphocytes and pro-
mote humoral response. This differentiation is obtained by the expression of one cytokine
gene and the permanent silencing of the other, controlled using epigenetic mechanisms. Re-
cent research, which focuses on isolating environmentally induced epigenetic change that
occurs during Th1/Th2 cell development, could explain how certain Th1/Th2-associated
conditions develop (Sanders, 2006). The authors hypothesize that diet, ageing, or use of
certain drugs could lead to changes responsible for shift in Th1/Th2 profile which would,
in turn, affect disease susceptibility and resistance.
In a recent article (Chang and Aune, 2007), the authors also considered those two lineages,
and focused on the locus encoding interferon-γ (Ifng locus). In particular, they explored his-
tone modifications. Methylation of H3K9 across the locus was found to be rapidly induced
during differentiation, and to be conserved in Th1 cells. On the contrary, for Th2 cells,
methylation is limited to H3K27. With much of the immune experience dependent on ini-
tial priming (Ruskin and Burns, 2006), it is evident that understanding epigenetic changes
can provide further information on initial system status and differentiation of immune cells.
7.3.2 HIV-related epigenetic changes
Epigenetic patterns, related to HIV infection, are also under consideration. There is a grow-
ing argument that highly active antiretroviral therapy is not a viable solution to stop disease
progression, as multi-drug resistant HIV (MDR-HIV) strains have appeared (Little et al.,
2002). Alternative therapies are currently being sought, and epigenetic inhibitors such as
peptide nucleic acids (PNA), which targets transcription of specific regions of viral mRNA,
are considered to be good prospects (Sei, 2005).
Research is also focusing on methylation patterns. Methylation of specific regions of viral
genetic material has been shown to be associated with inhibition of transcription (Bednarik
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et al., 1987; Schulze-Forster et al., 1990), which implies, potentially, an important role in
viral latency. Recent studies have confirmed this, showing that CpG sites in the 5’ long ter-
minal repeat (LTR8) are selectively hypermethylated, and that TNF-α-induced reactivation
is associated with demethylation of the 5’ LTR (Ishida et al., 2006). In vivo experiments
are, however, limited by low copy numbers of HIV provirus, which prevent direct analysis
of CpG methylation.
Further studies are, therefore, required to fully understand involved mechanisms, but epige-
netic “treatment” is a promising long-term project. This, of course, implies a better compre-
hension of multiple epigenetic interactions, and in silico models would certainly advance
this.
7.4 An example of infection-induced epigenetic perturbation
7.4.1 Context of the study
As a proof of concept for computational models of epigenetic changes, a study on infection-
induced epigenetic perturbations is presented here. The model and target medical condition
are the result of initial discussions on collaboration with Toshikazu Ushijima9 and his team.
Their main objective is to better understand epigenetic changes in the context of cancer
initiation, and to apply this to improve prevention, early-stage diagnostics and treatment.
The motivation is that epigenetic alterations in non-disease tissues can be used as markers
for disease risk and past exposure to some disease-inducing factors. In particular, current
focus in on detection of aberrant DNA methylation in non-cancerous gastric mucosae, as
the presence of such patterns can be used as a marker for both the risk of gastric cancers and
past exposure to Helicobacter pylori. A detailed presentation in the context of this study is
available in Nakajima et al. (2008). For convenience, main points are summarised here.
8LTRs are characteristic of viral genetic material. They flank functional genes, and their main function is to
mediate integration of the retroviral DNA into host chromosome. The five prime, (5’), end refers to the end of
the DNA, (or RNA), strand that has the fifth carbon in the sugar-ring of the (deoxy)ribose at its terminus, (as
opposed to the 3’ end, which is terminating at the hydroxyl (-OH) group of the third carbon in the sugar-ring,
and is also known as the tail end.
9Carcinogenesis Division, National Cancer Center Research Institute, Tokyo, Japan.
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In cancer development, aberrant DNA methylation is involved at two levels:
• Overall hypomethylation, which affects repetitive DNA sequences and causes both
chromosomal instability, (and, therefore, tumours (Gaudet et al., 2003)), and aberrant
expression of normally methylated genes (Smet et al., 1999).
• Regional hypermethylation, most of which affects CpG islands and causes, (if these
islands are located in gene promotion region), transcriptional silencing of down-
stream gene. In the context of cancer, methylation affecting tumour suppressor genes
is well documented, (see e.g. Jones (2002); Baylin and Ohm (2006)). This is some-
times referred to as driver methylation, because of causal involvement in carcinogen-
esis, (as opposed to passanger methylation, which refers to genes whose methylation
is a consequence of cancer development, and therefore requires careful analysis of
newly detected genes (Ushijima, 2005)).
In the context of gastric cancers, gene inactivation, (e.g. for tumour suppressor gene p16), is
more frequently a consequence of aberrant promoter methylation than of defaults of the ge-
netic level (Ushijima and Sasako, 2004), but Ushijima and his team also observed that low
levels of aberrant methylation occur in non-cancerous mucosae of cancer patients (Kaneda
et al., 2002). This was tested against tissues from healthy individuals, and it was found that
methylation levels for these patients were 5.4 to 303-fold higher in H. pylori-positive indi-
viduals than H. pylori-negative individuals (Maekita et al., 2006). This is a very significant
finding, since H. pylori is known to be a major risk factor for gastric cancers.
It was also highlighted that part of this hypermethylation is temporary and will decrease
after eradication of infection. This is not due active demethylation, but to cell turnover. The
structure of the gastric crypt, (one stem cell, multiple progenitor cells and many differenti-
ated cells, as shown in Figure 7.3), is the cause for this two-part methylation, where:
• Permanent component is due to methylation of stem cells. Since methylation is con-
served during cell division, progenitor and differentiated cells obtained from aber-
rantly methylated stem cell will exhibit identical abnormal patterns.
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• Temporary component is due to methylated in progenitor and differentiated cells
which, if stem cell of the crypt is not methylated, will disappear because of cell
turnover and creation of new, unmethylated, cells.
Gaining a better insight into these methylation dynamics during infection, (summarised in
Figure 7.4a, p.115), and in the long term, (Figure 7.4b), is the objective of the prototype
model we have developed, detailed in the following.
D i f f e r e n t i a t e d  c e l l s
P r o g e n i t o r  c e l l s
S t e m  c e l l
Figure 7.3: Structure of a gastric crypt, with one stem cell, a few progenitor cells and
approximately one hundred differentiated cells on each side
7.4.2 Implementation
To investigate the dynamics of infection-induced aberrant methylation in the crypt, we im-
plement an object-oriented model of the entities involved. The structure of this crypt model
is shown in Figure 7.5, (p.117). Key attributes in the model are the infection status of the
crypt, its size, the methylation status of each cell, and the overall methylation level in the
crypt.
A sample, which mimics in silico the samples obtained in vivo during NCC experiments,
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(a) During H. Pylori infection, cells can be methylated, with different probabil-
ities depending on their type. Methylation status is conserved through cell
division, (from stem to progenitor cell, and from progenitor to differentiated
cell).
(b) After eradication, only crypts were the stem cell was methylated conserve
aberrant methylation, (which is propagated through the whole crypt, during
cell divisions).
Figure 7.4: Methylation dynamics in gastric crypts.
Colour represents cell type, (black for stem cells, grey for progenitor cells, white for differentiated
cells), and aberrant methylation is shown with a cross inside the cell.
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is implemented as an array of crypts. Each crypt is initialised with one stem cell, six pro-
genitor cells, and one hundred differentiated cells on each “wall” on the crypt. No cell is
aberrantly methylated.
At each time step, (i.e. every minute of “real time”), each crypt is updated, as follows. First,
cells at the top of both “walls” are checked, and removed if they are too old. When there is
no infection, their life span is approximately three days. During an infection, it is reduced
to almost two and a half days.
Then, we update the bottom of the crypt. A new cell may be created on each side, with a
probability p, which is set to approximately 2.3 × 10−3 in normal conditions. During an
infection, p is increased, and ranges from 7.0× 10−3 to 2.6× 10−2, as shown in Table 7.1.
We then update progenitor cells, which can only produce a limited number of differentiated
cells before being replaced by a new progenitor cell.
Finally, we update the methylation status of the progenitor and stem cells. They have methy-
lation probabilities α and β, respectively. The proposed values for α and β are discussed
next.
Size increase Observed frequency Corresponding range for p
(estimation provided by T. Ushijima)
2-3 times 30% [7.0× 10−3, 1.0× 10−2]
4-5 times 30% [1.0× 10−2, 1.7× 10−2]
6-7 times 20% [1.7× 10−2, 2.3× 10−2]
8-10 times 20% [2.3× 10−2, 2.6× 10−2]
Table 7.1: Crypt size during infection: range of possible sizes, and corresponding values
for the probability p to produce a new cell during the crypt update.
7.4.3 Results
The hypothesis from NCC is that, in normal conditions, stem cell methylation is not possible
and that, during H. Pylori infection, the probability to methylate these remains significantly
lower than that of progenitor cells. As a consequence, the model is built with α = 2×10−7
and β = 0 under normal conditions, and α = 6× 10−5 and β = 3× 10−8 during infection.
116
C r y p t
+ s i z e R i g h t :  i n t
+ s i z e L e f t :  i n t
+ i s I n f e c t e d :  b o o l
+ m e t h y l a t i o n L e v e l :  b o o l
- c e l l P o p u l a t i o n :  i n t
- p r o g e n i t o r C e l l s [ 6 ] :  i n t
- s t e m C e l l :  i n t
- c e l l s :  C e l l *
- i n f e c t e d S i z e P a r a m e t e r :  i n t
C e l l
- c e l l T y p e :  C e l l T y p e
- m e t h y l a t e d :  b o o l
- t i m e I n d i c a t o r :  i n t
Figure 7.5: Crypt implementation: class diagram
A sample of one hundred crypts is created, and several simulations are performed. Infection,
in simulations where it is included, starts at week 5, (i.e. day 35). When H. Pylori eradica-
tion is scheduled, this takes place at week 55, (i.e. day 385). This mimics the experimental
conditions of the in vivo results provided. The results obtained from these simulations are
shown in Figure 7.6 for the crypt size, and Figure 7.7 for the methylation levels, (p.119).
It is technically difficult to count cells in the crypt once it has expanded, and quantitative
comparison with simulated crypts is, therefore, limited. However, the in silico results are,
qualitatively, in accordance with the known influence of H. Pylori infection on the crypt.
The crypt size initially drops because of the quicker removal of cells near the end of the
crypt, but this is rapidly more than compensated by the increased production of cells, and
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the crypt expands. The range of sizes successfully reproduces the estimation provided. Af-
ter eradication, the crypt size starts decreasing after an 18-hour delay, and initially drops
below the original size. The normal regime is restored after approximately four days.
The proposed values for α and β confirm the validity of the NCC hypothesis. The probabil-
ity exists to have infection-induced methylation of progenitor cells 2000-fold greater than
that of stem cells, resulting in the two-part methylation. The values for these probabilities
in the simulations give ranges for the methylation level in all conditions, (i.e. infection or
not, eradication or not), which closely reproduce the in vivo results10 provided.
The model implemented confirms, therefore, both the hypothesis formulated, (since we
were able to reproduce it), and the need for in silico epigenetic models, (since, in confirm-
ing the hypothesis, we provided additional information which was not accessible during the
physical experiments, i.e. quantitative values for the methylation susceptibilities).
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(a) H. Pylori infection reduces the life span of crypt
cells, resulting in initial drop in crypt size, but
also induces an increased production, which
leads to a significant increase of crypt size.
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(b) After eradication, the cells produced in excess
are rapidly removed. This results in a crypt size
temporarily below normal levels, but this is re-
stored to normal size within days.
Figure 7.6: Simulated crypt size dynamics on a sample of 100 crypts.
Plain and dashed lines correspond to average crypt size, while dot-dash lines correspond to minimal
and maximal crypt sizes.
7.4.4 Applications
The model developed is a useful complement to in vivo experiments and provides the dy-
namics of infection-induced aberrant methylation. This is crucial to a better understanding
10Confidential results unpublished yet, at the time of writing. A manuscript is in preparation.
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Figure 7.7: Simulated methylation level on a sample of 100 crypts.
Without infection, methylation is almost absent. H. Pylori infection leads to progenitor cell methy-
lation, which results in rapid fluctuations of the methylation level, since these cells have a finite life
span and are replaced with unmethylated cells, (unless the stem cell is methylated). The infection
also leads, with a smaller probability, to stem cell methylation, which results in permanent and com-
plete methylation of the corresponding crypt, (and therefore a sharp increase of the methylation level
of the sample).
of the initiation of gastric cancers.
Methylation levels were observed to be significantly higher in cases of gastric cancer than
in healthy volunteers (Maekita et al., 2006), and significantly higher in patients with mul-
tiple gastric cancers than in those with a single gastric cancer (Nakajima et al., 2006a).
Since patients with multiple cancers are considered to have a higher risk of gastric cancers
(Nakajima et al., 2006b), these results demonstrate the potential of methylation levels in
non-cancerous gastric mucosae to act as a biomarker for gastric cancer risk.
This is likely to be generalised to other types of cancer: aberrant DNA methylation in non-
cancerous tissues was also identified e.g. in the colon (Issa et al., 1994), the liver (Kondo
et al., 2000), and the stomach (Waki et al., 2002). In silico models can facilitate a quantita-
tive methylation analysis and investigate the influence of potential inducing factors.
Our epigenetic model layer is, therefore, a valuable tool by itself, but is also promising
in the context of the main immune model. Epigenetic mechanisms are involved both in
normal differentiation of immune cells and in HIV-induced perturbations, (Section 7.3).
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Providing data similar to that obtained from NCC for gastric cancers becomes available in
the immune context, our model can be applied to these perturbations. The results provided,
instead of indicating potential biomarkers as above, would then be used to refine the agent
implementation in the lymph node model.
7.5 Chapter summary
In this Chapter, it was demonstrated that it is possible to develop computer-based models
of epigenetic changes, and that these models can be a useful complement to physical exper-
iments, both in vivo and in vitro. Here, the model implemented can be used on its own, or
as an additional layer to the immune model detailed in earlier Chapters.
The results from the simulations performed confirm the hypothesis formulated at NCC that
H. Pylori infection induces aberrant DNA methylation in progenitor and stem cells of gas-
tric crypts. We were also able to provide estimations for the methylation susceptibility of
these cells, and to detail the crypt dynamics during infection, which are difficult to physi-
cally monitor.
Progress on epigenetic perturbations in the context of HIV infection will, in the long term,
permit the application of this model to HIV-induced aberrant changes, which will enable a
refined implementation of the agents in the lymph node model.
Finally, this epigenetic model, being the first to successfully reproduce epigenetic events in
silico, can be used as a proof of concept for further development of more ambitious models,
which would incorporate several epigenetic changes and the complex interactions between
them.
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Chapter 8
Summary and future research
8.1 Summary
The review in Chapter 2 clearly indicates limitations inherent in immune system modelling:
as a complex system, a full description by a single model has proven elusive to date, despite
some useful insights gained. Commonly, each new model or extension seeks to address
known limitations of existing implementations and to provide additional explanation on
components of the overall system. In what has been presented here, we have sought to
highlight the layers that obtain in building a model for a biological system, where these
are characterised by multiple dependencies. Our focus is still improvement of the immune
system model with specific entities, but we have also considered exploratory investigations
on the layers that sit below this, in particular in our effort to tie in genetic and epigenetic
influence. Three layers of complexity are tackled, and for each, limitations are identified
and addressed.
The main layer still focuses, at the phenotypical level, on immune response to HIV. To
better link known microscopic interactions to observed patterns of disease progression, the
use of the agent-based paradigm is advocated and, in that context, several limitations are
identified, and addressed.
Four types of agents are modelled which, we believe, fully account for cell-mediated re-
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sponse and HIV mechanisms, while this reduces agent diversity to a level which permits
simulation of large populations. A short time step, (fifty seconds), is proposed, to guar-
antee sensible granularity, which ensure that no significant interaction is unaccounted for.
Immune memory is implemented at the cell-level, in accordance with principles associated
with bottom-up programming. Antigen recognition is also improved, and refined to include
adaptability: recognition is not binary.
Further integration at this main layer is provided by linking key activity of lymph nodes in a
lymph network. This is crucial, in that it allows modelling of cell mobility both within nodes
and between them. This implementation requires, (and permits), parallelisation in order to
simulate large network sizes. Details of the implementation are given and where several
strategies are presented, tested, and optimised. In particular, a communication strategy,
based on a mimic of the lymph network, is identified as the best communication protocol
for proposed model.
This has permitted tests on large-scale simulations, as reported in Chapter 6. Known macro-
scopic signatures of HIV are successfully reproduced. Cell mobility, in particular, leads to
accurate representation of viral spread through the lymph network, with a rapid spread
within the initial lymph chain, and a slower progression throughout the body. An extension
to include localised effects in the gastrointestinal tract is proposed, and details of this new
extension are presented and tested.
Additional layers are considered in further chapters and in Appendix A, namely the iden-
tification through expression of genes involved in system functionality. Considerations for
extracting such information from microarrays are discussed and a new weighting scheme
is introduced, and successfully validated using an innovative assessment framework. This
scheme is then used in a parallel genetic algorithm which successfully identified co-regulated
genes. These results can be applied to all types of microarray datasets and can, in particular,
feed into the main layer to refine agent implementation in the lymph node model.
Finally, the sub-genetic model layer is considered, and in silico modelling for Epigenetics
is presented. Several challenges persist at this level, including overall lack of quantitative
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data, but the proposed model of infection-induced aberrant DNA methylation, (target to H.
Pylori), is an interesting proof of concept and very promising in terms of future research
directions.
8.2 Future research
While the overall multi-layer model addresses significant limitations of existing approaches,
it is not exempt from further problems itself. These will be the focus of future research, and
are detailed here, for the main layer, (i.e. the lymph network model).
Our first extension would be to consider possible multiple infections of each CD4 cell: a
cell can, indeed, be infected by several viral strains. In terms of our model implementation,
this should not require important changes. In the current version, CD4 agents can only be
infected once. This action is stored using a single integer representing viral strain, but this
is easily changed to a list of integers, (as can be found for APC agents and their list of pre-
sented antigens). This should not dramatically change model behaviour, but will introduce
further variability in disease experience.
In the extension for the lymph network model proposed for inclusion of the gastrointestinal
tract, it was explained that not all tissues are lymph nodes. In a first attempt, the generic
lymph node implementation was sufficient, but further work may consider refinement of
this. For instance, additional tissue may be implemented using smaller matrices and/or dif-
ferent connectivity between these. This will involve further review of the literature in what
is a fairly new development, to guarantee optimal implementation.
Cell mobility, as shown in this model, is crucial to both viral spread and immune activation,
and has been somewhat intermittently included in previous models. Our current imple-
mentation gave an interesting insight into how this affect the overall system, and further
refinement is likely be very useful. A few models dealing exclusively with cell recircu-
lation have been proposed (Farooqi and Mohler, 1989; Srikusalanukul et al., 2000; Stekel
et al., 1997). Direct integration of these features into our current model is not possible, as
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the approaches implemented are very distinct. The results reported, however, can provide a
basis for refined local mobility rules.
Another extension would be to explicitly implement thymus operation. In the current ver-
sion, input of new cells from the thymus is dealt with on a node to node basis, taking into
account pressure added by local cell depletion. This is acceptable for the input itself, but
neglects possible infection of the thymus itself. Data appears to be relatively sparse for this
very local aspect, but some interesting work exists (McCune, 1997). Successful implemen-
tation of the gastrointestinal tract is a cause for optimism with regard to the model ability
to account for this other localised effect. Further GI extensions detailed above will give
further experience as to which architecture is best suited for the thymus implementation,
(e.g. in terms of matrix size).
Adding a new type of agent, to account for drug intervention is likely to be very useful.
Large-scale simulations may, indeed, give interesting details on when and where treatment
should be targeted. This was detailed for the gastrointestinal tract, but is also true with
respect to the thymus, and to the overall system. This adds significant complexity, but
expertise within the research group can provide insight on techniques to facilitate imple-
mentation.
Finally, another extension would be to consider redevelopment of graphical output. As
shown in Figure 4.8, (p.58), such a feature was available in early stages of model develop-
ment, for single-node simulations. Visualisation, however, is non-trivial. In the lymph node
model, each matrix element can contain dozens of agents. There is no immediate way to
graphically represent an element in which are found two activated CD8 agents, three CD4
agents, one of which is infected, and four APCs! Initial graphical output was not satisfac-
tory, and not adapted to large-scale parallel simulations involving hundreds of lymph nodes.
Visualisation can, however, be useful, particularly in terms of dissemination if information
to non-Computer Science experts and is certainly worth detailed investigation. Two levels
seem indicated. At the lymph node level, initial output may be adapted and would pro-
vide an interesting way to demonstrate the impact of cell mobility. At the network level,
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a representation of viral spread, e.g. in terms of viral concentration in each lymph node
at a given time point, would help to demonstrate growth stages and key targets as well as
network vulnerability. This is already under consideration, as we recently outlined (Perrin
and Burns, 2008).
8.3 Final remarks
Model layers developed in this Thesis each represent a significant advance to modelling as-
pects of host response to adverse changes, in that they either address significant limitations
of existing models, or provide first attempts in new and promising areas.
Agent-based immune models have now been taken to a new scale, which can account for
more than a billion cells and account for crucial phenomena such as cell mobility, as well
as localised effects such as early infection in the gastrointestinal tract and, potentially, the
thymus.
The contribution to microarray biclustering methods, (Appendix A), is a formalised ap-
proach, in that there is a clear and objective framework on which to assess weighting
schemes of gene-condition networks, which have been shown to be important in deter-
mining gene involvement in specific conditions. Parallel genetic algorithms also provide a
powerful way to make the most of these schemes, including the one proposed here.
Epigenetic modelling is still, of course, at a very early stage, but the initial model is a signif-
icant first step towards a better understanding of involved phenomena. Attempts to integrate
several layers in human system-based modelling also represent a significant development,
and this Thesis, we contend, provides an important contribution to the Computational Biol-
ogy field.
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Appendix A
Beyond phenotype: understanding
gene expression
A.1 Objectives
The mechanisms leading to the development of the phenotype form a biological system at
least as complex as the immune response itself studied in the main body of this Thesis,
and the objective of this Chapter is not to provide a definitive description and model for
this system. Rather, it is to propose tools for a more efficient analysis, (and indicate how
these can be built in the main model). The results obtained from this enhanced analysis can
indeed, in the future, lead to a better understanding of gene function in the emergence of
immune responses. This would form an additional layer to the current main model, leading
to refined agent implementation. Here, a layer does not mean using these results directly
during the simulation, but rather refers to a layer of knowledge used during model develop-
ment. Gene function analysis in the context of the immune system is a novel area, (see e.g.
(Sarson et al., 2007)), but is very promising.
The link between these two layers is shown in Figure A.1, (p.129), but a better understand-
ing of gene function can of course be applied to several areas, and is not limited to HIV
modelling. Common techniques used to study gene expression include microarrays and
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related analysis techniques. Here, we chose biclustering to extract valuable information
from microarray datasets. This new layer therefore uses low-level information, (levels of
expression of thousands of genes), and produces refined data at the same modelling level,
(identification of genes with similar expression pattern). This classification of genes is use-
ful for all fields of biology, (immunology or otherwise). In the particular context of our
immune system model, such analysis, performed on microarrays specifically dealing with
immune cell lineages, can be used to refine the lymph node model, through a more detailed
implementation at the agent level.
Analysis methods for gene expression microarrays, even though widely used, often lack
formal validation and evaluation, either as a whole, (as outlined in Turner et al. (2005)), or
even of their main components. In particular, these techniques rely heavily on weighting
schemes which, given their importance, are surprisingly rarely analysed. This is also true
for algorithms underpinning the analysis, yet most are said to perform “reasonably”. This
presents difficulties in terms of meaningful evaluation and attempted improvements. Some
basic questions include:
• Is this technique efficient thanks to a well-designed weighting scheme? If this is the
case, then this scheme is portable, and efforts should focus on improving the analysis
algorithm.
• Is the analysis technique relying on a robust and efficient analysis algorithm? In that
case, the focus should be on improving the weighting scheme.
In some cases, both components of the analysis may represent considerable advances for
the field. It is also true that not all techniques work equally well under all circumstances.
However, a poor technique overall could still have, as one of its components, an interesting
weighting scheme or analysis algorithm.
A crucial objective of this Chapter is, therefore, to introduce evaluation of both analysis
components. A new weighting scheme and parallel genetic algorithm for biclustering are
presented and evaluated.
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Figure A.1: Biclustering as an additional layer of the overall model.
Low-level biomedical information, (i.e. level of expression of thousands of genes) is used as an
input to this layer. The results from the analysis, (identification of genes with similar expression
pattern), can be used directly by biologists, or can be used in the lymph node model to refine the
agent implementation and, in turn, enhance the realism of the immune system model. A biclustering
technique requires two components: a weighting scheme and an analysis algorithm. Here, a genetic
algorithm is chosen for the analysis.
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A.2 Gene expression microarrays
A.2.1 Measuring expression levels of genes
Microarray technologies are used for large-scale transcriptional profiling, through measure-
ment of expression levels of thousands of genes at the same time. The motivation here is
that by understanding gene expression, further insight will be gained into cell function and
cell pathology (Valafar, 2002).
Expression-intensity values, (based on fluorescent techniques), are recorded for multiple
microarray experiments carried out under several conditions, (e.g. environmental, biolog-
ical phases, different biological tissues). The data obtained is often presented as a real-
valued matrix: a row contains the expression pattern of one gene over all the conditions,
while a column represents the pattern of expression of all genes for one condition. Each
matrix element Xij is, therefore, the measured expression of a gene i under condition j.
Analysis is needed, to extract meaningful information, from the large datasets, about the
system being studied. Given the amount of data produced, this is not trivial.
A.2.2 Microarray biclustering
Several techniques have been developed over the years to analyse gene expression microar-
rays, (see e.g. Stolovitzky (2003) for a general review), and several of these are variations
of the concept of clustering. The objective here is to group genes, based on their expression
under multiple conditions (or over different time-points) or, conversely, to group conditions
according to expression of several genes (Raychaudhuri et al., 2001; Slonim, 2002).
Biclustering was introduced, by Cheng and Church (2000), as the simultaneous cluster-
ing of both genes and conditions. The authors identify three advantages over traditional
clustering:
• Biclustering is better at selecting genes and conditions with more coherent measure-
ment and dropping those representing noise.
• Grouping of genes through biclustering is based on similarity in the context of the
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subset of conditions. Biclustering, therefore, discovers both grouping and context, a
result more advanced than that obtained from successive clustering of rows and then
columns separately.
• Biclustering allows genes and conditions to be part of multiple biclusters, i.e. be iden-
tified by more than one functional category. This is reflective of actual functionality
of genes.
These authors also considered the NP-hardness of the problem, later shown to be NP-
complete (Peeters, 2003).
Several categories of biclustering algorithms coexist, and vary as to type of biclusters
achieved. While some look for biclusters with constant values on rows and/or columns,
(see e.g. Busygin et al. (2002)), it was highlighted, in a recent survery (Madeira and
Oliveira, 2004), that more advanced, improved algorithms locate biclusters with coherent
values (Wang et al., 2002) or coherent evolution (Liu and Wang, 2003). This latter category
is very interesting, since biclusters in this case are formed irrespective of the exact expres-
sion values, but rather by looking at evidence that a group of genes show similar expression
patterns, (up-regulated, or down-regulated), over a number of conditions. A widely-used
algorithm from this category is SAMBA1 (Tanay et al., 2002).
However, it is difficult to comprehensively evaluate existing tools when parts of the analy-
sis technique are not validated individually. The remainder of this Chapter will, therefore,
focus on development and analysis of the elements of a biclustering algorithm built on a
new weighting scheme and parallel genetic algorithm.
A.2.3 Problem formulation
The first of the proposed technique is to consider data from the gene expression matrix as bi-
partite graph. Two sets of nodes represent genes and experimental conditions, respectively.
Edges are limited to connecting these two sets, hence the bipartite structure. It is a complete
1SAMBA: Statistical-Algorithmic Method for Bicluster Analysis.
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bipartite graph (or biclique), since there is an edge linking any pair of gene-condition. An
example of a complete bipartite graph is displayed in Figure A.2.
Weights are then assigned to edges, based on expression data stored in the matrix, so that
Figure A.2: A complete bipartite graph with partitions of size 2 and 3
gene-condition pairs identified as “interesting” are given negative weights. In this context, a
bicluster is a subgraph which conserves the biclique structure. In other words, the proposed
algorithm will look for bicliques with minimum total weight.
Since the search domain is a complete bipartite graph, the biclique structure can be de-
scribed as follows (and is summarised in Equation A.1:
• An edge can not be included in the biclique if the associated gene is not included.
• An edge can not be included in the biclique if the associated condition is not included.
• If a gene and a condition are included in the biclique, then the edge linking them
together is also included.
The biclustering problem is, therefore, mathematically defined by Equation A.2. This prob-
lem being NP-hard, the mathematical formulation can not be used as is for large microar-
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rays, and a meta-heuristic method is implemented.

xij ≤ yi (edge not in the bicluster if gene not included)
xij ≤ yj (edge not in the bicluster if condition not included)
xij ≥ yi + yj − 1 (edge in the bicluster if both are included)
xij ∈ {0, 1} (xij is a boolean variable)
yi, yj ∈ {0, 1} (yi and yj are boolean variables)
(A.1)
Minimise
∑
i,j
cijxij (A.2)
conditions (A.1)
xij , yi, yj ∈ {0, 1}
cij ∈ R
A.3 Weighting schemes for microarrays
A.3.1 Importance of weighting schemes in analysis techniques
As highlighted in Section A.1, weighting schemes are a crucial element of microarray anal-
ysis techniques. All biclusters found by a particular technique are of course dependent on
the weights used to evaluate them. Different weights, all else being equal, provide different
results and interpretation of gene expression patterns.
A review of existing methods leads to the observation that there are almost as many weight-
ing schemes as there are analysis techniques, since most new techniques incorporate a new
weighting scheme, or a variant of an existing one.
Yet, these schemes are rarely explicitly validated, and results are often restricted to the
overall method. It is difficult to estimate whether this is a cause, or a consequence, of the
abundance of schemes, and it may appear that a new scheme is the last thing that is needed.
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Nevertheless, in the remainder of this Section, a new weighting scheme is introduced. This
scheme is technique-independent, which seems the best way to break the current “one tech-
nique - one scheme” rule for microarray analysis. This scheme is evaluated through a set
of criteria and, later in the Chapter, we use it ourselves as a key part of the biclustering
algorithm.
A.3.2 Development of a new weighting scheme
The underpinning motivation of the distribution-based scheme proposed here is that it is
difficult, if not impossible, to give an absolute characterisation of an interesting, and bi-
ologically significant, gene-condition couple. An absolute expression level, on its own,
means very little. On the other hand, the study of the expression level of a given couple
relatively to that of other related couples could give an interesting insight. A biologically
meaningful couple is one where we can highlight a significant effect of the condition.
It implies an expression level differing notably from the average expression pattern ob-
served for this gene over all the conditions. It also implies some deviation from the effect
this condition has on the whole set of genes: if a certain condition leads to over-expression
of virtually all the genes, it might not be very interesting to consider its effect on one of
these many genes.
In this approach, the microarray is considered as a matrix containing only positive values:
the expression levels. Some microarray datasets are only made available after they are trans-
formed into log space, (a result of the normalisation process), thus leading to some negative
values for low expression levels. For such cases, the first step is to transform the data back
from log space, to deal exclusively with positive values.
Actual expression levels are then replaced by expression ratios, obtained by dividing the
expression level of one gene under one condition by the average expression level of this
gene over all the conditions. For a given gene, we therefore obtain a series of positive val-
ues, of average unity, with values below unity when the gene is under-expressed under a
certain condition, and greater than unity for a gene over-expressed under the condition.
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The next step is used to account for the second aspect detailed above. For a given condition,
we want to differentiate between the genes that have a specific behavior and those that react
to the condition as most other genes do. This is achieved using a geometric series to create
categories with a small width for values close to unity, and increasing as ratios are further
from this value. Such series are used because of the skewness of the data: many genes show
very little response to a given condition and therefore having an expression ratio close to
unity. Two series are used: one for ratios greater than 1, and the other for ratios smaller
than unity. The common ratioR for each geometric series is calculated using Equation A.3,
where categories is the number of categories needed, and Min and Max are, respectively,
the smallest and the greatest value of the partial set considered for the series. For the [1;∞)
part of the dataset, Min = 1, and the category boundaries are, therefore, 1, R, R2, etc.,
with R ≥ 1. For the [0; 1] part of the dataset, Max = 1, and the category boundaries are,
therefore, 1, R, R2, etc., with R ≤ 1. For this part of the dataset, there can be a problem if
Min = 0, since R cannot be calculated on such cases. To prevent this from happening, we
only consider values different from 0 to compute Min.
R =
(
Max
Min
)1/categories
(A.3)
Once the categories have been created and populated, weights are given to the gene-condition
couples, depending on the size of the category they belong to. As most optimization tech-
niques are traditionally used to minimize a given objective function, we want to have neg-
ative weights for “interesting” couples, and positive ones for the others. The easiest way to
obtain size-dependent weights following this rule is to subtract the average population of a
category from the population of the category the couple belongs to: “small” categories get
negative weights, while the bigger ones get positive values. To avoid unnecessarily large
weights as the number of genes in a dataset increases, weights are then normalised using
this number of genes.
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A.3.3 Validation and analysis
A.3.3.1 Introducing an assessment procedure
As explained before, it is crucial that weighting schemes are validated on their own before
being used in a biclustering algorithm. An assessment procedure is needed. Discussions
with Gra´inne Kerr2, (see e.g. Kerr et al. (2008) for previous experience on microarrays
analysis), resulted in the five properties proposed below:
• Discrimination. Is the discrimination between “good” and “bad” gene-condition cou-
ples significant enough? Is the weighting scheme introducing false positives or false
negatives in terms of interesting couples?
• Robustness. Is the scheme’s response to noise and missing values reasonable?
• Configurability and parameter influence. How flexible is the scheme, and how does
this flexibility influence discrimination and robustness?
• Reusability. Is the proposed scheme effectively technique-independent?
• Biological meaning. If the weights can be interpreted biologically, discrimination
and reusability are increased, and validation is made easier.
A.3.3.2 Analysis of the proposed weighting scheme
The proposed scheme has some flexibility, through choice of the number of categories, k.
The influence of that parameter will be assessed through examination of the robustness and
discrimination achieved. The scheme is also technique-independent, since it was designed
without any particular subsequent analysis algorithm in mind. The only restriction here is
that microarrays are considered as bipartite graphs, but this representation is common in
current biclustering techniques, and does not limit the reusability of the scheme.
Biological meaning of the weights is a direct consequence of the weighting process: the
lower the weight, the more significantly the expression level of the gene deviates from that
2PhD Student. School of Computing, DCU, Ireland.
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observed for the majority of genes.
Several techniques exist to reduce noise or deal with missing values from microarray exper-
iments, (see e.g. Adjeroh et al. (2006); Verboven et al. (2007)). The objective here is not to
review techniques used to deal with them, but to evaluate how the scheme reacts to residual
noise and missing values. With this in mind, only low perturbations should be expected,
and the scheme is tested for perturbation levels up to 10%.
The influence of noise is summarised in Table A.1, for tests on the Gefitinib Treated Ka-
sumi Cell Line Dataset3. Similar results are obtained for two other datasets: the Yeast Cell
Cycle4 and the Lymphoma dataset5. Influence on the weights is reasonable for low noise
perturbation. “Stable” weights are those for which the variation is smaller than the noise
added to the dataset. It is an interesting indicator, because of the nature of the scheme:
when a gene-condition couple falls into a new category due to added noise, this changes
the weights for all couples in the new category as well as all those in the previous one.
Using this value may, therefore, give more insight into the scheme robustness, than us-
ing only the average absolute variation of the weights. Here, it confirms the behaviour is
satisfactory for expected levels of noise perturbation. The evolution of that proportion of
stable weights when the number of categories changes is displayed in Figure A.3a (p.140).
Clearly, as the number of categories increases, the width of each category decreases, and
gene-condition couples are more likely to change categories, leading to a smaller proportion
of stable weights. However, the average absolute variations are almost unchanged, (Figure
A.3b, p.140), so the effect of a larger number of categories on the weights assigned is rela-
tively small.
The influence of missing values is summarised in Table A.2, for the same dataset. Again,
the patterns obtained with the other datasets are similar. With respect to missing values, the
scheme is far less robust than in response to noise. Notably, the sign of the weights is not
3avalaible from the MIT Broad Institute website, http://www.broad.mit.edu/cgi-bin/
cancer/datasets.cgi.
4available from R.W. Davis’ website at Stanford, http://genomics.stanford.edu/yeast_
cell_cycle/cellcycle.html.
5available from the Lymphoma/Leukemia Molecular Profiling Project Gateway, http://llmpp.nih.
gov/lymphoma/
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Noise level 0% 1.5% 2.5% 5% 10%
Average absolute variation 0% 4.26% 6.47% 11.8% 21.6%
Proportion of “stable” weights 100% 84.2% 86.4% 86.5% 82.0%
Table A.1: Influence of noise (for 20 categories)
lost: a positive weight does not become negative, (except for cases when more than half
the values for a given gene are missing, but in those cases, it would almost certainly be ex-
cluded from the dataset before the scheme is applied). Biological significance is, therefore,
conserved. What is partially lost is the degree of over-expression, (or under-expression),
rather than the knowledge that this change of expression occurs. The evolution of the influ-
ence of missing values depending on the number of categories is displayed in Figure A.3c
(p.140) for the average absolute variation, and in Figure A.3b for the proportion of stable
weights.
As noted previously, a range of techniques dealing with missing values are not considered
here, but an extended evaluation of the scheme must account for these. Indeed, the re-
sults displayed correspond to untreated data, expected to create large perturbations in the
weights: for these missing values, an expression ratio of unity is artificially created, (a very
simple, conservative, and certainly very poor, correction technique). Future work might
reasonably include tests of the effect of the various correction techniques on the scheme
robustness.
Proportion of missing values 0% 1.5% 2.5% 5% 10%
Average absolute variation 0% 23.7% 38.5% 74.2% 141%
Proportion of “stable” weights 100% 35.28% 35.7% 32.6% 30.1%
Table A.2: Influence of missing values (for 20 categories)
The last series of tests consider the discrimination between gene-condition couples and
examines performance in terms of biological meaning. By construction, there is no “dam-
aging” false-positive or false-negative, at least in theory. In practice, these may occur for
weights very close to zero, (either positive or negative, depending on the number of cate-
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gories), but would not have a significant impact on biclustering. This, because these weights
are so close to zero, and correspond to “neutral” gene-condition couples. Not all gene-
condition couples with negative weight have to be included in any bicluster, of course, but
a significant change in expression patterns can not lead to a positive weight, while negative
weights are only obtained where there is a significant change. Since absolute, (positive vs.
negative), discrimination is guaranteed, the focus here is to assess relative discrimination,
i.e. the distribution of weight values. Results on the influence, of the number of categories,
on this discrimination are displayed in Table A.3. A first observation is that discrimina-
tion is good with, on average, just under 25,000 negative weights (out of 222,830). This
is consistent with the biological context: most genes are not specifically reacting to any
given condition. This value varies between 23,170 and 28,392, with a standard deviation
of 1,682. Discrimination is, therefore, very satisfactory for any number of categories in
the range tested. Weights obtained with fewer categories appear more refined, (except for
10 categories, which seems to indicate that going lower would be ill-advised). Given that
this range also corresponds to improved robustness, using k = 12 to 16 categories is rec-
ommended. This recommendation also applies to the other datasets, for which the results
obtained are similar.
Weights ≤-4 [-4;-3] [-3;-2] [-2;-1] [-1;0] [0;1] [1;2] [2;3] ≥ 3
10 categ. 5035 5630 4838 6230 6659 7327 4237 1772 181102
12 categ. 739 6241 5788 8217 5075 9371 6070 6010 175319
14 categ. 0 3210 7330 7603 7474 9197 7979 7957 172080
16 categ. 0 615 7823 8076 10137 6684 9168 11244 169083
18 categ. 0 0 6489 9283 7866 10708 7696 14108 166680
20 categ. 0 0 4318 9392 10350 10597 8686 11288 168199
22 categ. 0 0 2239 9834 11621 10975 11912 8494 167755
24 categ. 0 0 666 10747 12161 13237 8018 12875 165126
26 categ. 0 0 0 10806 13369 11863 10451 14696 161645
28 categ. 0 0 0 9369 13801 14670 11029 15410 158551
30 categ. 0 0 0 8266 15102 14362 13409 14972 156719
Table A.3: Influence of the number of categories on discrimination: distribution of weight
values
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Figure A.3: Evaluation of the robustness of the weighting scheme: influence of noise and
missing values
A.4 Biclustering through parallel genetic algorithms
A.4.1 Genetic algorithms and their application to microarrays
A genetic algorithm is an optimisation technique that was loosely inspired by mutations in
nature and how these lead to biological evolution through survival of the fittest elements
only (Holland, 1975).
The first step is to organise coordinates of points in the problem space as a sequence, in-
spired by gene sequences. A population of sequences is created and a search for optimal so-
lutions with respect to a fitness function is accomplished by mutating the sequences, hence
allowing transformation to new coordinates in the problem space. Each new sequence is
evaluated, to determine whether it represents a new optimum. Other techniques have been
added to mutations to create new sequences, as will be detailed when presenting the imple-
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mented algorithm.
Genetic algorithms have been extensively used in the context of biological applications,
such as DNA fragment assembly (Cedeno and Vemuri, 1993; Fickett and Cinkosky, 1993;
Parsons et al., 1995), multiple molecular sequence alignment (Zhang and Wong, 1997) and
phylogenetic analysis of proteins (Hill et al., 2005).
For microarray biclustering in particular, there have also been some attempts at developing
genetic algorithms (Chakraborty and Maka, 2005; Mitra and Banka, 2006), but assessment
of these implementations is limited, (Section A.1).
Moreover, a well-known limitation of genetic algorithms is that a large population of se-
quences is required (Goldberg and Deb, 1991; Jackson and Norgard, 2008). A solution is to
consider parallel implementations, and to the best of our knowledge none has been devel-
oped for biclustering. The objective of this Section is, therefore, to introduce and validate
a parallel genetic algorithm for biclustering of gene expression data from microarrays.
A.4.2 Parallel genetic algorithms
The parallel nature of genetic algorithms has been considered from the start and several
early implementations have been proposed (Grefenstette, 1981). Since then, different ap-
proaches have emerged. As proposed by Cantu-Paz (1995), we can categorize these as
follows:
• Global parallelisation. Evaluation of solutions and genetic evolution of the population
are explicitly parallelised, and each solution has a chance to combine with any other.
• Coarse grained parallelisation. Population of solutions is divided into subpopulations,
and these are isolated from each. To deal with these, this implementation introduces
a migration operator. Two types of implementation coexist in this category. In the is-
land model individuals can migrate to any other subpopulations, while in the stepping
stone model, migration is limited to neighbouring ones.
• Fine grained parallelisation. Subpopulations are very small, ideally only one solution
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is run on each processor. This, of course, requires a massively parallel computing
architecture.
• Hybrid parallelisation. The three previous strategies can be combined.
The most popular strategy is to use coarse grained parallelisation, (see e.g. Levine (1994);
Pereira and Lapa (2003)), and several implementation challenges have been reported (Cantu-
Paz, 1995; Katayama et al., 2003). These include:
• Topology. Connectivity of subpopulations affects convergence. Balance is required
between isolation, which allows development of new solutions, and efficient mixing,
which leads to propagation of good solutions.
• Migration rate and frequency. Again, balance is required between sharing too many
solutions, or too often, and not having a sufficient mixing, which would lead to inde-
pendent runs of genetic algorithms on small populations, producing poor results.
• Size of subpopulations. Larger samples mean better results, but also imply longer
computation time.
• Effectiveness of genetic operators.
With these in mind, the following algorithm has been implemented and tested.
A.4.3 Algorithm development
A.4.3.1 Parallel structure
The proposed architecture is coarse-grained parallelisation based on the stepping stone
model. For migrations, each subpopulation is sorted according to the total weight of the
encoded bicluster, and a bidirectional ring is used: solutions travelling clockwise are se-
lected from the “rich area”, (which contains the best solutions of the subpopulations, i.e.
solutions with lowest total weights), while solutions travelling anti-clockwise are selected
from the “poor area”, (which contains the solutions with the highest total weights). “Rich”
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and “poor” areas of a subpopulation are defined using threshold values for the total weight
of the encoded bicluster. This topology is detailed in Figures A.4 and A.5.
This parallel structure has six specific parameters:
• Number of subpopulations, s1, and size of each, s2.
• “Rich” area threshold, r. If a bicluster weighs less than r, (we are minimising), it is
considered a “rich” solution.
• “Poor” area threshold, p. If a bicluster total weight is greater than p, it is considered
a “poor” solution.
• Number of local iterations between two migration steps, n.
• Number of migrants sent in each direction at each migration step, m.
Figure A.4: Coarse-grained, stepping stone structure.
Here, four subpopulations are connected through a bidirectional ring. Selected solutions are
sent clockwise if they correspond to biclusters with a low total weight, and anti-clockwise
if they correspond to biclusters with a high total weight
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Figure A.5: Parallel topology.
Before a migration step, each subpopulation is sorted. Then, m solutions are selected from the
most promising ones, (i.e. those ranked below threshold r), and are sent clockwise. Similarly, m
solutions are selected from the least promising ones, (i.e. those ranked above threshold p), and are
sent anti-clockwise. Finally, new solutions are received: m good solutions arrive clockwise, and m
poor solutions arrive anti-clockwise.
A.4.3.2 Local genetic algorithm
Based on this parallel structure, the local genetic algorithm is developed, in collaboration
with Christophe Duhamel6, (who has previous experience on genetic algorithms, see e.g.
Potvin et al. (1996)).
Encoding the solution
The first step is to consider solution encoding as “genes”. Even though more advanced en-
codings are sometimes proposed (Chen et al., 2006), the traditional approach, chosen here,
is to encode solutions as genes using binary variables. Given the objective function defined
in Equation A.2, a naive solution would be to used edge presence in the solution bicluster
as a Boolean variable. The obvious limitation in this case is the length of the resulting
array: with 20,000 genes and 10 conditions in the dataset, (which is not unusual, as the
validation of the weighting scheme highlighted), 200,000 boolean variables are needed for
each solution! A second approach would be to have an array encoding presence of genes
and conditions in the solution bicluster. An important observation in this case is the relative
6Lecturer. Laboratoire d’Informatique et de Mode´lisation des Syste`mes, ISIMA, France.
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length for each part of the resulting array: there are often thousands of gene in a microarray
dataset, while finding a hundred or more conditions is very rare. The consequence is that
evolution operators will, statistically, mostly concern parts of the array corresponding to
genes, rather than conditions. Interestingly, explicitly encoding genes is not even necessary.
Indeed, once a subset of conditions is chosen, interesting biclusters only involve genes for
which the total weight over the selected conditions is negative. It is, therefore, possible to
perform biclustering while explicitly encoding only a small part of the bicluster.
Evolution operators
Evolution operators are used to increase the population of solutions, by introducing new so-
lutions obtained through small variations of existing ones. Since earliest implementations,
a characteristic operator is mutation. A solution is randomly chosen, and one of its boolean
variables is altered. This is summarised in Figure A.6a. A more drastic operator, based on
mutation, is also implemented in the proposed algorithm: the uniform mutation. A solu-
tion s is randomly chosen, and a boolean array u, of same length, is also created. A new
solution is then obtained by conserving the value of a boolean variable s[i] where u[i] is
equal to 1, and altering it otherwise, as shown in Figure A.6b. This operator induces more
diversity than traditional mutation, but can also degrade a good solution. It is, therefore,
recommended not to use it as frequently as the first one.
Another consequence of the bio-inspired nature of the algorithm is the use of crossover op-
erators, which are loosely based on the biological phenomenon occurring during meiosis.
Here, two existing solutions are chosen. These can be selected a uniform probability or it
can imposed, for instance, that one of them must belong the best 10% solutions. This sec-
ond approach is taken here, to ensure further “investigation” of promising solutions. Once
the two solutions are chosen, a cutting point is selected in the solution array, using a uniform
probability, and the solutions exchange the variables located after that point, as shown in
Figure A.6c. A variant exists where two cutting points are chosen, and solutions exchange
variables located between those two points, as detailed in Figure A.6d.
Selection
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1 1 0 1 1 0 0
1 1 0 0 1 0 0
(a) Mutation operator: a single boolean
variable is selected and altered
1 1 0 1 1 0 0
0 1 0 1 0 1 0
0 1 1 1 0 0 1
s
u
(b) Uniform mutation operator: several
boolean variables may be altered
1 1 0 1 1 0 0
0 0 1 0 0 0 1
s 1
s 2
1 1 0 1
1 0 00 0 1 0
0 0 1
(c) One-point crossover: two solutions ex-
change a section of their boolean array
1 1 0 1 1 0 0
0 0 1 0 0 0 1
s 1
s 2
1 1
0 1
1 0 0
0 0
1 0
0 0 1
(d) Two-point crossover: two solutions ex-
change a section of their boolean array
Figure A.6: Evolution operators for the “expansion” phase of the algorithm
A typical iteration of a genetic algorithm includes the creation of new solutions, (i.e. the
“expansion phase”), followed by the evaluation of population and selection of solutions that
will be conserved for the next iteration, the remainder being eliminated, (i.e. the “selection
phase”). Traditionally, between these two phases, it is necessary to consider “repair” func-
tions, which will restore validity of the new solutions created through evolution operations.
Here, because of the chosen encoding, any array is a valid solution, and such functions are
not required.
The final step is, therefore, to consider the “selection phase” of the algorithm. Here, sev-
eral approaches can be taken. In a first one, deterministic selection is used: if the initial
population was n, then the n best solutions in the expanded population are kept, and the
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other eliminated. The main advantage here is that, once the population is sorted, this type
of selection has a very low computing cost. Diversity, however, may be damaged. The
alternative approach is to consider “tournaments” between solutions, with the winner kept
and the loser eliminated. In this case, selection is obtained as follows: while solutions still
need to be removed, two elements within the current population are selected, and the one
with the best fitness value is chosen to be conserved with a probability p. This probability
is used to adjust the selection pressure: p = 1 is equivalent to the deterministic selection
described above, while p = 0.5 would correspond to a uniform selection which would not
take fitness into account.
Here, a hybrid approach is taken: the population is sorted, the n/2 best solutions are con-
served, while the others are involved in ‘tournaments” until we obtain a population of size
9n/10. Population size is then restored to n by introducing newly created solutions. Each
of these solutions is created as follows: (i) for each condition j, we count kj , the number of
times it appears in theN current solutions7; (ii) we generate random numbers rj , uniformly
in [0, N ]; (iii) condition j is included in the new solution if and only if rj > kj . This
improves the diversity in the overall population.
A.4.4 Validation of the genetic algorithm
A.4.4.1 Objectives and framework
The proposed genetic algorithm is implemented, and tested on a cluster architecture. The
objective of these tests is to determine whether, given a specific set of weights, the algorithm
can isolate useful biclusters. The results of these tests are detailed here.
To do this, it is, of course, necessary to extract these biclusters from the set. Mathematically,
it is possible, for a microarray dataset with m conditions, to find the best bicluster using k
conditions. Doing this, for all possible values of k ∈ [0,m], will extract these biclusters.
The main limitation here is, of course, the number of potential biclusters. In a microarray
withm conditions, there are 2m possible subsets of conditions, and the computation time of
7with N ∈ [9n/10, n].
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this exact method is, therefore, proportional to this value. With 10 conditions, this method
takes approximately half-a-second. This gives a computation time of the order of 2m−11
seconds. This corresponds to just over a minute with 17 conditions, four and a half hours
with 25 conditions, and already several thousand years with 50 conditions. This method is
obviously not practical, but for small microarrays, it offers the means to assess the genetic
algorithm.
A.4.4.2 Performance on small microarray datasets
Validation of the genetic algorithm is, therefore, performed on the two microarray datasets
used for assessment of the weighting scheme. Table A.4 shows results obtained from the
enumeration method and from the genetic algorithm, for those two datasets. On the KCL
dataset, the genetic algorithm performs very well, and even a single run of the local imple-
mentation with a population of size equal to the number of conditions, (here, n = k = 10),
finds the best solution. On the YCC dataset, however, the same local implementation is
more limited and some solutions it provides are quite far from the optimum. The parallel
implementation, (with local parameters unchanged and sixteen islands), still provides opti-
mal solutions. To further demonstrate the interest of this parallel implementation, severals
runs of each implementation are performed. Results are shown in Table A.5. The local
implementation finds each optimal solution in at least 10% of all runs, but just under half
of them are identified every time. The parallel implementation, with a similar computation
time, finds the best solutions every time.
A.4.4.3 Performance on large microarray datasets
For larger datasets, the exact method for extraction of the best biclusters can not be used,
and the results from the genetic algorithm can not be compared to known optimal solutions.
The alternative is to use a heuristic to identify “good” biclusters. Complexity is often non-
linear, and such techniques may not be practical for a regular use, but on a single large
dataset, they provide a basis by which to evaluate the performance of the genetic algorithm
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Kasumi Cell Line Yeast Cell Cycle
Enumeration G.A. P.G.A. Enumeration G.A. P.G.A.
1 condition -671,040 0% 0% -428,719 0% 0%
2 conditions -570,228 0% 0% -286,690 0% 0%
3 conditions -431,639 0% 0% -191,437 0% 0%
4 conditions -321,680 0% 0% -150,401 0% 0%
5 conditions -239,359 0% 0% -137,360 26% 0%
6 conditions -187,814 0% 0% -111,790 26% 0%
7 conditions -141,700 0% 0% -89,911 10% 0%
8 conditions -109,993 0% 0% -76,047 < 1% 0%
9 conditions -85,512 0% 0% -74,763 9% 0%
10 conditions -65,373 0% 0% -77,856 20% 0%
11 conditions N/A N/A N/A -77,651 15% 0%
12 conditions N/A N/A N/A -73,878 43% 0%
13 conditions N/A N/A N/A -68,084 39% 0%
14 conditions N/A N/A N/A -43,350 0% 0%
15 conditions N/A N/A N/A -27,093 0% 0%
16 conditions N/A N/A N/A -12,432 0% 0%
17 conditions N/A N/A N/A -7,665 0% 0%
Table A.4: Validation of the genetic algorithm on small microarray datasets.
Optimal values obtained by enumeration, and gap between these and values obtained by the local
genetic algorithm, (G.A.), and the parallel genetic algorithm (P.G.A.).
on large datasets. Here, we use the Lymphoma dataset, which contains 96 conditions.
The heuristic used for these tests has two components: (i) a promotion operator which,
given a current solution with k active conditions, finds the best non-active condition to add
to the bicluster and obtain a solution with k+1 conditions; (ii) a demotion operator which,
given a current solution with k active conditions, finds the active condition to remove from
the bicluster with the best effect and obtain a solution with k − 1 conditions. Recursively
using these two operators, starting with the “empty” solution and “complete” solution re-
spectively, we obtain useful biclusters of all possible sizes.
The profile obtained is compared with the profile generated by a single run of the parallel
genetic algorithm in Figure A.7, (p.151). The algorithm performs very well: for most bi-
cluster sizes, (especially over 40 conditions), it finds a solution with an overall weight sim-
ilar to that of the solution obtained from the heuristic method. However, there are regions
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Local G.A. Parallel G.A.
Gap St. dev. Optimal Gap St. dev. Optimal
1 condition 0% 0 100% 0% 0 100%
2 conditions 0% 0 100% 0% 0 100%
3 conditions 0% 0 100% 0% 0 100%
4 conditions 0.1% 0.4 95% 0% 0 100%
5 conditions 18.0% 11.2 25% 0% 0 100%
6 conditions 19.7% 9.5 15% 0% 0 100%
7 conditions 6.8% 5.2 35% 0% 0 100%
8 conditions 0.8% 0.9 30% 0% 0 100%
9 conditions 5.7% 5.0 40% 0% 0 100%
10 conditions 15.4% 6.4 10% 0% 0 100%
11 conditions 12.1% 9.9 35% 0% 0 100%
12 conditions 30.6% 18.9 25% 0% 0 100%
13 conditions 25.3% 19.1 35% 0% 0 100%
14 conditions 0% 0 100% 0% 0 100%
15 conditions 0% 0 100% 0% 0 100%
16 conditions 0% 0 100% 0% 0 100%
17 conditions 0% 0 100% 0% 0 100%
Table A.5: Local vs. parallel genetic algorithm.
Average gap to optimal solution, standard deviation and frequency at which optimal solutions are
found. (Results shown for the Yeast Cell Cycle dataset)
where the solutions obtained are poor, (15-35 conditions), and regions where the solutions
obtained are better than that of the heuristic method, (8-12 conditions). It must be noted
that this profile corresponds to a single run of the algorithm: while the heuristic method
always finds the same profile, variations may occur for the genetic algorithm, especially in
regions where the algorithm does not reach local optimal solutions.
To improve the overall performance of the algorithm, a fifth evolution operator is added.
An existing solution is randomly selected, and a local search performed: we add a con-
dition and remove an active one, (to maintain the bicluster size), as long as the solution
can be improved. For small microarray dataset, this operator does not improve the over-
all performance, as the parallel algorithm was already identifying the optimal solution for
each bicluster size. For large datasets, the profile obtained is shown in Figure A.8. The
overall performance is significantly improved, and the algorithm outperforms the previous
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implementation over the whole search domain. It also compares very well with the heuris-
tic method over the whole search domain, obtaining better solutions for small sizes, (0-12
conditions), and similar solutions elsewhere. Another interesting result is that the profile
obtained is largely conserved over multiple runs: 71 biclusters, (out of 96), are obtained
at each run and, among the remainder, 18 have a standard deviation smaller than 10% of
the average solution obtained. The latter ones correspond to non-optimal low-energy solu-
tions in which the algorithm gets “trapped”. Overall, these results suggest that most of the
solutions identified are optimal for their respective bicluster size.
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Figure A.7: Solution profile on the Lymphoma dataset.
A single run of the parallel genetic algorithm outperforms the heuristic method used to extract
biclusters in some regions, but is less efficient in others.
A.5 Analysis of the overall biclustering technique
A.5.1 Biological significance of the results obtained
We have implemented a biclustering technique consisting of two components which have
been assessed and are producing useful results: a weighting scheme, (Section A.3), and a
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Figure A.8: New solution profile on the Lymphoma dataset.
A single run of the “hybrid” algorithm significantly outperforms the “standard” parallel genetic
algorithm overall, and the heuristic method in a specific region , (low bicluster sizes), and obtains
results similar to that of this method elsewhere.
parallel genetic algorithm, (Section A.4).
The final step in assessing the biclustering technique is to analyse the biclusters obtained
using the overall method. This analysis is performed on the three datasets already used in
this Chapter. These datasets have been previously analysed, and this provides a description
of function for most of the genes present.
In the Yeast Cell Cycle dataset, the 13-condition bicluster with the smallest overall weight
contains two subsets of genes with related functions. The first is related to mitochondrial8
activity. It contains genes responsible for:
• activation of a mitochondrial acyl carrier protein.
• an ATP-dependent helicase9.
• a mitochondrial specificity factor which interacts with mitochondrial core polymerase
8Mitochondria are membrane-enclosed specialized subunits found in most eukaryotic cells. They produce
adenosine triphosphate, (ATP), which the cells use as a source of chemical energy.
9Helicases are enzymes which separate two complementary nucleic acid strands.
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Rpo41p.
• a subunit of a complex involved in the mitochondrial respiratory chain.
The second subset contains two genes, encoding a protein specifically required for au-
tophagy, and a protein that is a component of autophagosomes10. Of the last two genes, one
corresponds to a protein of unknown function. The other corresponds to a DNA replication
initiation factor. This may be related to helicase activity and to the first subset described.
Next, we consider a 90-condition bicluster obtained from the Lymphoma dataset. A first
subset in this bicluster clearly corresponds to immune activity, and contains genes encoding
chemokines, interferon11-inducible proteins, T cell transcription factors, and carboxypep-
tidase12 M. It has been observed that this enzyme is expressed on mature T cells, mainly
after activation (de Saint-Vis et al., 1995). Several other genes found in this bicluster have
been linked to cancer development, and may be grouped into one subset: phosphatidic acid
phosphatase13 type 2B (Benenson et al., 2004), c-Fos14 (Prusty and Das, 2005; Shen et al.,
2008), and cathepsin B (Yan and Sloane, 2003). The remaining genes have unknown func-
tions.
The results obtained from the Kasumi Cell Line dataset may appear less convincing: with
all conditions, the bicluster found contains 88 genes. With fewer conditions, the solutions
obtained are even larger. This is not due to the genetic algorithm, since the same solutions
are obtained with the exact enumeration method. This is not a consequence of poor weights
either, since interesting subsets appear in the biclusters. For instance, in the 88-gene biclus-
ter, we identify all occurences of the human 18S ribosomal RNA gene, which is present in
the dataset four times, (full sequence, bases 1-646, bases 647-1292, and bases 1293-1938).
We also identify nine proteins which belong to the same family, (associated with brain
10Autophagosomes are vesicles which store structures the cell targeted for destruction through autophagy, (a
cellular degradation pathway for the removal of damaged, or superfluous, proteins and cell subunits).
11Interferons are cytokines. They are produced by the cells of the immune system in response to viruses,
parasites or tumor cells.
12Carboxypeptidases are enzymes which hydrolyzes the carboxy-terminal, (C-terminal), end of a peptide
bond. They have diverse functions, (e.g. catabolism, protein maturation).
13This encoded protein is a membrane glycoprotein localized at the cell plasma membrane.
14This gene is part of the AP-1 transcription factor, which upregulates a wide range of genes.
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cells), and nine others which are associated with modifications of the p53 pathway. The
identification of these three meaningful subsets confirms the validity of our approach, and
the unusual size of the biclusters obtained is almost certainly a consequence of the config-
uration of this particular dataset, (more than 20,000 genes, but only ten conditions), which
limits discrimination between the genes.
A.5.2 Applications
The analysis technique developed provides useful biclusters on all datasets tested. Such
results can be used to better understand gene expression. Several microarray datasets have,
for instance, been used to elucidate aspects of cancer initiation, (see e.g. Somasundaram
et al. (2002)), identify genes involved in arthritis (Fujikado et al., 2006), or investigate neu-
rological disorders (Greenberg, 2001).
As outlined in Figure A.1, (p.129), these results can also be used to refine the lymph node
model, and in particular the agent implementation. Recently, microarrays have been de-
veloped specifically for the immune context. These include using a microarray to monitor
gene expression in the chicken immune system (Sarson et al., 2007), and analysis of bovine
macrophage cells (Jensen et al., 2006). Providing such techniques can be transferred to
produce microarrays for the human immune system, the biclustering technique developed
and tested in the Chapter would permit extraction of useful immune-specific genetic infor-
mation which can, in turn, be used to refine the agent implementation in the lymph node
model.
Very recently, Shendure (2008) questioned the future of microarray technologies, following
promising reports on next-generation sequencing applications (Cloonan et al., 2008; Mor-
tazavi et al., 2008). These techniques are, indeed, an interesting prospect, but we do not
think it diminishes the potential of the tools developed here. Irrelevant of the technique
employed to obtain them, large datasets always require analysis in order to extract useful
information. The technique presented in this Chapter is versatile, and can be adapted to
other types of data.
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In particular microarray-based techniques are developed for DNA methylation profiling,
(see e.g. Schumacher et al. (2006)). This type of data is suitable for analysis based on
techniques similar to that developed here, and would be useful for the refinement of the
main model layer, as methylation and other epigenetic changes are involved in the immune
system. These changes are detailed in Chapter 7.
A.6 Chapter summary
In this Chapter, we introduced a new layer to the immune system model. The motivation for
this layer, which investigates gene expression, is that the immune interactions implemented
in the lymph node model are, in part, controlled by underlying genes. To simultaneously
investigate the expression patterns of multiple genes under several conditions, microarrays
datasets are produced, and analysed using techniques such as biclustering. Here, we pro-
posed a new approach to biclustering, which incorporates a novel weighting scheme and a
parallel genetic algorithm. Both components are individually evaluated, and their combina-
tion is shown to provide biologically meaningful sets of genes.
The method implemented is a useful addition to the main model layer as well as a pow-
erful tool which can be applied to other systems where microarrays are also used, such as
identification of genes involved in cancer.
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Appendix B
Selected articles
B.1 ERCIM News 64
Perrin, D. (2006). Agent-Based Modelling of Viral Infection. ERCIM News, 64:50–51.
This article is a first introduction to the objectives and challenges of the immune system
model, and gives an early outline of the modelling process.
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n
o
t 
be
e
n
 
c
o
n
si
de
re
d 
in
it
ia
ll
y,
be
ca
u
se
 
th
e 
ce
ll-
m
ed
ia
te
d 
ar
m
 
pl
ay
s 
a
do
m
in
an
t 
ro
le
 
in
 
re
pe
lli
n
g 
at
ta
ck
.
 
Th
e
a
ge
n
ts
 
im
pl
e
m
e
n
te
d 
re
pr
e
se
n
t 
T
h
(he
lp
er
) a
n
d 
Tc
 
(cy
to
to
x
ic
) ly
m
ph
o
cy
te
s,
A
n
tig
e
n
 
Pr
e
se
n
tin
g 
C
e
lls
 
a
n
d 
v
iri
o
n
s.
Th
ey
 in
he
rit
 fr
om
 a
 c
o
m
m
o
n
 C
++
 c
la
ss
de
si
gn
ed
 
to
 
de
al
 
w
ith
 
fe
at
u
re
s 
su
ch
 
as
m
o
bi
lit
y.
 
Ea
c
h 
c
la
ss
 
th
e
n
 
im
pl
e
m
e
n
ts
th
ro
u
gh
 
at
tr
ib
u
te
s 
an
d 
m
et
ho
ds
 
th
e 
sp
e-
ci
fic
 
pr
o
pe
rt
ie
s 
o
f e
ac
h 
ce
ll 
ty
pe
,
 
su
ch
 
as
th
e 
ac
tiv
at
io
n
 
o
f a
 
Tc
 
ce
ll 
by
 
a 
Th
 
ce
ll.
Th
e 
ly
m
ph
 
n
o
de
 
is 
m
o
de
lle
d 
as
 
a 
m
at
rix
in
 
w
hi
c
h 
e
a
c
h 
e
le
m
e
n
t 
is
 
a
 
ph
ys
ic
a
l
n
ei
gh
bo
u
rh
o
o
d 
ab
le
 
to
 
co
n
ta
in
 
v
ar
io
u
s
ag
en
ts
 
o
f e
ac
h 
ty
pe
.
Th
e 
n
ex
t s
te
p 
is 
to
 
in
cr
ea
se
 
o
f t
he
 
n
u
m
-
be
r 
o
f 
ly
m
ph
 
n
o
de
s.
 
T
hi
s 
e
x
te
n
si
o
n
in
v
o
lv
es
 
m
ill
io
n
s 
o
f a
ge
n
ts
 
an
d 
re
qu
ire
s
m
ajo
r 
co
m
pu
ta
tio
n
al
 
ef
fo
rt
,
 
so
 
th
at
 
pa
ra
l-
le
liz
at
io
n
 
m
et
ho
ds
 
ar
e 
in
ev
ita
bl
e.
 
Th
e
u
se
 
o
f t
he
se
 
m
et
ho
ds
 
is 
a 
n
at
u
ra
l c
o
n
se
-
qu
en
ce
 
an
d 
ad
v
an
ta
ge
 
o
f t
he
 
m
u
lti
-
ag
en
t
ap
pr
o
ac
h.
 
A
 
hu
m
an
 
bo
dy
 
co
n
ta
in
s 
hu
n
-
dr
ed
s 
o
f l
ym
ph
 
n
o
de
s.
 
Th
e 
ai
m
 
he
re
 
is 
to
e
x
te
n
d 
th
e
 
si
z
e
 
a
n
d 
c
o
m
pl
e
x
ity
 
o
f t
he
sy
st
em
s 
th
at
 
ca
n
 
be
 
m
o
de
lle
d 
to
 
so
m
e-
th
in
g 
ap
pr
o
ac
hi
n
g 
re
al
ity
.
Th
e 
re
pr
es
en
ta
tio
n
 
o
f t
he
 
in
n
at
e 
re
sp
o
n
se
as
 
a 
co
m
m
o
n
 
ba
ck
gr
o
u
n
d 
an
d 
th
e 
ad
ap
-
tiv
e 
pa
rt
 
as
 
a 
ch
ar
ac
te
riz
ed
 
se
t o
f f
ea
tu
re
s
w
ill
 
be
 
th
e 
n
ex
t s
te
p.
 
 
Th
is 
w
ill
 
al
lo
w
 
th
e
de
v
e
lo
pm
e
n
t 
o
f a
 
la
rg
e
 
sy
st
e
m
 
to
 
be
st
u
di
ed
 
o
v
er
 
a 
lo
n
ge
r 
pe
rio
d,
 
in
 
o
rd
er
 
to
fo
cu
s 
o
n
 
di
se
as
e 
pr
o
gr
es
sio
n
 
en
dp
o
in
ts
an
d 
in
te
rv
en
tio
n
 
ef
fe
ct
s.
Th
e 
au
th
o
r 
w
o
u
ld
 
lik
e 
to
 
th
an
k 
th
e 
Iri
sh
R
e
se
a
rc
h 
C
o
u
n
c
il
 
fo
r 
Sc
ie
n
c
e
,
En
gi
n
e
e
ri
n
g 
a
n
d 
Te
c
hn
o
lo
gy
 
fo
r 
th
e
fu
n
di
n
g 
m
a
de
 
a
v
a
ila
bl
e
 
th
ro
u
gh
 
th
e
Em
ba
rk
 
In
iti
at
iv
e.
Pl
ea
se
 c
on
ta
ct
:  
D
im
itr
i P
er
rin
, D
ub
lin
 C
ity
 U
ni
ve
rs
ity
/
IU
A,
 Ir
el
an
d
E-
m
ai
l: 
dp
er
rin
@
co
m
pu
tin
g.
dc
u.
ie
Th
e 
ly
m
ph
 n
od
e 
(ad
ap
ted
 fr
om
N
. L
ev
y,
 P
at
ho
lo
gy
 o
f l
ym
ph
n
o
de
s,
 1
99
6) 
is 
mo
de
lle
d a
s a
m
at
rix
 in
 w
hi
ch
 e
ac
h 
el
em
en
t i
s
a 
ph
ys
ic
al
 n
ei
gh
bo
ur
ho
od
 a
nd
ca
n
 c
o
n
ta
in
 s
ev
er
al
 a
ge
nt
s 
of
ea
ch
 ty
pe
.
M
e
ta
he
u
ri
st
ic
s,
 
su
c
h 
a
s 
e
v
o
lu
tio
n
a
ry
al
go
rit
hm
s 
(E
A
), 
an
t 
co
lo
n
y 
o
pt
im
iz
a-
tio
n
 
(A
CO
), 
si
m
u
la
te
d 
an
n
ea
lin
g 
(S
A
)
an
d 
pa
rti
cl
e 
sw
ar
m
 o
pt
im
iz
at
io
n 
(P
SO
),
ar
e 
m
et
ho
ds
 
th
at
 
ca
n
 
be
 
ap
pl
ie
d 
su
cc
es
s-
fu
lly
 
to
 
a
lm
o
st
 
a
ll 
o
pt
im
iz
a
tio
n
 
pr
o
b-
le
m
s.
 
Fo
r 
m
an
y 
ha
rd
 
ta
sk
s 
in
 
a 
hu
ge
 
v
ar
i-
et
y 
o
f a
re
as
,
 
th
es
e 
al
go
rit
hm
s 
ar
e 
co
n
sid
-
er
ed
 
to
 
be
 
th
e 
st
at
e-
o
f-
th
e-
ar
t m
et
ho
ds
;
th
es
e 
ar
ea
s 
in
cl
u
de
 
en
gi
n
ee
rin
g 
ap
pl
ic
a-
tio
n
s,
 
bi
o
in
fo
rm
at
ic
s,
 
te
le
co
m
m
u
n
ic
a-
tio
n
s,
 
lo
gi
st
ic
s 
an
d 
bu
sin
es
s.
D
u
e 
to
 
th
ei
r 
pr
ac
tic
al
 
im
po
rt
an
ce
 
an
d 
th
e
n
ee
d 
to
 s
o
lv
e 
la
rg
e 
re
al
-w
or
ld
 in
sta
nc
es
o
f h
a
rd
 
pr
o
bl
e
m
s,
 
pa
ra
lle
l a
lg
o
rit
hm
s
ha
v
e
 
be
e
n
 
pr
o
po
se
d 
fo
r 
m
o
st
 
m
e
ta
-
he
u
ris
tic
s.
 
H
o
w
ev
er
,
 
m
o
st
 
ap
pr
o
ac
he
s 
do
n
o
t 
u
til
iz
e 
th
e 
fu
ll 
po
te
n
tia
l o
f p
ar
al
le
l
ex
ec
u
tio
n
 
be
ca
u
se
 
o
f t
he
ir 
sy
n
ch
ro
n
ic
ity
a
n
d 
e
x
e
c
u
tio
n
 
o
n
 
c
lu
st
e
rs
 
o
f h
o
m
o
ge
-
n
eo
u
s 
m
ac
hi
n
es
.
 
A
ll 
th
is 
m
ak
es
 
it 
di
ffi
-
cu
lt 
to
 
ap
pl
y 
th
em
 
to
 
in
te
re
st
in
g 
pa
ra
lle
l
sy
st
em
s 
su
ch
 
as
 
dy
n
am
ic
al
ly
 
re
co
n
fig
-
Th
e ‘
De
ce
nt’
 
Pr
oje
ct: 
De
ce
ntr
ali
ze
d M
eta
he
ur
ist
ics
by
 E
nr
iq
ue
 A
lb
a 
an
d 
M
ar
tin
  M
id
de
nd
or
f
Th
e 
pr
oje
ct 
‘D
ec
en
t’ 
(D
ec
en
tra
liz
ed
 M
et
ah
eu
ris
tic
s) 
is
 d
ev
el
op
in
g 
n
ew
 s
w
ar
m
-
ba
se
d 
m
et
ah
eu
ris
tic
s 
in
 
w
hi
ch
 
a 
de
ce
n
tr
al
iz
ed
 
de
si
gn
 
le
ad
s 
to
 
em
er
ge
n
t
ph
en
om
en
a.
 
Th
es
e 
ar
e 
no
t o
nl
y i
m
po
rta
nt
 
fo
r s
ol
vi
ng
 
co
m
pl
ex
 
pr
ob
le
m
s,
 
bu
t a
re
su
ita
bl
e 
fo
r 
pa
ra
lle
l e
xe
cu
tio
n
 
in
 
co
m
pu
tin
g 
gr
id
s 
an
d 
m
u
lti
-
ta
sk
 
ha
rd
w
ar
e
pl
at
fo
rm
s. 
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Perrin, D., Ruskin, H. J., Burns, J. and Crane, M. (2006). An agent-based approach to im-
mune modelling. Lecture Notes in Computer Science, 3980:612–621.
In this article, we introduce the overall challenges of immune system modelling, and pre-
sente the agent-based lymph node model. We also give a first outline of the lymph network
model, and of the requirements for a parallel implementation.
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A
n
A
g
e
n
t-
B
a
se
d
A
p
p
ro
a
ch
to
Im
m
u
n
e
M
o
d
e
ll
in
g
D
im
it
ri
P
er
ri
n,
H
ea
th
er
J.
R
us
ki
n,
Jo
hn
B
ur
ns
,a
nd
M
ar
ti
n
C
ra
ne
D
u
b
li
n
C
it
y
U
n
iv
er
si
ty
,
S
ch
o
o
l
o
f
C
o
m
p
u
ti
n
g
,
D
u
b
li
n
9
,
Ir
el
a
n
d
d
p
e
r
r
i
n
@
c
o
m
p
u
t
i
n
g
.
d
c
u
.
i
e
A
b
st
ra
c
t.
T
h
is
st
u
d
y
fo
cu
se
s
o
n
tr
y
in
g
to
u
n
d
er
st
a
n
d
w
h
y
th
e
ra
n
g
e
o
f
ex
p
er
ie
n
ce
w
it
h
re
sp
ec
t
to
H
IV
in
fe
ct
io
n
is
so
d
iv
er
se
,
es
p
ec
ia
ll
y
a
s
re
g
a
rd
s
to
th
e
la
te
n
cy
p
er
io
d
.
T
h
e
ch
a
ll
en
g
e
is
to
d
et
er
m
in
e
w
h
a
t
a
s-
su
m
p
ti
o
n
s
ca
n
b
e
m
a
d
e
a
b
o
u
t
th
e
n
a
tu
re
o
f
th
e
ex
p
er
ie
n
ce
o
f
a
n
ti
g
en
ic
in
va
si
o
n
a
n
d
d
iv
er
si
ty
th
a
t
ca
n
b
e
m
o
d
el
le
d
,
te
st
ed
a
n
d
a
rg
u
ed
p
la
u
-
si
b
ly
.
T
o
in
v
es
ti
g
a
te
th
is
,
a
n
a
g
en
t-
b
a
se
d
a
p
p
ro
a
ch
is
u
se
d
to
ex
tr
a
ct
h
ig
h
-l
ev
el
b
eh
av
io
u
r
w
h
ic
h
ca
n
n
o
t
b
e
d
es
cr
ib
ed
a
n
a
ly
ti
ca
ll
y
fr
o
m
th
e
se
t
o
f
in
te
ra
ct
io
n
ru
le
s
a
t
th
e
ce
ll
u
la
r
le
v
el
.
A
p
ro
to
ty
p
e
m
o
d
el
en
co
m
p
a
ss
es
lo
ca
l
va
ri
a
ti
o
n
in
b
a
se
li
n
e
p
ro
p
er
ti
es
co
n
tr
ib
u
ti
n
g
to
th
e
in
d
iv
id
u
a
l
d
is
-
ea
se
ex
p
er
ie
n
ce
a
n
d
is
in
cl
u
d
ed
in
a
n
et
w
o
rk
w
h
ic
h
m
im
ic
s
th
e
ch
a
in
o
f
ly
m
p
h
a
ti
c
n
o
d
es
.
D
ea
li
n
g
w
it
h
m
a
ss
iv
el
y
m
u
lt
i-
a
g
en
t
sy
st
em
s
re
q
u
ir
es
m
a
jo
r
co
m
p
u
ta
ti
o
n
a
l
eff
o
rt
s.
H
ow
ev
er
,
p
a
ra
ll
el
is
a
ti
o
n
m
et
h
o
d
s
a
re
a
n
a
t-
u
ra
l
co
n
se
q
u
en
ce
a
n
d
a
d
va
n
ta
g
e
o
f
th
e
m
u
lt
i-
a
g
en
t
a
p
p
ro
a
ch
.
T
h
es
e
a
re
im
p
le
m
en
te
d
u
si
n
g
th
e
M
P
I
li
b
ra
ry
.
K
e
y
w
o
rd
s:
H
IV
,
im
m
u
n
e
re
sp
o
n
se
,
co
m
p
le
x
sy
st
em
,
a
g
en
t-
b
a
se
d
,
p
a
r-
a
ll
el
is
a
ti
o
n
m
et
h
o
d
s.
1
In
tr
o
d
u
ct
io
n
T
he
ob
je
ct
iv
e
of
th
is
st
ud
y
is
to
un
de
rs
ta
nd
w
hy
th
e
ra
ng
e
of
ex
pe
ri
en
ce
w
it
h
re
sp
ec
t
to
H
IV
in
fe
ct
io
n
is
so
di
ve
rs
e.
In
pa
rt
ic
ul
ar
,
th
e
w
or
k
ai
m
s
to
ad
dr
es
s
qu
es
ti
on
s
re
la
ti
ng
to
va
ri
at
io
n
in
le
ng
th
in
in
di
vi
du
al
la
te
nc
y
pe
ri
od
.T
hi
s
m
ay
be
ve
ry
lo
ng
(f
or
re
la
ti
ve
ly
lo
w
su
cc
es
s
of
an
ti
pa
th
et
ic
m
ut
at
io
n)
in
on
e
in
di
vi
du
al
,
co
m
pa
re
d
to
an
ot
he
r
w
it
h
m
uc
h
hi
gh
er
m
ut
at
io
n
le
ve
ls
.
T
he
in
di
ca
ti
on
s
ar
e
th
at
th
e
ob
se
rv
ed
va
ri
at
io
n
lie
s
in
th
e
pr
im
in
g
an
d
in
it
ia
l
le
ve
lo
ffi
tn
es
s
of
th
e
im
m
un
e
re
sp
on
se
of
th
e
in
di
vi
du
al
,t
og
et
he
r
w
it
h
th
e
va
ri
ou
s
fa
ct
or
s
in
flu
en
ci
ng
th
is
[1
].
If
su
ch
“p
ri
m
in
g
pa
tt
er
ns
”
ca
n
be
re
co
gn
is
ed
,o
r
ev
en
pr
ed
ic
te
d,
th
en
in
th
e
lo
ng
te
rm
w
e
m
ay
ha
ve
a
w
ay
of
“t
yp
in
g”
an
in
di
vi
du
al
an
d
ta
rg
et
in
g
in
te
rv
en
ti
on
ap
pr
op
ri
at
el
y.
U
nf
or
tu
na
te
ly
,u
nd
er
st
an
di
ng
ho
w
th
e
im
m
un
e
sy
st
em
is
pr
im
ed
by
ex
pe
ri
en
ce
of
an
ti
ge
ni
c
in
va
si
on
an
d
di
ve
rs
it
y
is
no
n-
tr
iv
ia
l
[1
].
T
he
ch
al
le
ng
e
is
to
de
te
rm
in
e
w
ha
t
as
su
m
pt
io
ns
ca
n
be
m
ad
e
ab
ou
t
th
e
na
tu
re
of
th
e
ex
pe
ri
en
ce
,c
an
be
m
od
el
le
d,
te
st
ed
ag
ai
ns
t
cl
in
ic
al
da
ta
an
d
he
nc
e
ar
gu
ed
pl
au
si
bl
y.
T
he
ai
m
is
to
un
de
rs
ta
nd
ho
w
th
e
ce
ll
in
te
ra
ct
io
ns
le
ad
to
th
e
ob
se
rv
ed
en
dp
oi
nt
s.
T
he
im
m
un
e
re
sp
on
se
is
dy
na
m
ic
an
d
in
cl
ud
es
gr
ow
th
an
d
re
pl
en
is
hm
en
t
of
ce
lls
an
d
in
-b
ui
lt
ad
ap
ta
bi
lit
y,
th
ro
ug
h
m
ut
at
io
n
of
it
s
de
fe
nc
es
to
m
ee
t
ne
w
th
re
at
s.
It
al
so
in
cl
ud
es
as
pe
ct
s
of
ce
ll
m
ob
ili
ty
,w
hi
ch
m
ay
be
ca
pt
ur
ed
,b
y
m
ea
ns
M
.
G
a
v
ri
lo
v
a
e
t
a
l.
(E
d
s.
):
IC
C
S
A
2
0
0
6
,
L
N
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S
3
9
8
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p
p
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6
1
2
–
6
2
1
,
2
0
0
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.
c ©
S
p
ri
n
g
e
r-
V
e
rl
a
g
B
e
rl
in
H
e
id
e
lb
e
rg
2
0
0
6
A
n
A
g
en
t-
B
a
se
d
A
p
p
ro
a
ch
to
Im
m
u
n
e
M
o
d
el
li
n
g
6
1
3
of
de
fin
in
g
m
ov
em
en
t
an
d
affi
ni
ty
of
ce
ll-
ty
pe
s
in
a
de
fin
ed
sp
at
ia
lf
ra
m
ew
or
k.
In
pa
rt
ic
ul
ar
,t
hi
s
w
ill
en
ab
le
st
ud
y
of
va
ri
at
io
n
in
vi
ra
ll
oa
d
an
d
th
e
w
ay
in
w
hi
ch
ho
st
re
sp
on
se
m
ay
le
ad
to
de
gr
ad
at
io
n
of
pr
ot
ec
ti
on
.
T
o
in
ve
st
ig
at
e
th
es
e
qu
es
ti
on
s,
an
“a
ge
nt
-b
as
ed
”
ap
pr
oa
ch
is
ch
os
en
,
as
a
m
ea
ns
of
in
fe
rr
in
g
hi
gh
-l
ev
el
be
ha
vi
ou
r
fr
om
a
sm
al
l
se
t
of
in
te
ra
ct
io
n
ru
le
s
at
th
e
ce
llu
la
r
le
ve
l.
Su
ch
be
ha
vi
ou
r
ca
nn
ot
be
ex
tr
ac
te
d
an
al
yt
ic
al
ly
fr
om
th
e
se
t
of
ru
le
s
[1
],
bu
t
em
er
ge
s
as
a
re
su
lt
of
st
oc
ha
st
ic
ev
en
ts
,w
hi
ch
pl
ay
an
im
po
rt
an
t
pa
rt
in
th
e
im
m
un
e
re
sp
on
se
[2
].
T
he
in
it
ia
lm
od
el
co
ns
is
ts
of
fu
nc
ti
on
al
un
it
s,
ca
lle
d
ag
en
ts
,w
it
h
de
si
gn
at
ed
pr
op
er
ti
es
w
hi
ch
m
im
ic
th
e
op
er
at
io
n
of
a
si
ng
le
ly
m
ph
no
de
.T
hi
s
te
st
-c
as
e
pr
o-
to
ty
pe
,
ho
w
ev
er
,
in
cl
ud
es
al
l
kn
ow
n
in
te
ra
ct
io
ns
co
nt
ri
bu
ti
ng
to
ce
ll-
m
ed
ia
te
d
im
m
un
it
y
an
d
th
e
lo
ca
le
vo
lu
ti
on
of
th
e
vi
ri
on
s.
T
he
an
ti
bo
dy
-m
ed
ia
te
d
re
sp
on
se
ha
s
no
t
be
en
co
ns
id
er
ed
in
it
ia
lly
,
be
ca
us
e
th
e
ce
ll-
m
ed
ia
te
d
ar
m
pl
ay
s
a
do
m
i-
na
nt
ro
le
in
re
pe
lli
ng
at
ta
ck
.
T
he
ag
en
ts
im
pl
em
en
te
d
re
pr
es
en
t
T
h
(h
el
pe
r,
or
C
D
4)
an
d
T
c
(c
yt
ot
ox
ic
,
or
C
D
8)
ly
m
ph
oc
yt
es
,
A
nt
ig
en
P
re
se
nt
in
g
C
el
ls
,
an
d
vi
ri
on
s.
T
he
co
m
pu
ta
ti
on
al
st
ru
ct
ur
e
of
th
e
nu
m
er
ic
al
ex
pe
ri
m
en
ts
is
ba
se
d
on
in
he
ri
ta
nc
e
fr
om
a
co
m
m
on
C
+
+
cl
as
s
de
si
gn
ed
to
de
al
w
it
h
fe
at
ur
es
su
ch
as
th
e
m
ob
ili
ty
an
d
th
en
ea
ch
cl
as
s
in
cl
ud
es
sp
ec
ifi
c
at
tr
ib
ut
es
an
d
m
et
ho
ds
to
im
pl
e-
m
en
t
sp
ec
ifi
c
pr
op
er
ti
es
of
ea
ch
ce
ll
ty
pe
.
T
he
ly
m
ph
no
de
it
se
lf
is
m
od
el
le
d
as
a
m
at
ri
x,
in
w
hi
ch
ea
ch
el
em
en
t
re
pr
es
en
ts
th
e
ph
ys
ic
al
ne
ig
hb
ou
rh
oo
d
of
a
ce
ll
ty
pe
,
(i
n
te
rm
s
of
it
s
ag
en
t
ne
ig
hb
ou
rs
).
T
he
fr
eq
ue
nc
y
w
it
h
w
hi
ch
an
in
fe
ct
ed
ce
ll
w
ill
pr
od
uc
e
a
ne
w
vi
ri
on
is
us
ed
as
th
e
si
m
ul
at
io
n
ti
m
e-
st
ep
.
A
t
ea
ch
ti
m
e
st
ep
,
ag
en
ts
ca
n
m
ov
e
fr
om
on
e
m
at
ri
x
el
em
en
t
to
an
ot
he
r,
an
d
in
te
ra
ct
w
it
h
th
e
ot
he
r
ag
en
ts
pr
es
en
t
in
th
ei
r
ph
ys
ic
al
ne
ig
hb
ou
rh
oo
d
(i
.e
.
w
it
h
ce
ll
ty
pe
s
in
th
e
sa
m
e
ne
ig
hb
ou
rh
oo
d)
.
C
ur
re
nt
de
ve
lo
pm
en
t
is
fo
cu
se
d
on
in
cr
ea
si
ng
th
e
nu
m
be
r
of
ly
m
ph
no
de
s,
w
hi
ch
in
vo
lv
es
m
ill
io
ns
of
ag
en
ts
,r
eq
ui
ri
ng
m
aj
or
co
m
pu
ta
ti
on
al
eff
or
t
an
d
pa
r-
al
le
lis
at
io
n
m
et
ho
ds
.
T
he
se
ar
e,
ho
w
ev
er
,a
na
tu
ra
l
co
ns
eq
ue
nc
e
an
d
ad
va
nt
ag
e
of
th
e
m
ul
ti
-a
ge
nt
ap
pr
oa
ch
[3
].
T
he
ai
m
is
to
ex
te
nd
th
e
si
ze
an
d
co
m
pl
ex
it
y
of
th
e
sy
st
em
s
m
od
el
le
d
to
so
m
et
hi
ng
ap
pr
oa
ch
in
g
re
al
is
m
.
2
A
C
o
m
p
le
x
B
io
lo
g
ic
a
l
M
e
ch
a
n
is
m
2.
1
T
h
e
Im
m
u
n
e
R
es
p
on
se
A
ga
in
st
a
V
ir
al
A
tt
ac
k
Im
m
un
it
y
ca
n
be
de
fin
ed
as
al
lm
ec
ha
ni
sm
s
w
hi
ch
al
lo
w
th
e
bo
dy
re
co
gn
it
io
n
of
th
at
w
hi
ch
be
lo
ng
s
to
it
s
sy
st
em
an
d
co
ns
eq
ue
nt
ly
to
le
ra
te
it
,a
nd
re
co
gn
is
e
w
ha
t
do
es
no
t
an
d
fig
ht
to
er
ad
ic
at
e
it
.
T
he
im
m
un
e
sy
st
em
is
co
m
pl
ex
an
d
in
vo
lv
es
va
ri
ou
s
ty
pe
s
of
ce
lls
.W
he
n
a
fo
re
ig
n
el
em
en
t
is
re
co
gn
is
ed
,i
t
ca
n
be
de
al
t
w
it
h
in
tw
o
di
ffe
re
nt
w
ay
s:
th
e
im
m
un
e
re
sp
on
se
ca
n
be
no
n-
sp
ec
ifi
c
or
sp
ec
ifi
c.
A
no
n-
sp
ec
ifi
c
re
sp
on
se
is
ba
se
d
up
on
th
e
fa
ct
th
at
th
e
fo
re
ig
n
el
em
en
t
do
es
no
t
sh
ow
,a
t
it
s
su
rf
ac
e,
th
e
an
ti
ge
ns
ch
ar
ac
te
ri
si
ng
th
e
ce
lls
be
lo
ng
in
g
to
th
e
bo
dy
.
T
hi
s
is
th
e
re
sp
on
se
th
at
ha
s
to
be
di
m
in
is
he
d
w
he
n
tr
an
sp
la
nt
s
ar
e
ca
rr
ie
d
ou
t.
In
co
nt
ra
st
,
th
e
sp
ec
ifi
c
re
sp
on
se
is
ba
se
d
on
th
e
ac
cu
ra
te
re
co
gn
it
io
n
of
fo
re
ig
n
an
ti
ge
ns
.T
hi
s
re
sp
on
se
ca
n
be
ce
ll-
m
ed
ia
te
d
or
an
ti
bo
dy
-m
ed
ia
te
d.
T
he
se
co
nd
on
e,
al
so
kn
ow
n
as
hu
m
or
al
re
sp
on
se
,
is
ca
rr
ie
d
ou
t
by
B
ly
m
ph
oc
yt
es
159
6
1
4
D
.
P
er
ri
n
et
a
l.
an
d
m
ai
nl
y
ta
rg
et
ed
at
ba
ct
er
ia
l
at
ta
ck
s.
W
e
pr
es
en
t
he
re
a
fe
w
de
ta
ils
ab
ou
t
th
e
ce
ll-
m
ed
ia
te
d
re
sp
on
se
,t
ar
ge
te
d
m
or
e
sp
ec
ifi
ca
lly
at
vi
ra
la
tt
ac
ks
an
d
ta
ki
ng
pl
ac
e
in
ly
m
ph
at
ic
no
de
s.
M
or
e
de
ta
ils
ab
ou
t
th
e
im
m
un
e
sy
st
em
ca
n
be
fo
un
d
in
sp
ec
ia
lis
ed
jo
ur
na
ls
an
d
im
m
un
ol
og
y
co
ur
se
s,
su
ch
as
[4
].
T
he
eff
ec
to
r
ce
ll,
in
th
e
ce
ll-
m
ed
ia
te
d
re
sp
on
se
,i
s
th
e
T
c
ly
m
ph
oc
yt
e.
H
ow
-
ev
er
,i
t
ca
nn
ot
ac
t
on
it
s
ow
n,
ne
ed
in
g
a
ch
ai
n
re
ac
ti
on
to
ac
hi
ev
e
ac
ti
va
ti
on
T
he
fir
st
st
ep
is
ca
rr
ie
d
ou
t
by
A
nt
ig
en
P
re
se
nt
in
g
C
el
ls
w
hi
ch
re
co
gn
is
e
fo
re
ig
n
bi
-
ol
og
ic
al
en
ti
ti
es
an
d
st
ar
t
pr
es
en
ti
ng
th
es
e
an
ti
ge
ns
at
th
ei
r
su
rf
ac
e.
It
w
ill
th
en
en
co
un
te
r
T
h
ly
m
ph
oc
yt
es
.
If
a
T
h
ce
ll
en
co
un
te
rs
an
A
P
C
pr
es
en
ti
ng
an
an
ti
-
ge
n,
w
hi
ch
it
ha
s
be
en
sp
ec
ifi
ca
lly
de
si
gn
ed
to
re
co
gn
is
e,
it
ac
ti
va
te
s
it
se
lf.
T
he
T
h
ce
lls
m
ai
n
fu
nc
ti
on
is
th
en
to
co
or
di
na
te
th
e
im
m
un
e
re
sp
on
se
by
ac
ti
va
ti
ng
sp
ec
ifi
c
T
c
ce
lls
.
2.
2
T
h
e
H
IV
E
x
p
an
si
on
S
tr
at
eg
y
H
IV
vi
ri
on
s
us
e
th
e
T
h
ce
lls
de
sc
ri
be
d
ab
ov
e
as
ho
st
s
to
m
ul
ti
pl
y
th
em
se
lv
es
,a
s
de
ta
ile
d
in
[5
].
T
he
gp
12
0
gl
yc
op
ro
te
in
of
th
e
vi
ri
on
en
ve
lo
pe
fir
st
at
ta
ch
es
it
se
lf
to
th
e
C
D
4
re
ce
pt
or
,c
ha
ra
ct
er
is
ti
c
of
th
es
e
im
m
un
e
ce
lls
.T
he
n
th
e
vi
ri
on
fu
se
s
w
it
h
th
e
ly
m
ph
oc
yt
e
us
in
g
gp
41
an
d
th
e
vi
ra
l
R
N
A
is
fr
ee
d
in
to
th
e
ce
ll.
T
he
vi
ra
l
re
ve
rs
e
tr
an
sc
ri
pt
as
e
co
pi
es
th
e
R
N
A
in
to
D
N
A
an
d
in
te
gr
at
es
it
in
to
th
e
ce
llu
la
r
D
N
A
.
T
o
be
su
cc
es
sf
ul
,
th
is
in
te
gr
at
io
n
ha
s
to
ta
ke
pl
ac
e
in
ac
ti
va
te
d
ce
lls
.
M
or
e
de
ta
ils
ab
ou
t
th
is
pr
oc
es
s
ca
n
be
fo
un
d
in
[6
].
A
n
im
po
rt
an
t
as
pe
ct
is
th
e
hi
gh
ra
te
of
m
ut
at
io
n:
th
er
e
is
on
av
er
ag
e
a
tr
an
sc
ri
pt
io
n
er
ro
r
ev
er
y
10
.0
00
nu
cl
eo
ti
de
s.
Si
nc
e
th
e
H
IV
ge
no
m
e
co
nt
ai
ns
ab
ou
t
10
.0
00
nu
cl
eo
ti
de
s,
th
is
m
ea
ns
th
er
e
is
on
av
er
ag
e
a
si
ng
le
di
ffe
re
nc
e
be
tw
ee
n
tw
o
“b
ro
th
er
vi
ri
on
s”
.
A
ll
th
es
e
m
ut
an
ts
of
co
ur
se
ha
ve
va
ri
ou
s
fa
te
s.
O
n
th
e
on
e
ha
nd
,
m
os
t
of
th
em
w
ill
re
su
lt
,f
or
in
st
an
ce
,i
n
th
e
su
pp
re
ss
io
n
of
an
en
zy
m
e,
an
d
w
ill
be
un
su
cc
es
sf
ul
.
O
n
th
e
ot
he
r
ha
nd
,
a
m
ut
at
io
n
ca
n
be
su
cc
es
sf
ul
an
d,
fo
r
in
st
an
ce
,
m
od
ify
th
e
en
ve
lo
pe
gl
yc
op
ro
te
in
,t
hu
s
al
lo
w
in
g
th
e
ne
w
vi
ri
on
to
te
m
po
ra
ri
ly
es
ca
pe
fr
om
th
e
im
m
un
e
sy
st
em
.
T
he
m
ac
ro
sc
op
ic
ev
ol
ut
io
n
of
th
e
di
se
as
e
is
di
vi
de
d
in
to
th
re
e
ph
as
es
.
T
he
fir
st
on
e
co
rr
es
po
nd
s
to
th
e
ty
pi
ca
li
m
m
un
e
re
sp
on
se
ag
ai
ns
t
a
vi
ra
la
tt
ac
k.
T
he
pr
od
uc
ti
on
of
ly
m
ph
oc
yt
es
sp
ec
ifi
c
to
th
e
vi
ra
ls
tr
ai
ns
is
la
un
ch
ed
,a
nd
w
it
hi
n
a
fe
w
w
ee
ks
,a
ll
th
e
or
ig
in
al
st
ra
in
s
ar
e
er
ad
ic
at
ed
.T
he
m
ut
at
io
n
ra
te
he
re
be
co
m
es
cr
it
ic
al
.
It
ha
s
al
lo
w
ed
th
e
ap
pe
ar
an
ce
of
ne
w
st
ra
in
s,
w
hi
ch
ha
ve
no
t
be
en
de
-
te
ct
ed
by
th
e
or
ga
ni
sm
ye
t,
an
d
ca
n
th
er
ef
or
e
de
ve
lo
p
fr
ee
ly
.A
s
so
on
as
a
st
ra
in
be
co
m
es
to
o
in
tr
us
iv
e,
it
s
de
te
ct
io
n
pr
ob
ab
ili
ty
in
cr
ea
se
s
an
d
it
is
er
ad
ic
at
ed
.
D
ur
in
g
th
is
se
co
nd
ph
as
e,
th
er
e
ar
e
no
sy
m
pt
om
s.
T
hi
s
is
kn
ow
n
as
th
e
la
te
nc
y
pe
ri
od
,a
nd
ca
n
la
st
up
to
te
n
ye
ar
s.
T
he
im
m
un
e
sy
st
em
is
he
av
ily
lo
ad
ed
,a
nd
th
e
de
st
ru
ct
io
n
of
ea
ch
st
ra
in
al
so
im
pl
ie
s
th
e
de
st
ru
ct
io
n
of
th
e
in
fe
ct
ed
ce
ll.
A
ti
m
e
co
m
es
w
he
n
th
e
im
m
un
e
sy
st
em
ca
nn
ot
co
pe
w
it
h
th
e
ev
er
in
cr
ea
si
ng
nu
m
be
r
of
st
ra
in
s
or
re
m
ai
n
vi
ab
le
,g
iv
en
a
st
ro
ng
de
cr
ea
se
of
th
e
nu
m
be
r
of
th
e
T
h
ce
lls
.
D
ur
in
g
th
is
la
st
ph
as
e,
kn
ow
n
as
A
ID
S
(a
cq
ui
re
d
im
m
un
od
efi
ci
en
cy
sy
nd
ro
m
e)
,
th
e
w
ho
le
im
m
un
e
sy
st
em
is
di
m
in
is
he
d
an
d
op
po
rt
un
is
ti
c
di
se
as
es
st
ar
t
ap
pe
ar
in
g,
le
ad
in
g
to
th
e
de
at
h
of
th
e
pa
ti
en
t.
A
n
A
g
en
t-
B
a
se
d
A
p
p
ro
a
ch
to
Im
m
u
n
e
M
o
d
el
li
n
g
6
1
5
3
S
im
p
le
R
u
le
s
to
C
o
n
tr
o
l
th
e
A
g
e
n
ts
3.
1
T
h
e
A
ge
n
t-
B
as
ed
A
p
p
ro
ac
h
T
he
re
is
no
un
iq
ue
de
fin
it
io
n
of
w
ha
t
an
ag
en
t
is
.
H
ow
ev
er
,
W
oo
ld
ri
dg
e
an
d
Je
nn
in
gs
pr
op
os
ed
in
[7
]a
de
fin
it
io
n
w
hi
ch
is
w
id
el
y
ac
ce
pt
ed
an
d
sp
ec
ifi
es
ch
ar
-
ac
te
ri
st
ic
s
th
at
an
ag
en
t
m
us
t
ha
ve
.A
n
ag
en
t
ha
s
to
be
au
to
no
m
ou
s:
it
ca
n
ac
t
w
it
ho
ut
an
y
in
te
rv
en
ti
on
an
d
ha
s
so
m
e
co
nt
ro
l
ov
er
it
s
ac
ti
on
s
an
d
it
s
in
te
rn
al
st
at
e.
It
ha
s
a
so
ci
al
be
ha
vi
ou
r:
it
ca
n
in
te
ra
ct
w
it
h
ot
he
r
ag
en
ts
th
an
ks
to
a
sp
ec
ifi
c
la
ng
ua
ge
.
It
ca
n
al
so
re
ac
t:
th
e
ag
en
t
ha
s
th
e
ab
ili
ty
to
sc
an
pa
rt
of
it
s
en
vi
ro
nm
en
t
an
d
ch
an
ge
it
s
be
ha
vi
ou
r
to
ta
ke
ad
va
nt
ag
e
of
it
.
T
he
ag
en
t
is
pr
oa
ct
iv
e:
it
no
t
on
ly
re
ac
ts
to
it
s
en
vi
ro
nm
en
t
bu
t
al
so
ac
ts
an
d
ta
ke
s
in
it
ia
ti
ve
s
so
as
to
sa
ti
sf
y
go
al
s.
B
ui
ld
in
g
on
th
is
de
fin
it
io
n
an
ag
en
t-
ba
se
d
m
od
el
is
a
m
od
el
in
w
hi
ch
th
e
ke
y
ab
st
ra
ct
io
n
el
em
en
ts
ar
e
ag
en
ts
.
O
bv
io
us
ly
,e
ac
h
ag
en
t
ha
s
on
ly
a
lim
it
ed
kn
ow
le
dg
e
of
th
e
w
or
ld
in
w
hi
ch
it
ev
ol
ve
s,
an
d
co
m
m
un
ic
at
io
n
be
tw
ee
n
ag
en
ts
is
th
er
ef
or
e
an
im
po
rt
an
t
as
pe
ct
of
th
is
ap
pr
oa
ch
.T
hi
s
co
m
m
un
ic
at
io
n
is
so
m
et
im
es
re
fe
rr
ed
to
as
lin
gu
is
ti
c
ac
ti
on
s,
as
op
po
se
d
to
no
n-
lin
gu
is
ti
c
ac
ti
on
s
w
hi
ch
ar
e
m
od
ifi
ca
ti
on
s
of
th
e
en
vi
ro
nm
en
t.
In
te
ra
ct
io
n
be
tw
ee
n
ag
en
ts
is
no
t
lim
it
ed
to
co
m
m
un
ic
at
io
n:
th
ey
ha
ve
to
sh
ar
e
th
ei
r
en
vi
ro
nm
en
t.
T
hi
s
im
pl
ie
s
th
at
ag
en
ts
’a
ct
io
ns
ha
ve
to
be
co
or
di
na
te
d.
O
f
co
ur
se
co
or
di
na
ti
on
do
es
no
t
m
ea
n
co
op
er
at
io
n:
a
go
od
co
m
pe
ti
to
r
m
ax
im
iz
es
hi
s
ad
va
nt
ag
e
by
co
or
di
na
ti
ng
hi
s
ac
ti
on
s
ac
co
rd
in
g
to
th
e
ot
he
rs
’
de
ci
si
on
s.
It
al
so
do
es
no
t
im
pl
y
re
ci
pr
oc
it
y
of
ac
ti
on
:
a
ca
r
dr
iv
er
ca
n
go
pa
st
an
ot
he
r
an
d
co
or
di
na
te
th
is
sa
fe
ly
w
it
ho
ut
th
e
se
co
nd
dr
iv
er
kn
ow
in
g
it
.
T
he
ke
y
fa
ct
or
w
he
n
ch
oo
si
ng
a
co
or
di
na
ti
on
st
ra
te
gy
is
th
e
si
ze
of
th
e
ag
en
t
po
pu
la
ti
on
.I
fe
ve
ry
ag
en
t
ca
n
in
te
ra
ct
w
it
h
ev
er
y
ot
he
r
on
e,
th
e
nu
m
be
r
of
in
te
ra
ct
io
n
pa
ir
s
in
cr
ea
se
s
qu
ad
ra
ti
ca
lly
w
it
h
th
e
po
pu
la
ti
on
si
ze
.
If
in
te
ra
ct
io
n
ca
n
oc
cu
r
be
tw
ee
n
se
ve
ra
l
ag
en
ts
in
st
ea
d
of
pa
ir
s,
th
e
co
or
di
na
ti
on
ov
er
he
ad
in
cr
ea
se
s
ex
po
ne
nt
ia
lly
an
d
ca
n
ea
si
ly
ex
ce
ed
th
e
co
m
pu
ti
ng
fa
ci
lit
ie
s
[8
].
D
ev
el
op
in
g
a
co
or
di
na
ti
on
st
ra
t-
eg
y
is
th
er
ef
or
e
bo
th
es
se
nt
ia
l
an
d
di
ffi
cu
lt
.
In
m
an
y
ca
se
s,
m
an
ag
in
g
to
av
oi
d
co
nfl
ic
ts
an
d
bl
oc
ks
is
it
se
lf
an
im
po
rt
an
t
ac
hi
ev
em
en
t.
T
hi
s
gi
ve
s
us
th
e
op
po
r-
tu
ni
ty
to
pu
t
th
e
em
ph
as
is
on
th
e
m
ai
n
dr
aw
ba
ck
of
th
is
ap
pr
oa
ch
:i
t
is
hi
gh
ly
re
so
ur
ce
-c
on
su
m
in
g.
H
ow
ev
er
,t
he
ap
pr
oa
ch
al
so
pr
ov
id
es
a
so
lu
ti
on
as
it
is
of
te
n
co
m
bi
ne
d
w
it
h
pa
ra
lle
lm
et
ho
ds
.
W
e
de
ve
lo
p
th
is
id
ea
la
te
r
on
(s
ec
ti
on
4.
2)
.
T
hi
s
ap
pr
oa
ch
be
in
g
ge
ne
ri
c,
it
ha
s
be
en
us
ed
in
va
ri
ou
s
fie
ld
s.
It
ha
s
fo
r
in
st
an
ce
be
en
us
ed
fo
r
ae
ri
al
tr
affi
c
pl
an
ni
ng
[9
],
ve
hi
cl
e
m
on
it
or
in
g
[1
0]
an
d
ev
en
to
m
an
ag
e
ch
ir
ur
gi
ca
li
nt
en
si
ve
ca
re
un
it
s
[1
1]
.I
t
ha
s
al
so
be
en
ex
te
ns
iv
el
y
us
ed
in
N
at
ur
al
Sc
ie
nc
es
,
as
it
pr
ov
id
es
a
ve
ry
in
tu
it
iv
e
w
ay
to
m
od
el
sy
st
em
s:
bi
ol
og
ic
al
en
ti
ti
es
ar
e
im
pl
em
en
te
d
as
ag
en
ts
,
an
d
in
te
ra
ct
io
ns
be
tw
ee
n
th
em
ar
e
de
al
t
w
it
h
th
ro
ug
h
lin
gu
is
ti
c
an
d
no
n-
lin
gu
is
ti
c
ac
ti
on
s
am
on
g
th
e
ag
en
t
po
pu
la
ti
on
.I
n
pa
rt
ic
ul
ar
,t
he
im
m
un
e
sy
st
em
it
se
lf
is
a
di
sc
re
te
sy
st
em
in
w
hi
ch
th
e
in
di
vi
du
al
be
ha
vi
ou
r
of
ev
er
y
ce
ll
ad
ds
to
cr
ea
te
to
hi
gh
-l
ev
el
be
ha
vi
ou
r
of
th
e
w
ho
le
sy
st
em
.
A
si
m
pl
e
se
t
of
lo
ca
l
ru
le
s
ca
n
th
er
ef
or
e
pr
ov
id
e
an
ac
cu
ra
te
m
od
el
of
th
is
co
m
pl
ex
sy
st
em
.
T
hi
s
is
th
e
ap
pr
oa
ch
w
e
ha
ve
ch
os
en
to
ta
ke
.
A
s
w
e
ha
ve
se
en
ea
rl
ie
r,
m
os
t
of
th
e
im
m
un
e
re
sp
on
se
ag
ai
ns
t
H
IV
is
ta
ki
ng
pl
ac
e
in
th
e
ly
m
ph
at
ic
no
de
s.
T
he
w
or
ld
w
e
m
od
el
ne
ed
on
ly
be
a
ne
tw
or
k
of
160
6
1
6
D
.
P
er
ri
n
et
a
l.
su
ch
no
de
s.
T
he
co
m
m
un
ic
at
io
n
in
si
de
th
e
ne
tw
or
k
w
ill
be
di
sc
us
se
d
la
te
r
(s
ec
-
ti
on
4.
1)
.
E
ac
h
no
de
is
im
pl
em
en
te
d
as
a
m
at
ri
x.
E
ac
h
el
em
en
t
of
th
e
m
at
ri
x
co
rr
es
po
nd
to
a
ph
ys
ic
al
ne
ig
hb
ou
rh
oo
d.
A
ll
th
e
in
te
ra
ct
io
ns
be
tw
ee
n
th
e
ag
en
ts
th
er
ef
or
e
ha
pp
en
in
si
de
th
is
lo
ca
l
el
em
en
t
an
d
th
er
e
is
no
ne
ed
to
co
ns
id
er
su
r-
ro
un
di
ng
m
at
ri
x
el
em
en
ts
as
w
ou
ld
be
do
ne
if
us
in
g
M
oo
re
or
V
on
N
eu
m
an
n
ne
ig
hb
ou
rh
oo
ds
[1
2]
.
3.
2
T
h
e
Im
p
le
m
en
te
d
F
ea
tu
re
s
T
he
re
ar
e
se
ve
ra
lp
la
tf
or
m
s
su
pp
or
ti
ng
ge
ne
ri
c
ag
en
t-
ba
se
d
en
vi
ro
nm
en
ts
,
su
ch
as
Sw
ar
m
[1
3]
.H
ow
ev
er
,d
ue
to
th
e
hi
gh
nu
m
be
r
of
ag
en
ts
w
e
pl
an
to
si
m
ul
at
e,
w
e
th
in
k
it
is
m
or
e
effi
ci
en
t
to
ha
ve
an
ap
pr
oa
ch
fu
lly
de
di
ca
te
d
to
th
is
pa
rt
ic
ul
ar
en
vi
ro
nm
en
t,
an
d
th
er
ef
or
e
op
ti
m
iz
ed
.
B
ec
au
se
of
th
e
ve
ry
de
ta
ill
ed
kn
ow
le
dg
e
of
th
e
ce
ll
in
te
ra
ct
io
ns
,
w
e
ar
e
us
in
g
a
bo
tt
om
-u
p
ap
pr
oa
ch
:
w
e
fir
st
sp
ec
ify
in
de
ta
il
th
e
in
di
vi
du
al
pa
rt
s
of
th
e
sy
st
em
(h
er
e,
th
e
ag
en
ts
),
w
e
th
en
lin
k
th
em
to
ge
th
er
to
fo
rm
la
ye
r
co
m
po
na
nt
s
(h
er
e,
th
e
ly
m
ph
at
ic
no
de
),
w
hi
ch
ar
e
in
tu
rn
lin
ke
d
un
ti
l
a
co
m
pl
et
e
sy
st
em
is
fo
rm
ed
(h
er
e,
th
e
ly
m
ph
at
ic
ne
tw
or
k)
.
A
s
no
te
d
ea
rl
ie
r,
th
is
st
ud
y
fo
cu
se
s
on
th
e
ce
ll-
m
ed
ia
te
d
re
sp
on
se
.T
hu
s,
w
e
fir
st
ne
ed
to
im
pl
em
en
t
th
re
e
ty
pe
s
of
ce
lls
,
co
rr
es
po
nd
in
g
in
th
e
co
de
to
th
re
e
ty
pe
s
of
ag
en
ts
:
T
h
an
d
T
c
ly
m
ph
oc
yt
es
,
an
d
A
nt
ig
en
P
re
se
nt
in
g
C
el
ls
(A
P
C
).
O
f
co
ur
se
,
w
e
al
so
ne
ed
a
fo
ur
th
ty
pe
of
ag
en
t
to
m
od
el
th
e
vi
ri
on
s.
E
ac
h
ty
pe
is
im
pl
em
en
te
d
in
to
th
e
co
de
us
in
g
a
sp
ec
ifi
c
C
+
+
cl
as
s.
In
te
re
st
in
gl
y,
ev
en
if
al
l
fo
ur
ty
pe
s
of
ce
lls
ha
ve
to
ta
lly
di
ffe
re
nt
ro
le
s,
th
ey
ha
ve
a
co
m
m
on
fe
at
ur
e
th
at
w
e
w
an
t
to
ta
ke
in
to
ac
co
un
t,
i.e
.
th
ei
r
m
ob
ili
ty
.
T
hi
s
is
im
pl
em
en
te
d
by
an
ot
he
r
cl
as
s.
T
hi
s
cl
as
s
is
th
en
in
he
ri
te
d
by
th
e
fo
ur
ty
pe
s
de
sc
ri
be
d
ab
ov
e.
It
al
so
im
pl
em
en
ts
ot
he
r
ba
si
c
pr
op
er
ti
es
su
ch
as
th
e
ag
e
of
th
e
ag
en
ts
an
d
al
lo
w
us
to
ha
ve
th
e
fo
ur
ag
en
t
cl
as
se
s
co
nt
ai
n
on
ly
sp
ec
ifi
c
fe
at
ur
es
;a
n
ad
va
nt
ag
e
of
ob
je
ct
-o
ri
en
te
d
pr
og
ra
m
m
in
g.
A
n
ag
en
t
co
di
ng
a
vi
ri
on
on
ly
ha
s
on
e
sp
ec
ifi
c
at
tr
ib
ut
e
in
th
e
m
od
el
,
it
s
vi
ra
l
st
ra
in
.
In
or
de
r
to
pr
ev
en
t
th
e
co
de
fr
om
al
lo
ca
ti
ng
to
o
m
uc
h
m
em
or
y
fo
r
ea
ch
ag
en
t,
th
e
vi
ra
l
st
ra
in
is
on
ly
co
de
d
as
an
in
te
ge
r
w
hi
ch
lin
ks
to
th
e
co
rr
es
po
nd
in
g
st
ra
in
in
an
ar
ra
y
co
nt
ai
ni
ng
al
lt
he
us
ef
ul
pr
op
er
ti
es
of
th
e
st
ra
in
(e
.g
.
ly
m
ph
oc
yt
es
w
hi
ch
re
co
gn
iz
e
it
,
im
m
un
og
en
ic
it
y,
et
c.
).
T
he
ag
en
t
ha
s
a
sh
or
t-
te
rm
an
d
pa
rt
ia
l
kn
ow
le
dg
e
of
it
s
en
vi
ro
nm
en
t.
It
is
pa
rt
ia
l
in
th
e
se
ns
e
th
at
it
is
on
ly
kn
ow
s
w
he
th
er
th
er
e
ar
e
T
h
ce
lls
in
it
s
ph
ys
ic
al
ne
ig
hb
ou
rh
oo
d
(i
.e
.t
he
m
at
ri
x
el
em
en
t)
.I
t
is
sh
or
t-
te
rm
in
th
e
se
ns
e
th
at
it
ha
s
no
m
em
or
y
of
th
e
ev
ol
ut
io
n
of
th
e
nu
m
be
r
of
ly
m
ph
oc
yt
es
.T
hi
s
kn
ow
le
dg
e
is
th
e
on
ly
pi
ec
e
of
in
fo
rm
at
io
n
it
ne
ed
s,
si
nc
e
it
s
un
iq
ue
ob
je
ct
iv
e
is
to
in
fe
ct
a
T
h
ce
ll.
T
he
re
fo
re
,
th
e
ty
pi
ca
l
be
ha
vi
ou
r
of
a
vi
ri
on
in
th
e
m
od
el
ca
n
be
gi
ve
n
as
th
e
fo
llo
w
in
g
tr
ip
ty
ch
,
re
pe
at
ed
un
ti
l
a
ly
m
ph
oc
yt
e
is
in
fe
ct
ed
:
th
e
ag
en
t
m
ov
es
,
sc
an
s
it
s
en
vi
ro
nm
en
t
lo
ok
in
g
fo
r
a
T
h
ce
ll,
an
d
if
po
ss
ib
le
in
fe
ct
s
th
e
im
m
un
e
ce
ll.
A
T
h
ag
en
t
ha
s
th
re
e
sp
ec
ifi
c
at
tr
ib
ut
es
in
th
e
m
od
el
:
an
in
te
ge
r
co
di
ng
it
s
su
rf
ac
e
an
ti
ge
ns
,a
no
th
er
in
te
ge
r
co
di
ng
it
s
“a
ct
iv
at
io
n
st
at
e”
an
d
a
th
ir
d
in
te
ge
r
co
di
ng
it
s
“i
nf
ec
ti
on
st
at
e”
.
O
nc
e
ag
ai
n,
it
ha
s
no
m
em
or
y
of
it
s
en
vi
ro
nm
en
t
an
d
th
e
on
ly
pa
rt
it
kn
ow
s
of
it
is
re
du
ce
d
to
th
e
pr
es
en
ce
,o
r
no
t,
of
T
c
ag
en
ts
.
If
th
e
ag
en
t
is
ne
it
he
r
ac
ti
va
te
d
no
r
in
fe
ct
ed
,b
ot
h
in
te
ge
rs
co
di
ng
th
e
st
at
es
ar
e
A
n
A
g
en
t-
B
a
se
d
A
p
p
ro
a
ch
to
Im
m
u
n
e
M
o
d
el
li
n
g
6
1
7
se
t
to
ze
ro
,
an
d
th
e
ag
en
t’
s
ob
je
ct
iv
e
is
on
ly
to
be
re
ad
y
to
an
sw
er
an
at
ta
ck
.
T
he
re
is
th
er
ef
or
e
no
pa
rt
ic
ul
ar
ac
ti
on
,
ap
ar
t
fr
om
m
ov
in
g.
T
he
ob
je
ct
iv
e
of
an
ac
ti
va
te
d
ag
en
t
is
to
ac
ti
va
te
T
c
ce
lls
.
It
s
“a
ct
iv
at
io
n
st
at
e”
is
se
t
to
th
e
va
lu
e
co
di
ng
th
e
vi
ra
l
st
ra
in
s
w
hi
ch
ac
ti
va
te
d
it
,
so
th
at
it
ca
n
co
m
m
un
ic
at
e
on
th
e
th
re
at
.
If
th
e
ag
en
t
is
in
fe
ct
ed
,
it
pr
od
uc
es
ne
w
vi
ri
on
s
be
lo
ng
in
g
to
th
e
st
ra
in
co
de
d
in
it
s
“i
nf
ec
te
d
st
at
e”
,o
r
to
a
ne
w
on
e
if
th
er
e
is
a
m
ut
at
io
n.
A
T
c
ag
en
t
ha
s
fo
ur
sp
ec
ifi
c
at
tr
ib
ut
es
:
it
s
su
rf
ac
e
an
ti
ge
ns
,
it
s
“a
ct
iv
at
io
n
st
at
e”
,i
ts
“e
xp
an
si
on
st
at
e”
an
d
it
s
“m
em
or
y
st
at
e”
,a
ll
im
pl
em
en
te
d
as
in
te
ge
rs
.
T
he
T
c
ag
en
ts
al
so
ha
ve
a
sh
or
t-
te
rm
an
d
pa
rt
ia
l
vi
ew
of
th
ei
r
en
vi
ro
nm
en
t:
ea
ch
lo
ok
s
on
ly
fo
r
ag
en
ts
ha
vi
ng
th
e
an
ti
ge
ns
co
rr
es
po
nd
in
g
to
th
e
st
ra
in
w
hi
ch
ac
ti
va
te
d
it
,a
nd
de
st
ro
ys
th
em
.W
he
n
ac
ti
va
te
d,
an
ag
en
t
m
ul
ti
pl
ie
s
it
se
lf
du
ri
ng
an
ex
pa
ns
io
n
ph
as
e,
co
rr
es
po
nd
in
g
to
a
no
n-
ze
ro
“e
xp
an
si
on
st
at
e”
.
A
ft
er
an
im
m
un
e
re
sp
on
se
,
a
sm
al
l
am
ou
nt
of
th
e
T
c
ag
en
ts
w
ill
be
co
m
e
m
em
or
y
ce
lls
:
th
ei
r
“m
em
or
y
st
at
e”
w
ill
ke
ep
tr
ac
k
of
th
e
st
ra
in
th
ey
fo
ug
ht
,
th
e
re
ac
ti
va
ti
on
w
ill
be
ea
si
er
,a
nd
if
re
ac
ti
va
te
d,
th
e
ex
pa
ns
io
n
ph
as
e
w
ill
be
m
or
e
pr
od
uc
ti
ve
.
A
n
A
P
C
ag
en
t
on
ly
ha
s
on
e
sp
ec
ifi
c
at
tr
ib
ut
e,
it
s
“p
re
se
nt
in
g
st
at
e”
,
co
de
d
as
an
in
te
ge
r.
A
s
lo
ng
as
th
e
ag
en
t
is
no
t
pr
es
en
ti
ng
an
y
an
ti
ge
n
at
it
s
su
rf
ac
e,
th
e
in
te
ge
r
st
ay
s
at
ze
ro
,a
nd
th
e
ag
en
t’
s
be
ha
vi
ou
r
is
fo
cu
se
d
on
m
ov
in
g
an
d
lo
ok
in
g
fo
r
“f
or
ei
gn
”
en
ti
ti
es
in
it
s
ph
ys
ic
al
ne
ig
hb
ou
rh
oo
d,
in
or
de
r
to
ge
t
an
ti
ge
ns
to
pr
es
en
t.
T
he
n,
th
e
“p
re
se
nt
in
g
st
at
e”
co
de
s
th
e
st
ra
in
co
rr
es
po
nd
in
g
to
th
e
an
ti
ge
ns
,a
nd
th
e
ag
en
ts
st
ar
ts
lo
ok
in
g
fo
r
T
h
ag
en
ts
in
or
de
r
to
ac
ti
va
te
th
em
,
if
th
ey
ar
e
ge
ar
ed
re
co
gn
is
e
th
is
pa
rt
ic
ul
ar
an
ti
ge
n.
A
no
th
er
as
pe
ct
of
th
e
im
pl
em
en
ta
ti
on
ch
os
en
is
th
e
al
lo
ca
ti
on
of
th
e
ag
en
ts
.
M
em
or
y
al
lo
ca
ti
on
s
ar
e
am
on
g
th
e
sl
ow
es
t
op
er
at
io
ns
on
a
co
m
pu
te
r,
an
d
he
re
,
w
e
ha
ve
a
m
od
el
in
w
hi
ch
th
ou
sa
nd
s
of
ag
en
ts
ar
e
cr
ea
te
d
an
d
de
st
ro
ye
d
ev
er
y
it
er
at
io
n.
D
yn
am
ic
al
lo
ca
ti
on
s
w
ou
ld
m
ak
e
th
e
pr
og
ra
m
to
o
sl
ow
.T
he
ap
pr
oa
ch
w
e
ha
ve
ch
os
en
is
to
ha
ve
,
in
ea
ch
m
at
ri
x
el
em
en
t,
a
st
at
ic
al
lo
ca
ti
on
of
th
e
m
ax
im
um
nu
m
be
r
of
ag
en
ts
w
e
w
an
t
to
im
pl
em
en
t.
T
he
n,
an
ag
en
t
m
ov
in
g
fr
om
an
el
em
en
t
to
an
ot
he
r
is
co
de
d
as
th
e
tr
an
sf
er
of
it
s
at
tr
ib
ut
es
fr
om
on
e
st
at
ic
m
em
or
y
sl
ot
to
an
ot
he
r.
E
ve
ry
ag
en
t
be
in
g
sm
al
l
an
d
w
it
h
fe
w
at
tr
ib
ut
es
,
th
is
gi
ve
s
sa
ti
sf
yi
ng
re
su
lt
s.
3.
3
H
ow
to
D
ea
l
w
it
h
S
to
ch
as
ti
c
E
ve
n
ts
?
In
th
is
m
od
el
,m
os
t
m
et
ho
ds
an
d
fu
nc
ti
on
s
ha
ve
to
in
cl
ud
e
ra
nd
om
nu
m
be
r
ge
n-
er
at
io
n.
T
hi
s
is
du
e
to
th
e
fa
ct
th
at
m
an
y
as
pe
ct
s
of
th
e
re
al
-l
ife
sy
st
em
in
vo
lv
e
st
oc
ha
st
ic
ev
en
ts
.M
or
e
de
ta
ils
ca
n
be
fo
un
d
in
[2
],
bu
t
he
re
ar
e
a
fe
w
ex
am
pl
es
.
F
ir
st
,
an
as
pe
ct
w
e
ha
ve
to
de
al
w
it
h
is
th
e
pr
oc
es
s
by
w
hi
ch
ne
w
ly
m
ph
oc
yt
es
ar
e
cr
ea
te
d.
A
ly
m
ph
oc
yt
e
ca
n
on
ly
re
co
gn
iz
e
a
sp
ec
ifi
c
se
t
of
an
ti
ge
ns
so
,t
o
pr
o-
te
ct
it
se
lf
ag
ai
ns
t
an
y
at
ta
ck
,t
he
bo
dy
ha
s
to
ge
ne
ra
te
th
ou
sa
nd
s
of
“v
ar
ia
ti
on
s”
be
tw
ee
n
ly
m
ph
oc
yt
es
.T
hi
s
ha
s
to
be
im
pl
em
en
te
d
us
in
g
ra
nd
om
nu
m
be
rs
.L
ik
e-
w
is
e,
w
e
no
te
d
th
at
on
e
of
th
e
m
os
t
de
ci
si
ve
fe
at
ur
es
of
th
e
vi
ri
on
s
is
th
ei
r
hi
gh
m
ut
at
io
n
ra
te
,
an
d
th
is
im
pl
ie
s
an
ot
he
r
us
e
of
ra
nd
om
nu
m
be
rs
.
F
in
al
ly
,
th
er
e
is
no
se
ns
ib
le
w
ay
to
de
al
w
it
h
m
ob
ili
ty
un
le
ss
w
e
in
cl
ud
e
st
oc
ha
st
ic
it
y.
St
oc
ha
st
ic
ev
en
ts
ar
e
es
se
nt
ia
l
to
th
is
w
or
k
an
d
a
re
lia
bl
e
ra
nd
om
nu
m
be
r
ge
ne
ra
to
r
is
ne
ed
ed
.
A
fu
ll-
sc
al
e
m
od
el
w
ill
in
vo
lv
e
m
ill
io
ns
of
ag
en
ts
in
ve
ry
161
6
1
8
D
.
P
er
ri
n
et
a
l.
lo
ng
si
m
ul
at
io
ns
.T
he
re
fo
re
,t
he
ge
ne
ra
to
r
al
so
ha
s
to
be
ve
ry
effi
ci
en
t.
A
s
pa
ra
l-
le
la
sp
ec
ts
ar
e
in
vo
lv
ed
,i
t
w
ou
ld
al
so
be
a
pl
us
fo
r
th
e
ge
ne
ra
to
r
to
in
cl
ud
e
su
ch
fe
at
ur
es
.
T
he
re
ar
e
m
an
y
ge
ne
ra
to
rs
av
ai
la
bl
e,
an
d
go
od
on
es
ca
n
al
so
be
de
-
si
gn
ed
ex
pl
ic
it
el
y
(s
ee
e.
g.
[1
4]
).
H
ow
ev
er
,d
ue
to
ou
r
m
od
el
re
qu
ir
em
en
ts
,w
ha
t
is
ne
ed
ed
he
re
is
a
to
p-
qu
al
it
y
pa
ra
lle
lg
en
er
at
or
,a
nd
w
e
ch
os
e
to
us
e
th
e
Sc
al
ab
le
P
ar
al
le
lR
an
do
m
N
um
be
r
G
en
er
at
or
s
lib
ra
ry
(S
P
R
N
G
)
[1
5]
.
T
hi
s
lib
ra
ry
in
co
r-
po
ra
te
s
re
ce
nt
,s
ta
te
-o
f-
th
e-
ar
t,
de
ve
lo
pm
en
ts
in
th
e
m
at
he
m
at
ic
s
an
d
co
m
pu
te
r
sc
ie
nc
e
of
pa
ra
lle
lp
se
ud
or
an
do
m
nu
m
be
r
ge
ne
ra
ti
on
.I
t
an
effi
ci
en
t
lib
ra
ry
w
it
h
an
ex
is
ti
ng
,
ac
ti
ve
,
us
er
ba
se
,
en
su
ri
ng
hi
gh
st
an
da
rd
s.
It
al
lo
w
s
th
e
st
re
am
s
to
be
al
so
ab
so
lu
te
ly
re
pr
od
uc
ed
,f
or
co
m
pu
ta
ti
on
al
ve
ri
fic
at
io
n,
in
de
pe
nd
en
t
of
th
e
nu
m
be
r
of
pr
oc
es
so
rs
us
ed
in
th
e
co
m
pu
ta
ti
on
an
d
of
th
e
lo
ad
in
g
pr
od
uc
ed
by
sh
ar
in
g
of
th
e
pa
ra
lle
lc
om
pu
te
r.
U
si
ng
it
,
w
e
ca
n
be
co
nfi
de
nt
w
e
w
ill
pr
od
uc
e
st
at
is
ti
ca
lly
si
gn
ifi
ca
nt
re
su
lt
s
at
a
ve
ry
lo
w
co
m
pu
ti
ng
co
st
.
4
In
te
ra
ct
io
n
s
B
e
tw
e
e
n
th
e
L
y
m
p
h
a
ti
c
N
o
d
e
s
4.
1
S
h
ar
in
g
K
n
ow
le
d
ge
an
d
T
ra
n
sf
er
ri
n
g
A
ge
n
ts
T
he
im
m
un
e
sy
st
em
is
or
ga
ni
se
d
so
th
at
ev
er
y
ly
m
ph
at
ic
no
de
is
a
sm
al
ld
ef
en
ce
un
it
in
w
hi
ch
th
e
im
m
un
e
re
sp
on
se
is
ta
ki
ng
pl
ac
e.
T
he
re
is
no
ne
ed
fo
r
th
e
re
sp
on
se
to
ta
ke
pl
ac
e
in
ev
er
y
no
de
,
w
hi
ch
is
w
hy
w
e
bu
ilt
ou
r
m
od
el
as
a
ne
tw
or
k
of
in
de
pe
nd
en
t
m
at
ri
ce
s
(p
ut
ti
ng
th
e
em
ph
as
is
on
th
e
lo
ca
lm
od
el
of
th
e
no
de
).
T
he
on
ly
ph
ys
ic
al
ex
ch
an
ge
be
tw
ee
n
ly
m
ph
at
ic
no
de
s
ha
pp
en
s
th
ro
ug
h
th
e
re
ci
rc
ul
at
io
n
an
d
th
e
m
ob
ili
ty
of
ce
lls
w
hi
ch
go
fr
om
on
e
no
de
to
an
ot
he
r.
E
ac
h
no
de
in
th
e
m
od
el
th
er
ef
or
e
ne
ed
s
an
en
tr
y
po
in
t
an
d
an
ex
it
po
in
t.
If
,
w
he
n
m
ov
in
g
in
si
de
th
e
no
de
,
an
ag
en
t
re
ac
he
s
th
e
ex
it
po
in
t,
it
is
re
m
ov
ed
fr
om
th
e
no
de
an
d
pu
t
in
to
a
tr
an
sf
er
lis
t.
T
he
lis
t
is
de
al
t
w
it
h
at
th
e
en
d
of
th
e
it
er
at
io
n.
In
th
e
m
ea
nt
im
e,
ot
he
r
ag
en
ts
m
ov
e,
in
te
ra
ct
io
ns
ta
ke
pl
ac
e,
as
ti
m
e
pa
ss
es
.T
hi
s
ac
co
un
ts
fo
r
th
e
ti
m
e
it
ta
ke
s
th
e
ag
en
t
in
re
al
-l
ife
to
co
m
m
ut
e
be
tw
ee
n
tw
o
no
de
s.
T
he
w
ay
in
w
hi
ch
ag
en
ts
ar
e
tr
an
sf
er
re
d
be
tw
ee
n
th
e
no
de
s
m
im
ic
s
th
e
tr
an
sf
er
be
tw
ee
n
m
at
ri
x
el
em
en
ts
:w
e
co
ns
id
er
on
ly
at
tr
ib
ut
es
,r
at
he
r
th
an
th
e
ag
en
t
it
se
lf.
T
hu
s,
an
en
tr
y
in
th
e
tr
an
sf
er
lis
t
co
nt
ai
ns
th
e
ty
pe
of
th
e
ag
en
t,
it
s
at
tr
ib
ut
es
,a
nd
it
s
de
st
in
at
io
n.
A
t
th
e
en
d
of
th
e
it
er
at
io
n,
al
ll
is
ts
ar
e
pu
t
to
ge
th
er
an
d
th
e
m
ov
in
g
ag
en
ts
ar
e
tr
an
sf
er
re
d
to
th
e
en
tr
y
po
in
t
of
th
ei
r
de
st
in
at
io
n
no
de
.
T
he
ot
he
r
as
pe
ct
of
th
e
co
m
m
un
ic
at
io
n
be
tw
ee
n
ou
r
no
de
s
is
in
he
re
nt
to
ou
r
im
pl
em
en
ta
ti
on
.
Si
nc
e
w
e
de
ci
de
d
no
t
to
pu
t
al
l
th
e
st
ra
in
pr
op
er
ti
es
in
to
ea
ch
ag
en
t,
w
e
ne
ed
a
w
ay
to
co
de
th
em
so
m
ew
he
re
an
d
m
ak
e
th
em
av
ai
la
bl
e
to
al
lt
he
ag
en
ts
,w
he
re
ve
r
th
ey
ar
e
in
th
e
m
od
el
.
T
he
se
ar
e
im
po
rt
an
t
pr
op
er
ti
es
,
an
d
m
us
t
no
t
be
ne
gl
ec
te
d.
Fo
r
in
st
an
ce
w
e
ne
ed
to
kn
ow
,f
or
ea
ch
st
ra
in
,w
hi
ch
ly
m
ph
oc
yt
es
w
ill
re
co
gn
is
e
it
fo
r
su
re
an
d
w
hi
ch
ly
m
ph
oc
yt
es
m
ig
ht
re
co
gn
is
e
it
.
O
ne
ch
ar
ac
te
ri
st
ic
is
th
at
w
he
n
a
ly
m
ph
oc
yt
e
fr
om
th
e
se
co
nd
ca
te
go
ry
re
co
gn
is
e
th
e
st
ra
in
,i
t
m
ov
es
fr
om
th
e
se
co
nd
in
to
th
e
fir
st
.T
hi
s
is
cr
it
ic
al
to
th
e
re
al
is
m
of
th
e
m
od
el
,
si
nc
e
it
al
lo
w
s
us
to
in
tr
od
uc
e
so
m
e
ad
ap
ta
bi
lit
y
an
d
em
er
ge
nt
be
ha
vi
ou
r.
O
ne
an
sw
er
co
ul
d
ha
ve
be
en
to
cr
ea
te
a
lin
ke
d
lis
t
co
nt
ai
ni
ng
th
e
st
ra
in
s
ac
ti
ve
in
th
e
cu
rr
en
t
si
m
ul
at
io
n.
T
he
ob
vi
ou
s
ad
va
nt
ag
e
is
to
lim
it
th
e
A
n
A
g
en
t-
B
a
se
d
A
p
p
ro
a
ch
to
Im
m
u
n
e
M
o
d
el
li
n
g
6
1
9
si
ze
al
lo
ca
te
d
to
th
e
st
ra
in
s
to
w
ha
t
is
ac
tu
al
ly
ne
ed
ed
.H
ow
ev
er
,i
t
ha
s
on
e
m
aj
or
dr
aw
ba
ck
w
hi
ch
m
ak
es
it
po
in
tl
es
s
in
ou
r
ca
se
,
na
m
el
y
th
at
th
e
hi
gh
m
ut
at
io
n
ra
te
m
ea
ns
a
la
rg
e
nu
m
be
r
of
st
ra
in
s,
in
cr
ea
si
ng
as
th
e
si
m
ul
at
io
n
co
nt
in
ue
s.
T
he
bi
gg
er
th
e
lis
t,
th
e
lo
ng
er
it
w
ill
ta
ke
to
ge
t
th
e
pr
op
er
ti
es
fo
r
a
pa
rt
ic
ul
ar
st
ra
in
an
d
si
nc
e
th
is
lis
t
ha
s
to
be
ac
ce
ss
ed
th
ou
sa
nd
s
of
ti
m
es
in
ev
er
y
it
er
at
io
n,
th
is
pr
oc
es
s
w
ou
ld
sl
ow
th
e
w
ho
le
pr
og
ra
m
do
w
n.
W
e
th
er
ef
or
e
de
ci
de
d
to
ha
ve
an
ar
ra
y
of
st
ra
in
s.
T
hi
s
ar
ra
y
is
la
rg
e
(i
.e
.
te
ns
of
th
ou
sa
nd
s
of
st
ra
in
s)
an
d
re
pr
es
en
ts
po
te
nt
ia
l
st
ra
in
s
fo
r
th
e
si
m
ul
at
io
n
to
be
im
pl
em
en
te
d.
C
on
si
de
ri
ng
th
at
a
st
ra
in
in
th
e
ar
ra
y
ca
n
ac
co
un
t
fo
r
va
ri
ou
s
st
ra
in
s
in
re
al
lif
e
(i
ft
he
y
di
ffe
r
on
pr
op
er
ti
es
w
e
do
no
t
co
de
ex
pl
ic
it
el
y)
,
w
e
ar
e
co
nfi
de
nt
th
is
sh
ou
ld
gi
ve
us
en
ou
gh
di
ve
rs
it
y.
4.
2
P
ar
al
le
li
sa
ti
on
E
ff
or
ts
W
he
n
th
e
pr
og
ra
m
is
ru
nn
in
g
at
fu
ll
sc
al
e,
ea
ch
no
de
co
nt
ai
ns
hu
nd
re
ds
of
th
ou
-
sa
nd
s
of
ag
en
ts
.I
n
re
al
lif
e,
a
hu
m
an
bo
dy
co
nt
ai
ns
ab
ou
t
a
th
ou
sa
nd
ly
m
ph
at
ic
no
de
s.
M
at
ch
in
g
th
is
va
lu
e
is
a
lo
ng
-t
er
m
ob
je
ct
iv
e
an
d
m
ay
no
t
be
ac
hi
ev
ab
le
,
bu
t
ev
en
w
it
h
fif
ty
no
de
s,
w
e
w
ou
ld
ha
ve
to
de
al
w
it
h
m
ill
io
ns
of
ag
en
ts
.
T
he
ti
m
e-
st
ep
of
th
e
pr
og
ra
m
is
ab
ou
t
fif
ty
se
co
nd
s,
so
ab
ou
t
si
x
m
ill
io
n
it
er
at
io
ns
ar
e
ne
ed
ed
fo
r
a
10
-y
ea
r
si
m
ul
at
io
n.
R
un
ni
ng
su
ch
a
pr
og
ra
m
on
a
si
ng
le
co
m
-
pu
te
r
w
ou
ld
ta
ke
m
on
th
s,
an
d
no
t
ev
en
ha
ve
en
ou
gh
m
em
or
y
m
ig
ht
be
av
ai
la
bl
e
to
in
it
ia
liz
e
al
l
th
e
m
at
ri
ce
s.
If
w
e
al
so
co
ns
id
er
th
e
fa
ct
th
at
w
e
ha
ve
to
ru
n
se
ve
ra
ls
im
ul
at
io
ns
to
st
at
is
ti
ca
lly
as
se
ss
th
e
ro
le
of
ea
ch
pa
ra
m
et
er
su
ch
as
th
e
m
ut
at
io
n
ra
te
,a
pa
ra
lle
la
pp
ro
ac
h
m
ak
es
ev
en
m
or
e
se
ns
e.
T
he
ap
pr
oa
ch
w
e
de
ve
lo
p
he
re
is
to
m
im
ic
th
e
im
m
un
e
sy
st
em
,
in
th
e
se
ns
e
th
at
ea
ch
ly
m
ph
at
ic
no
de
w
ill
be
co
m
pu
te
d
by
a
di
ffe
re
nt
co
m
pu
te
r
(a
ls
o
ca
lle
d
no
de
)
on
a
cl
us
te
r.
A
s
th
e
ly
m
ph
at
ic
no
de
s
ar
e
m
ai
nl
y
in
de
pe
nd
en
t
fr
om
ea
ch
ot
he
r,
th
is
is
th
e
be
st
w
ay
to
ta
ke
ad
va
nt
ag
e
of
th
e
pa
ra
lle
l
op
ti
on
.
M
or
eo
ve
r,
th
e
lo
ca
l
m
od
el
is
al
re
ad
y
kn
ow
n
to
ru
n
on
a
si
ng
le
co
m
pu
te
r
so
ap
pr
ox
im
at
e
ex
pe
ct
at
io
ns
on
pe
rf
or
m
an
ce
s
ar
e
kn
ow
n
al
so
.T
hi
s
ty
pe
of
sp
at
ia
lp
ar
al
le
lis
at
io
n
ha
s
be
en
st
ud
ie
d
in
[1
6]
fo
r
M
on
te
-C
ar
lo
si
m
ul
at
io
ns
.T
he
m
ai
n
di
sa
dv
an
ta
ge
in
th
at
st
ud
y
is
th
e
co
m
m
un
ic
at
io
n
ov
er
lo
ad
.
H
er
e,
m
os
t
of
th
e
co
m
m
un
ic
at
io
n
ta
ki
ng
pl
ac
e
on
th
e
cl
us
te
r
is
th
e
tr
an
sf
er
of
ag
en
ts
fr
om
on
e
no
de
to
an
ot
he
r.
U
si
ng
th
e
lis
t
pr
oc
es
s
de
sc
ri
be
d
ab
ov
e,
th
is
is
ke
pt
to
a
m
in
im
um
.
T
hi
s
pa
ra
lle
l
ap
pr
oa
ch
is
im
pl
em
en
te
d
us
in
g
th
e
M
es
sa
ge
-P
as
si
ng
In
te
rf
ac
e
(M
P
I)
[1
7,
18
].
It
is
un
de
r
va
lid
at
io
n
on
a
cl
us
te
r
co
m
po
se
d
of
a
D
el
l
P
ow
er
E
dg
e
17
50
ac
ti
ng
as
th
e
m
as
te
r
no
de
an
d
si
xt
ee
n
of
th
es
e
m
ac
hi
ne
s
ac
ti
ng
as
sl
av
es
.M
or
e
im
po
rt
an
t
cl
us
te
rs
w
ill
al
so
be
us
ed
fo
r
fu
ll-
sc
al
e
ru
ns
.
T
he
m
os
t
di
ffi
cu
lt
pa
rt
he
re
is
to
de
al
w
it
h
th
e
up
da
te
s
of
th
e
ar
ra
y
co
nt
ai
ni
ng
th
e
st
ra
in
.O
n
th
e
on
e
ha
nd
,i
f
w
e
ke
ep
on
ly
on
e
ar
ra
y
(o
n
th
e
m
ai
n
no
de
of
th
e
cl
us
te
r)
it
w
ou
ld
le
ad
to
ex
ce
ss
iv
e
co
m
m
un
ic
at
io
n:
ea
ch
ag
en
t
w
ou
ld
ha
ve
to
as
k
fo
r
th
e
vi
ra
l
st
ra
in
pr
op
er
ti
es
at
ea
ch
it
er
at
io
n.
O
n
th
e
ot
he
r
ha
nd
,
ha
vi
ng
an
ar
ra
y
lin
ke
d
to
ev
er
y
no
de
w
ou
ld
im
po
se
a
pr
oc
es
s
to
m
ak
e
su
re
th
at
at
ev
er
y
in
st
an
t
al
l
ar
ra
ys
co
nt
ai
n
th
e
sa
m
e
in
fo
rm
at
io
n,
fo
r
al
l
th
e
st
ra
in
s.
U
si
ng
M
P
I
ad
va
nc
ed
fe
at
ur
es
,t
hi
s
ca
n
be
do
ne
th
ro
ug
h
“c
ol
le
ct
iv
e
co
m
m
un
ic
at
io
n”
.
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6
2
0
D
.
P
er
ri
n
et
a
l.
T
hi
s
ap
pr
oa
ch
pr
ov
id
es
an
in
tu
it
iv
e
w
ay
to
co
m
bi
ne
th
e
pa
ra
lle
l
co
m
pu
ti
ng
fe
at
ur
es
w
it
h
a
pr
oc
es
s
w
hi
ch
m
im
ic
s
th
e
im
m
un
e
sy
st
em
.
T
he
tr
an
sf
er
of
th
e
ag
en
ts
is
cu
rr
en
tl
y
be
in
g
op
ti
m
iz
ed
.
T
hi
s
w
ill
al
lo
w
us
to
th
en
ru
n
fu
ll-
sc
al
e
si
m
ul
at
io
ns
.O
ur
ob
je
ct
iv
e
is
to
fir
st
re
pr
od
uc
e
th
e
th
re
e-
ph
as
e
ev
ol
ut
io
n
of
th
e
di
se
as
e
an
d
th
en
al
te
r
th
e
pa
ra
m
et
er
s
(m
ob
ili
ty
,
vi
ra
l
lo
ad
)
to
st
ud
y
ho
w
th
ey
aff
ec
t
th
e
la
te
nc
y
pe
ri
od
le
ng
th
.
5
C
o
n
c
lu
si
o
n
T
he
ob
je
ct
iv
e
of
th
is
st
ud
y
is
to
un
de
rs
ta
nd
w
hy
th
e
ra
ng
e
of
ex
pe
ri
en
ce
w
it
h
re
sp
ec
t
to
H
IV
in
fe
ct
io
n
is
so
di
ve
rs
e,
ad
dr
es
si
ng
in
pa
rt
ic
ul
ar
qu
es
ti
on
s
re
la
ti
ng
to
va
ri
at
io
n
in
le
ng
th
in
in
di
vi
du
al
la
te
nc
y
pe
ri
od
.T
o
in
ve
st
ig
at
e
th
es
e
qu
es
ti
on
s,
an
“a
ge
nt
-b
as
ed
”
ap
pr
oa
ch
is
ch
os
en
,a
s
a
m
ea
ns
of
in
fe
rr
in
g
hi
gh
-l
ev
el
be
ha
vi
ou
r
fr
om
a
sm
al
l
se
t
of
in
te
ra
ct
io
n
ru
le
s
at
th
e
ce
llu
la
r
le
ve
l
as
w
el
l
as
in
cl
ud
in
g
st
oc
ha
st
ic
ev
en
ts
.
T
he
m
od
el
de
ve
lo
pe
d
m
im
ic
th
e
im
m
un
e
sy
st
em
,a
s
it
is
or
ga
ni
se
d
as
a
ne
t-
w
or
k
of
m
at
ri
ce
s,
ea
ch
of
th
em
co
rr
es
po
nd
in
g
to
a
ly
m
ph
at
ic
no
de
.
M
at
ri
x
el
e-
m
en
ts
ca
n
ho
st
se
ve
ra
la
ge
nt
s,
of
fo
ur
di
ffe
re
nt
ty
pe
s,
ac
co
un
ti
ng
fo
r
vi
ri
on
s,
T
h
an
d
T
c
ly
m
ph
oc
yt
es
,a
nd
A
nt
ig
en
P
re
se
nt
in
g
C
el
ls
.T
hu
s,
it
is
po
ss
ib
le
to
m
od
el
th
e
H
IV
sp
re
ad
in
g
st
ra
te
gy
an
d
th
e
ce
ll-
m
ed
ia
te
d
im
m
un
e
re
sp
on
se
.
B
ec
au
se
th
e
sy
st
em
w
e
st
ud
y
is
so
co
m
pl
ex
,
m
ill
io
ns
of
ag
en
ts
ar
e
ne
ed
ed
,
an
d
it
is
no
t
po
ss
ib
le
to
ru
n
th
e
m
od
el
on
a
si
ng
le
co
m
pu
te
r.
T
he
re
fo
re
,p
ar
al
le
l
m
et
ho
ds
ar
e
im
pl
em
en
te
d.
U
si
ng
M
P
I,
ev
er
y
ly
m
ph
at
ic
no
de
is
al
lo
ca
te
d
to
a
di
ffe
re
nt
co
m
pu
te
r
on
a
cl
us
te
r,
an
d
“c
ol
le
ct
iv
e
co
m
m
un
ic
at
io
n”
is
us
ed
to
sh
ar
e
kn
ow
le
dg
e
co
m
m
on
to
al
ln
od
es
.
T
hi
s
pa
ra
lle
l
im
pl
em
en
ta
ti
on
is
cu
rr
en
tl
y
be
in
g
te
st
ed
an
d
th
e
fir
st
re
su
lt
s
sh
ou
ld
be
av
ai
la
bl
e
in
th
e
co
m
in
g
m
on
th
s.
A
ck
n
o
w
le
d
g
e
m
e
n
ts
T
he
au
th
or
s
w
ou
ld
lik
e
to
th
an
k
th
e
Ir
is
h
R
es
ea
rc
h
C
ou
nc
il
fo
r
Sc
ie
nc
e,
E
n-
gi
ne
er
in
g
an
d
T
ec
hn
ol
og
y
fo
r
th
e
fu
nd
in
g
m
ad
e
av
ai
la
bl
e
th
ro
ug
h
th
e
E
m
ba
rk
In
it
ia
ti
ve
.
R
e
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n
c
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1
.
B
u
rn
s,
J
.:
E
m
er
g
en
t
n
et
w
o
rk
s
in
im
m
u
n
e
sy
st
em
sh
a
p
e
sp
a
ce
.
P
h
D
th
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is
,
D
u
b
li
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C
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U
n
iv
er
si
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,
S
ch
o
o
l
o
f
C
o
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p
u
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n
g
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G
er
m
a
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,
R
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h
e
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e
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b
a
b
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S
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st
em
C
o
n
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A
d
a
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v
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m
u
n
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S
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em
.
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S
y
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g
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M
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A
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a
d
m
a
p
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f
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h
a
n
d
d
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el
-
o
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m
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L
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B.3 ERCIM News 72
Perrin, D., Ruskin, H. J., Crane, M., and Walshe, R. (2008). Epigenetic modelling. ERCIM
News, 72:46.
This article introduces to a non-specialist audience, (mathematicians and computer scien-
tists), the field of Epigenetics, and presents our overall research project. The model pre-
sented in this Thesis is a proof of concept for this long-term study.
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Early advances in genetics led to the all-
genetic paradigm: phenotype (an organ-
ism's characteristics/behaviour) is deter-
mined by genotype (its genetic make-
up). This was later amended and
expressed by the well-known formula 
P = G + E, encompassing the notion that
the visible characteristics of a living
organism (the phenotype, P) is a combi-
nation of hereditary genetic factors (the
genotype, G) and environmental factors
(E). However, this method fails to
explain why in diseases such as schizo-
phrenia we still observe differences
between identical twins. Furthermore,
the identification of environmental fac-
tors (such as smoking and air quality for
lung cancer) is relatively rare. The for-
mula also fails to explain cell differenti-
ation from a single fertilized cell.
In the wake of early work by Wadding-
ton, more recent results have empha-
sized that the expression of the genotype
can be altered without any change in the
DNA sequence. This phenomenon has
been tagged as epigenetics. To form the
chromosome, DNA strands roll over
nucleosomes, which are a cluster of nine
proteins (histones), as detailed in Fig-
ure 1. Epigenetic mechanisms involve
inherited alterations in these two struc-
tures, eg through attachment of a func-
tional group to the amino acids (methyl,
acetyl and phosphate). These 'stable
alterations' arise during development
and cell proliferation and persist
through cell division. While information
within the genetic material is not
changed, instructions for its assembly
and interpretation may be. Modelling
this new paradigm, P = G + E + EpiG, is
the object of our study. 
To our knowledge, no previous efforts
have sought to model directly the mech-
anisms that affect epigenetic changes.
Biological research on epigenetic phe-
nomena is ongoing, but while some very
promising articles are being published,
most still contain only qualitative
descriptions of epigenetic changes. This
is not ideal when trying to develop com-
puter-based models, but it is also not
unusual. Over a decade ago the basics of
HIV infection were understood, but
quantitative data were sparse. Yet as
early as 1992, differential equation
models were proposed, while cell-medi-
ated micro-models date from the 1990s.
As more data have become available,
these models have improved in sophisti-
cation, incorporating features such as
shape-space formalism and massively
multi-agent, parallel systems.
As a first step, we propose a micro-
scopic model for chromatin structures.
From the current biological results, it
clearly appears that each unit (eg his-
tone, DNA strand or amino acid) has a
distinct role in epigenetic changes, and
this role can alter depending on the type
or location of the unit (eg which partic-
ular amino acid, what part of the DNA
strand etc). For efficiency, this is best
modelled using an object-oriented
approach and a C++ implementation.
The main objective of this early model
is to provide a description and hierarchy
for epigenetic changes at the cell level,
as well as an investigation into the
dynamics and time scales of the
changes. These results will then be used
to 'feed into' other models. Already in
development are approaches such as
agent-based modelling of cell differen-
tiation and complex recurrent networks
of cancer initiation by epigenetic
changes.
Another early model uses Probabilistic
Bayesian Networks. These represent a
set of variables and their probabilistic
dependencies and are constructed as
directed acyclic graphs, for which
nodes represent variables and arcs
encode conditional dependencies
between the variables. The variables
can be of any type, ie a measured
parameter, a latent variable or even a
hypothesis. These networks can be used
for inference, parameter estimation and
refinement, and structure learning. This
approach has been successfully used in
medicine (eg breast cancer diagnosis)
and biology (eg protein structure pre-
diction), and epigenetic mechanisms
appear amenable to such techniques.
Though still in its infancy, the project is
gaining momentum and early work on
the different approaches looks very
promising. Active involvement from
biologists and medical researchers is
currently being sought in order to
secure access to data and guarantee
model realism (as highlighted by a pres-
entation at the International Agency for
Research on Cancer in early December
2007). Previous modelling experience
from the group promises sensible inte-
gration of the various approaches and
efficient implementations. Several pub-
lications and presentations are expected
in the coming year, all of which will
appear on the group's Web site (link
below).
Links:
http://www.computing.dcu.ie/~dperrin/
http://www.computing.dcu.ie/~msc/pub
lications.shtml
Please contact:
Dimitri Perrin
School of Computing, Dublin City
University, Ireland
Tel: +353 1 700 8449
E-mail:
dimitri.perrin@computing.dcu.ie
Epigenetic Modelling
by Dimitri Perrin, Heather J. Ruskin, Martin Crane and Ray Walshe
The field of epigenetics looks at changes in the chromosomal structure that affect gene
expression without altering DNA sequence. A large-scale modelling project to better understand
these mechanisms is gaining momentum.
Figure 1: A nucleosome, the fundamental
subunit of the chromosome (adapted from 
C. Brenner, PhD thesis, Université Libre de
Bruxelles, 2005).
R&D and Technology Transfer
165
B.4 ERCIM News 74
Perrin, D., and Burns, J. (2008). Large-scale immune models and visualization. ERCIM
News, 74:33–34.
This article summarises the development of our large-scale lymph network model, and in-
troduces the current collaborative efforts to develop visualisation tools for such simula-
tions.
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Appendix C
Abstracts
C.1 CGCS ’06
Perrin, D., Ruskin, H. J., and Crane, M. (2006). HIV Modelling – Parallel Implementa-
tion Strategies. Third International Conference on Cluster and Grid Computing Systems
(CGCS’06), Venice, Italy.
Abtract:
We report on the development of a model to understand why the range of experience with
respect to HIV infection is so diverse, especially with respect to the latency period. To in-
vestigate this, an agent-based approach is used to extract highlevel behaviour which cannot
be described analytically from the set of interaction rules at the cellular level. A network
of independent matrices mimics the chain of lymph nodes. Dealing with massively multi-
agent systems requires major computational effort. However, parallelisation methods are a
natural consequence and advantage of the multi-agent approach and, using the MPI library,
are here implemented, tested and optimized. Our current focus is on the various imple-
mentations of the data transfer across the network. Three communications strategies are
proposed and tested, showing that the most efficient approach is communication based on
the natural lymph-network connectivity.
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Keywords: HIV, Immune modelling, MPI, Parallelisation.
C.2 ICMS ’06
Perrin, D., Ruskin, H. J., and Crane, M. (2006). An agent-based approach to immune
modelling, Priming individual response. Third International Conference on Modeling and
Simulation (ICMS’06), Cairo, Egypt.
Abtract:
This study focuses on examining why the range of experience with respect to HIV infection
is so diverse, especially in regard to the latency period. An agent-based approach in mod-
elling the infection is used to extract high-level behaviour which cannot be obtained analyt-
ically from the set of interaction rules at the cellular level. A prototype model encompasses
local variation in baseline properties, contributing to the individual disease experience, and
is included in a network which mimics the chain of lymph nodes. The model also accounts
for stochastic events such as viral mutations. The size and complexity of the model require
major computational effort and parallelisation methods are used.
Keywords: HIV, Immune modelling, Agent-based system, Individual response.
C.3 ICCM 2007
Perrin, D., Duhamel, C., Ruskin, H. J., and Crane, M. (2007). Microarray biclustering:
mathematical model and metaheuristic alternatives. International Conference on Computa-
tional Methods (ICCM2007), Hiroshima, Japan.
Abtract:
DNA microarrays are extensively used as a means to obtain expression levels of several
genes under a set of conditions, see e.g. [1]. Typically, thousands of genes are considered
under tens of conditions. Biclustering is then applied to extract a subset of genes and a
169
subset of conditions for which it is possible to identify common behaviour [2]. Here, we
transform the biclustering into a graph optimisation problem: the microarray is represented
as a bipartite graph in which we look for relevant subgraphs. We propose a mathematical
formulation for this problem. For the optimisation to give meaningful results, we also intro-
duce a new weighting function, aimed at isolating relevant gene-condition couples. These
weights are based on a categorization of the expression ratio. An exact enumerative method
is developed and tested on medium-sized arrays (i.e. less than ten conditions) and returns
the best solution within a few seconds. Metaheuristics are also implemented, for bigger
datasets. Results are again very satisfying and the computation time remains sensible.
Keywords: DNA microarray, biclustering, mathematical formulation, metaheuristics.
References:
[1] F. Oana, T. Homma, H. Takeda, A. Matsuzawa, S. Akahane, M. Isaji, M. Akahane: DNA
microarray analysis of white adipose tissue from obese (fa/fa) Zucker rats treated with a 3-
adrenoceptor agonist, KTO-7924, Pharmacological Research, Vol.52, pp.395-400, 2005.
[2] H. Turner, T. Bailey, W. Krzanowski: Improved biclustering of microarray data demon-
strated through systematic performance tests, Computational Statistics and Data Analysis,
Vol.48, pp. 235-254, 2005.
C.4 ICG 2008
Perrin, D., and Ruskin, H. J. (2008). The case for epigenetic modelling (poster). XX Inter-
national Congress of Genetics, Berlin, Germany.
Abtract:
Objectives. Advances in Genetics incorporate the all-genetic paradigm through the notion
that phenotype (P ) of an organism is a combination of its genotype (G) and environmen-
tal factors (E), i.e. P = G + E. More recent work has emphasised ”stable alterations”
of the chromatin, arising during development and cell proliferation, and persisting through
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cell division. While information within the genetic material remains unchanged, instruc-
tions for its assembly and interpretation may be modified. Modelling this new paradigm,
P = G+ E + EpiG, is the object of our study.
Methods. To our knowledge, no previous efforts have sought to model directly epige-
netic mechanisms. Research on epigenetic phenomena is ongoing, but while promising
advances are being reported, most still contain only qualitative descriptions of epigenetic
changes. This is not ideal when trying to develop computer-based models, but is also not
unusual. A similar situation in the early 1990s necessitated phenomenological development
of computer-based models of HIV infection. As more data have become available, these
models have improved in sophistication, incorporating new features, and are now a valuable
tool for ongoing biological research. Here, we present a development framework based on
this experience. Models implemented include microscopic representations and high-level
network-based approaches.
Results. Current status of the approaches offers a intuitive and comprehensive represen-
tation of epigenetic mechanisms. Efforts at the microscopic level are targeted towards es-
tablishing a hierarchy of epigenetic changes, while network-based approaches provide the
basis for better development of biomarkers for early detection of cancer.
Conclusion. Though still in its infancy, the project is gaining momentum and early work
on the different approaches is encouraging. This establishes a new field, computer-based
epigenetic modelling, which is expected to provide valuable insight on key biological ques-
tions.
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Appendix D
Source Code
The accompanying CD contains commented source code for the three model layers. This
code was tested on several platforms. Apart from the MPI library, it does not require instal-
lation of extra software.
Unless stated otherwise, all files are written by Dimitri Perrin.
D.1 Agent-based lymph network model
All files required for the main model layer are located in the “HIV” folder. For random
number generation, we provide an interface with Mersenne Twister, and this generator is
included in the folder, (“mersenne-twister.h”).
This is to avoid requirements for SPRNG installation.
D.2 Microarray biclustering
D.2.1 Weighting scheme
All files required for weights generation are available in the “Weights” folder, in “Microar-
ray”. As an exemple, we also provide a dataset ready to use, (“MIT.txt”), and the corre-
sponding weights obtained (“weights-MIT.txt”).
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In this folder, the file “main.c” is the only one directly referring to the work implemented in
this Thesis. The other files exclusively deal with data storage, through a previously existing
matrix structure implemented by Nicolas Aunai. They are only provided here because they
are required to compile and run the algorithm.
D.2.2 Parallel genetic algorithm
All files required for weights generation are located in the “GA” folder, in “Microarray”.
In this folder, the files “genetic.c” and “main.c” are the only ones directly referring to the
work implemented in this Thesis. Other files were developed by Christophe Duhamel,
remain his property, and are only provided here because they are required to compile and
run the genetic algorithm.
As an exemple, we also provide a set of weights, (“DATA/weights-MIT.txt”). With the
makefile is provided, compile with “make release”.
D.3 Epigenetic model
All files required for the epigenetic model are available in the “Crypt model” folder.
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Glossary
Adaptive immune response: In contrast to the innate response, the specific, or adap-
tive, immune response is based on the accurate recognition of foreign non-self antigens.
Antigen-specific response has two arms, namely cell-mediated and antibody-mediated re-
sponses. The latter, also known as the humoral response, features B lymphocytes as effector
cells, and mainly targets bacterial attacks. Humoral response is characterised by produc-
tion, by these cells, neutralizing antibodies, following activation by CD4+ T helper cells
through release of interleukin IL-4. Cell-mediated response is targeted more specifically at
viral attacks and takes place in lymph nodes.
Agent: an intelligent agent is a modelling object with specific properties which include
autonomy, social behaviour, reactivity, and proactivity.
Agent-based model: a model in which the key abstraction elements are agents. When
using several agents, such a model is often called a multi-agent system.
AIDS: Acquired ImmunoDeficiency Syndrome. Collection of symptoms and infections
resulting from the specific damage to the immune system caused by the human immunode-
ficiency virus. This is the last phase of HIV infection progression.
Antigenic determinant: see epitope.
Autophagosomes: vesicles which store structures the cell has targeted for destruction
through autophagy, (a cellular degradation pathway for the removal of damaged, or super-
fluous, proteins and cell subunits).
Biclustering: simultaneous clustering of both genes and conditions.
Carboxypeptidases: enzymes which hydrolyzes the carboxy-terminal, (C-terminal),
end of a peptide bond. They have diverse functions, (e.g. catabolism, protein maturation).
Chemokines: family of small cytokines. They induce directed chemotaxis, (innate
movement), in nearby cells, hence their name.
Chromosomes: complex combination, called chromatin, of DNA and proteins, which
store all genomic information. Major proteins involved are histones. Nine histones combine
to form a nucleosome. The characteristic structure of a nucleosome is that of four pairs of
histones forming a core around which about 146 base pairs of DNA is wrapped. This is
maintained in place by a linker histone, H1, and repeats over the chromatin every 200 base
pairs. The remaining 50 base pair of this repeating unit consists of “linker DNA”.
Clustering: grouping of genes, based on their expression under multiple conditions (or
over different time-points) or, conversely, grouping of conditions according to expression
of several genes.
CpG dinucleotide: a cytosine followed by a guanine in the DNA sequence.
CpG islands: areas with higher proportion of CpG, and formally defined as follows: (i)
Length of the considered region is at least 200 base pairs; (ii) GC percentage is greater than
50%, (i.e. more than half of amino-acids are cytosine or guanine); (iii) Observed/expected
CpG ratio that is greater than 60%. In humans, these islands are found in or near to 70% of
gene promoters.
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Cytokines: a category of diverse signalling proteins and glycoproteins, which are es-
sential to cellular communication. Other categories of signalling proteins include hormones
and neurotransmitters.
DNA methylation: addition of a methyl group to a DNA strand. In humans, only
1% of DNA bases undergo DNA methylation. In differentiated cells, DNA methylation is
typically limited to CpG dinucleotides. Non-CpG methylation can be found in embryonic
stem cells. Of particular interest are CpG islands. While most CpG are methylated over
the genome, these regions have a very distinct pattern: methylation of a CpG island cor-
responds to silencing of the associated gene. Aberrant changes in CpG island methylation
are, therefore, linked with abnormal gene expression.
DNA methyltransferases: enzymes controlling DNA methylation, (e.g. Dnmt1, Dnmt3a
and Dnmt3b in mammals).
Dynamic model: conceptual model which describes the states, transitions, events, ac-
tions, activities and interactions of the system structures, which characterise system be-
haviour.
Enzymes: molecules which increase the rates of chemical reactions. This is referred to
as a catalytic action.
Epigenetics: study of the heritable changes in gene function that may occur without a
change in the DNA sequence. These changes include, for instance, DNA methylation and
histone modifications.
Epitope: a protein site which is recognised by the immune system, (specifically by an-
tibodies, B cells, or T cells). For simplicity, an epitope can be considered as a 3D surface
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features of a molecule. These “shapes” fit precisely and thus bind to specific antibodies.
Epitopes are also known as antigenic determinant.
FLOPS: FLoating Operations Per Second.
Foamy viruses: see spumaviruses.
Functional model: conceptual model which describes data flow during system activity,
both within and between components.
Gene: basic biological unit of heredity, composed of DNA, (or RNA, for some viruses).
They are responsible for the encoding of all biological functions. The total set of genes in
an organism is known as its genome.
Gene expression: genes have specific functions. Even though each cell contains the
whole genetic material, it only uses a fraction of this. The others are silenced. These
complex dynamics are time dependent and cell-type dependent, and are referred to as gene
expression.
Genome: the genome of any living organism is its whole hereditary information. It is
encoded in the DNA or, for some viruses such as HIV, the RNA.
Hamming distance: for two strings of equal length, minimum number of substitutions
required to change one into the other.
Hemocytoblasts: precursors of lymphoblasts.
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Histones: see chromosomes.
Histone modification: epigenetic change characterised by the addition, (or removal),
of a functional group, (methyl, acetyl, etc.), to specific amino acids of histone proteins.
Modifications can occur on tails of histones H3 and H4, and in the core of H2A and H3.
Some amino-acids can undergo several successive modifications. Lysine 79 of histone H3
can, for instance, be mono-, di-, or trimethylated. The role of the changes is modification-
specific and molecule-specific.
HIV: Human Immunodeficiency Virus. Retrovirus targeting immune cells and using
them as hosts. This results in massive depletion of immune cell populations. Infection pro-
gression is typically divided in three phases, ending with AIDS.
Innate immune response: a non-specific, or innate, response is based upon recogni-
tion of the pattern of the microbial surface components of the pathogens, rather than by a
specific antigenic sequence. Innate response does not confer long-lasting immunity to the
host, i.e. there is no memory of previous responses.
Lamina propria mucosae: “the mucosa’s own special layer”, in Latin. A thin layer of
tissue which, together with the epithelium, constitutes the mucosa. It is often referred to as
lamina propria.
Lentiviruses: cytopathogens, responsible for slow-progression infections, (hence their
name).
Long-term nonprogressors: individuals who have been living with HIV for over 10
years (there is no agreed time span, but authors generally use 10 to 12 years as a threshold),
have stable CD4+ counts of 600 or more cells per cubic millimeter of blood, show no sign
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of HIV-related diseases, and have not received any antiretroviral therapy.
LTR: long terminal repeat are characteristic of viral genetic material. They ank func-
tional genes, and their main function is to mediate integration of the retroviral DNA into
host chromosome. The ve prime, (5), end refers to the end of the DNA, (or RNA), strand
that has the fth carbon in the sugar-ring of the (deoxy)ribose at its terminus, (as opposed
to the 3 end, which is terminating at the hydroxyl (-OH) group of the third carbon in the
sugar-ring, and is also known as the tail end.
Lymphoblasts: immature immune cells, formed in the bone marrow, by differentiation,
from precursor hemocytoblasts. These are immature cells, from which prolymphocytes, di-
rect precursors of lymphocytes, are derived.
Lymphopoiesis: generation of lymphocytes. Details of cells and precursors can be
found in the glossary.
Macrophages: a type of white blood cell that ingests foreign material. In that sense,
they are involved in the non-specific immune response. They are also involved in the spe-
cific immune response: they carry the antigen on their surface and present it to T cells.
Microarray: technology used for large-scale transcriptional profiling, through mea-
surement of expression levels of thousands of genes at the same time and under several
experimental conditions, (or different time points).
Mitochondria: membrane-enclosed specialized subunits found in most eukaryotic cells.
They produce adenosine triphosphate, (ATP), which the cells use as a source of chemical
energy.
207
MPI: Message-Passing Interface, a communications protocol used for parallel imple-
mentation of programs. MPI provides support for point-to-point and collective commu-
nications, inquiry routines to query the execution environment, as well as constants and
data-types.
Multi-agent system: see agent-based model.
Neonate: a human infant less than four weeks old.
Non-specific immune response: see innate immune response.
Nucleosomes: see chromosomes.
Object model: conceptual model which gathers all details on objects within the sys-
tem, describes their structure, their relations and the operations they support.
Oncoviruses: the largest sub-family of retroviruses. They can induce several types of
tumours, e.g carcinoma, lymphoma and leukemia. They have been isolated in humans as
soon as early 1980s.
Pathogen: a biological agent which causes disease or illness to its host.
Prolymphocyte: immature immune cells, obtained from lymphoblasts. The last devel-
opment step in lymphopoiesis, from prolymphocyte to lymphocyte, can take place in two
different locations, which will decide the final role of the cells: the prolymphocytes matur-
ing in the bone marrow itself become B lymphocytes, while those maturing in the thymus
become T lymphocytes.
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Rapid progressors: individuals who progress to AIDS within four years of HIV infec-
tion.
Reverse transcriptase: enzyme which transcribes single-stranded RNA into double-
stranded DNA. This process is the reverse of the normal transcription, which corresponds
to the synthesis of RNA from DNA. These enzymes are also known as RNA-dependent
DNA polymerases.
RNA-dependent DNA polymerase: see reverse transcriptase.
Specific immune response: see adaptive immune response.
Spumaviruses: non-pathogens viruses, also known as foamy viruses. They are mainly
prevalent in non-human primates, and were first described in the early 1950s. They are
easily isolated, thanks to the characteristic foam-like effect they induce.
209
